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List of abbreviations 
 
ABS  automated blood sampling
ACTH  adrenocorticotropic hormone
ADX  adrenalectomy
ANS  autonomous nervous system
AVP  arginine vasopressin
ChIP  chromatin immunoprecipitation
CNS  central nervous system
CORT  corticosterone
CRH  corticotrophin releasing hormone
Dex  dexamethasone
DG  dentate gyrus
GH  growth hormone
GnRH  gonadotrophin-releasing hormone
GR  glucocorticoid receptor
GRE  glucocorticoid response element
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MR  mineralocorticoid receptor






Everything has rhythm, hormones are no exception. Rapid oscillations in steroid levels are a 
ubiquitous phenomenon in hormonal systems and are not restricted to glucocorticoids. For 
instance, highly fluctuating levels of  gonadotrophin-releasing hormone, growth hormone 
and insulin have been described previously. Furthermore, frequency encoding via circulating 
hormones as intracellular signals is a well accepted method of  communication within mam-
malian systems. Accordingly, these ultradian hormone patterns are tightly controlled and 
are consequently required for appropriate action of  receptors and target tissue sensitivity. 
However, dysregulation of  the secretory pattern of  single hormones in disease states and 
subsequently the underlying signalling mechanism, is well defined in most cases.
Pronounced ultradian and circadian rhythms in the hormones of  the hypothalamic-pi-
tuitary-adrenal (HPA) axis (i.e. glucocorticoids), one of  the body’s major neuroendocrine 
axes, were already demonstrated several decades ago. Until now, the clinical relevance of  
the pulsatile nature of  glucocorticoids was poorly understood or sometimes even regarded 
as not important. Its evolutionary conservation across many species however implies bio-
logical significance. Indeed, glucocorticoids have been proven to be crucial for a plethora 
of  bodily functions, for example emotion, cognition and the central mechanism underlying 
the adaptation to stress. Furthermore, disturbances in the characteristic temporal pattern of  
glucocorticoid exposure have often been described in stress-related pathology. However, 
the significance of  glucocorticoids secretory patterns for physiology, stress responsiveness 
and nuclear receptor signalling is still largely unexplored. As such, this thesis will discuss 








    




1.1 Pulsatile patterns of  glucocorticoid release
1.2 Glucocorticoid pulsatile patterns and stress responsiveness
1.3 Changes in glucocorticoid pulsatile patterns
1.4 Coordination of  glucocorticoid pulsatile patterns
1.5 Glucocorticoid pulsatile patterns and corticosteroid receptors
1.6 Significance of  glucocorticoid pulsatility
1.7 Scope of  the thesis
 
13
1.1 Pulsatile patterns of glucocorticoid release 
 
The hypothalamic-pituitary-adrenal (HPA) axis is one of  the major neuroendocrine axes of  
the body as it controls a plethora of  functions in the brain and periphery via its end secre-
tory product, the glucocorticoids [Box 1; (Fig. 1)]. Stress, either physical or psychological, 
rapidly triggers alterations in physiological states. Consequently, an acute elevation in glu-
cocorticoids (cortisol in humans, corticosterone in rodents) facilitates prompt restoration 
of  homeostasis in anticipation of  new events. This occurs in part via negative feedback 
regulation of  glucocorticoids indicating that these hormones are essential in the adaptation 
to stress (de Kloet et al. 2005, McEwen 2007). 
The actions of  glucocorticoids are mediated via two steroid hormone receptors, the mine-
ralocorticoid and glucocorticoid receptor (MR and GR) that together maintain HPA axis 
activity [Box 2; (Reul & de Kloet 1985)]. While MR is considered to regulate tonic HPA axis 
activity and the threshold of  the system to stress (‘proactive’ mode), GR promotes recovery 
from stress [‘reactive’ mode; (De Kloet et al. 1998)]. The receptor mechanisms and their 
relation to glucocorticoid pulsatility are extensively discussed later in this chapter. In short, 
glucocorticoids are considered to enable an individual to respond and adapt to a certain 
stressor and prepare for a subsequent event via permissive, suppressive and preparative 
steroid actions (Sapolsky et al. 2000).
 Circadian rhythms in HPA axis activity  
The circadian (or diurnal) rhythm (from the Latin circa diem, ‘around a day’), is a roughly 24 
hour-cycle in all bodily processes (i.e. biochemical, physiological, endocrine or behavioural) 
in all organisms including plants, animals, fungi and cyanobacteria (Panda et al. 2002, Rep-
pert & Weaver 2002). These rhythms allow organisms to anticipate and prepare for precise 
and regular environmental changes (i.e. light/dark cycle, seasonal changes) thereby increa-
sing the efficiency in metabolic demand. 
Under basal conditions, there is a pronounced circadian rhythm in HPA axis activity (Veld-
huis et al. 1990, Young et al. 2004). In man, peak levels of  cortisol are observed at the end 
of  the resting period in preparation of  the increased metabolic demands of  the active phase. 
Nocturnal animals such as rodents, peak in corticosterone levels towards the end of  the 
afternoon when the dark cycle begins (Fig. 2). Besides many other processes, lack of  diurnal 
corticosterone variation not only attenuates stress responsiveness (Akana et al. 1992), it 
also changes serotonin receptor 1a functioning (Leitch et al. 2003) and attenuates neuroge-









concentrations are thought to be fundamental for the maintenance of  physiology and well 
being, as deviations from the normal release pattern are considered to enhance vulnerability 
to stress-related disease (Young et al. 2004, de Kloet et al. 2005, Herbert et al. 2006). 
 
Figure 1 | Schematic representation of  the different components of  the HPA axis. Adapted and modified with 
permission from (Hyman 2009).
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Box 1. The stress response 
Stress is broadly defined as an actual or anticipated (physical or psychological) disrup-
tion of  homeostasis or threat to well-being. It provokes rapid alterations in physiological 
states and the activation of  two systems that together function in a controlled manner 
to rapidly restore homeostasis and balance (de Kloet et al. 2005, McEwen 2007). First, 
the autonomic nervous system (ANS) responds within seconds to disturbances in the 
body via sympathetic and parasympathetic innervations throughout the body. The sym-
pathetic activation primarily increases circulating levels of  adrenalin and noradrenalin in 
blood plasma but also increases heart rate and force of  contraction, peripheral vasocon-
striction and mobilises energy preparing the body for an adequate response to the stres-
sor, hence the ‘fight-or-flight’ response. A few minutes later, activation of  the secondary, 
slightly slower, HPA axis results in acute elevation of  circulating glucocorticoid levels by 
the adrenal cortex (Fig. 1). This occurs via activation of  the parvocellular region of  the 
paraventricular nucleus (PVN) of  the hypothalamus which is a major relay centre for 
processing cognitive and emotional information from limbic areas, but also physical pro-
cesses such as inflammation (Ulrich-Lai & Herman 2009). The neuroendocrine cells in 
the PVN synthesise and secrete the hormones corticotrophin-releasing hormone (CRH) 
and arginine vasopressin (AVP). These peptides are secreted into the hypophysial portal 
vasculature in the external zone of  the median eminence from where they travel through 
the portal system to induce release of  adrenocorticotropic hormone (ACTH) from the 
anterior pituitary gland. Stress-induced ACTH release is primarily triggered by CRH but 
is known to be potentiated by AVP (Gillies et al. 1982, Rivier & Vale 1983). ACTH in turn 
acts on the inner adrenal cortex (zona fasciculata) to initiate the synthesis and release of  
glucocorticoid hormones. 
Glucocorticoids have many important functions including regulation of  glucose, fat and 
protein metabolism, anti-inflammatory actions and can affect mood and cognitive func-
tions (De Kloet et al. 1998, Dallman et al. 2003). As mentioned above, these hormones 
are also implicated in the regulation of  the primary response to stress. Accordingly during 
stress, glucocorticoids feedback to different areas in the brain and pituitary via an inhi-
bitory negative feedback loop (Fig. 1). This rapidly shuts down the stress response by 
tightly controlling the degree and duration of  stress-induced ACTH and corticosterone 
responses thereby restoring homeostasis (Dallman et al. 1987, Dallman 2005). Via this 
mechanism, glucocorticoids also maintain physiology under normal basal conditions by 
feedback on the pituitary gland to inhibit further hormone release (Jones et al. 1977, Dall-
man et al. 1987, Watts 2005). Negative feedback inhibition is therefore suggested to be 









 Ultradian corticosterone rhythms   
The development of  high frequency (automated) sampling paradigms, intra-tissue mi-
crodialysis in non-stressed conditions and statistical algorhythms has greatly facilitated 
the knowledge on glucocorticoid rhythms. It especially led to the discovery that circadian 
release of  glucocorticoids in fact consists of  more frequently released hormone bursts 
reflected in blood plasma as a distinct ultradian rhythm (< 24 hours), previously regarded as 
‘experimental noise’ (Fig. 2). Ultradian glucocorticoid hormone pulses are characteristically 
released with a periodicity of  approximately 60 min in blood plasma and have been descri-
bed in numerous species including rat (Jasper & Engeland 1991, Windle et al. 1998b), rhesus 
monkey (Holaday et al. 1977, Tapp et al. 1984), sheep (Cook 2001) and humans (Weitzman 
et al. 1971, Lewis et al. 2005, Henley et al. 2009). 
The secretory pattern of  glucocorticoids is also maintained across the blood-brain-barrier 
in the extracellular fluid suggesting that target tissues such as the brain (but also the recep-
tors located there) are exposed to rapidly fluctuating steroid levels (Cook 2001, Droste et al. 
2008). Ultradian pulses increase in amplitude and to a lesser extent in frequency, according 
the time of  day due to increased adrenal sensitivity to ACTH (Ulrich-Lai et al. 2006) and 
increased CRH drive (Walker et al. 2010), resulting in a circadian profile of  hormone release 
(Fig. 2). Superimposed on these rhythms is the central nervous system (CNS) mediated 
glucocorticoid response to a stressor. 
 Ultradian rhythms in other hormonal systems
 
Rapid oscillations in hormone levels seem to be a ubiquitous phenomenon in hormonal 
systems and are not restricted to glucocorticoids. For instance, highly dynamic secretory 
patterns have been described for gonadotrophin-releasing hormone [GnRH; (Belchetz et al. 
1978, Rothman & Wierman 2007)], luteinising hormone [LH; (Knobil et al. 1980)], growth 
hormone [GH; (Waxman et al. 1995)], noradrenalin (Tapp et al. 1981) and insulin (Matthews 
et al. 1983). These pulsatile patterns are considered biologically significant: they are highly 
conserved during evolution and across species and are required for appropriate actions of  
receptors and target tissues (Hauffa 2001). For instance, rapidly fluctuating levels of  GH eli-
cit significant sexual dimorphic effects on gene expression (Waxman et al. 1995). Similarly, 
modulation of  episodic release of  GnRH influences the secretory patterns of  LH and FSH 
and prevents receptor desensitisation (Belchetz et al. 1978, Wildt et al. 1981). Furthermore, 
intermittent, in contrast to continuous administration of  parathyroid hormone is beneficial 
for bone formation (Schmitt et al. 2000), while continuous GH administration attenuates 
growth (Gevers et al. 1996). Also, insulin in men is more efficient when delivered in a phasic, 
rather than tonic fashion (Matthews et al. 1983). Therefore, it is generally believed that rapid 
oscillations in hormone presentation not only exist to maintain receptor responsiveness in 
target tissues as it will otherwise desensitise/down-regulate with tonic exposure, hormonal 
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actions also seem more efficient when delivered in a pulsatile manner (Hauffa 2001). With 
respect to glucocorticoid biology it is however currently not known what (and how) ultra-
dian hormone signalling contributes to physiology and nuclear receptor functioning.
Figure 2 | Ultradian (smooth line) and circadian rhythm (dotted line) of  corticosterone under basal conditions 
in a male Sprague-Dawley rat. Representative individual 19-h profile of  corticosterone in blood plasma automati-
cally collected every 10 minutes between 13.00 and 05.00 and every 20 minutes between 10.00 – 13.00. The grey 
area indicates the dark period of  the light/dark cycle.
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Box 2. Mineralocorticoid and glucocorticoid receptors 
The actions of  glucocorticoids are exerted by the corticosteroid receptors that reside in target tis-
sues: mineralocorticoid and glucocorticoid receptors, MR and GR respectively. GR is ubiquitously 
expressed in the brain and periphery while MR localisation is more restricted to the hippocampus, 
prefrontal cortex and amygdala, structures essential for learning, memory formation and emotional 
behaviour (van Eekelen et al. 1987, Arriza et al. 1988, Ahima & Harlan 1990). Both receptors colo-
calise in neurons from several areas including the hippocampus (Han et al. 2005). MR has a 10-fold 
higher affinity for corticosterone (Kd: 0.5 nM) than GR (Kd: 5 nM) which renders the hippocam-
pus responsive to both basal and stress-induced elevations of  corticosterone. MR is thus extensively 
occupied under basal conditions regulating tonic HPA activity while GR is additionally recruited 
when corticosterone levels rise, such as during stress, the circadian rise in corticosterone (Reul & de 
Kloet 1985, Spencer et al. 1993, De Kloet et al. 1998, Kitchener et al. 2004) and the peak of  hourly 
ultradian pulses (Conway-Campbell et al. 2007, Stavreva et al. 2009). 
MR and GR belong to the superfamily of  nuclear receptors (de Kloet 1995, Mangelsdorf  et al. 1995). 
It is currently believed that in their inactive state the receptors reside in the cytoplasm, stabilised 
by chaperone molecules [i.e. heat shock proteins and immunophilins (Wochnik et al. 2005, Nishi & 
Kawata 2006, Picard 2006)]. Upon glucocorticoid binding, the transport machinery (i.e. importins) is 
recruited which actively translocates the entire complex to the nucleus using the microtubule network 
as a guiding scaffold (Pratt et al. 2004, Fitzsimons et al. 2008). In the nucleus, the receptors function 
as a ligand-activated transcription factors to modulate genomic events via transcription of  gluco-
corticoid target genes. This occurs via transactivation by interacting directly with the chromatin of  
glucocorticoid-responsive promoter regions and subsequent recruitment of  coactivators or via trans-
repression by protein-protein interactions with other transcription factors and corepressors (Datson 
et al. 2008, van der Laan & Meijer 2008). 
Besides the classical nuclear receptors, accumulating anatomical and electrophysiological data have 
described membrane-bound variants of  MR and GR (Orchinik et al. 1991, Di et al. 2003, Johnson 
et al. 2005, Karst et al. 2005), suggested to mediate rapid non-genomic glucocorticoids effects via 
second messenger pathways. Recently, it was discovered that non-genomic MR in limbic structures 
enhances the presynaptic glutamate release probability and reduces postsynaptic hyperpolarisation 
via the ERK1/2 pathway and K+-conductance with the net result to enhance excitatory transmission 
(Karst et al. 2005, Olijslagers et al. 2008). On the other hand in the PVN, non-genomic GR reduces 
net neuronal excitatory transmission via endocannabinoids and nitric oxide (Di et al. 2003, Di et al. 
2009). At least for membrane MR it is known that it requires stress-induced levels of  corticosterone 
as its affinity is much lower than that of  the nuclear MR. This receptor is thus implicated in the onset 
of  stress while the reaction is contained by genomic GR–mediated events. It is therefore currently 
believed that the nuclear and membrane-bound variants of  MR and GR act together to maintain basal 
and stress-induced HPA axis activity.
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1.2 Glucocorticoid pulsatile patterns and stress responsiveness
 
Abolishing diurnal corticosterone rhythms alters HPA axis responsiveness to stress (Dall-
man et al. 1987, Jacobson et al. 1988, Akana et al. 1992). The interaction of  glucocorticoid 
ultradian patterns and stress responsiveness is however not very clear. The application of  
high frequency blood sampling has greatly added to the understanding of  this relationship. 
Post-hoc analysis of  hormone profiles of  rats exposed to noise stress indicated that animals 
only responded with increased corticosterone when the stress coincided with an ascending 
phase of  an ultradian pulse (Fig. 3). Stress during a falling phase, however, did not result in a 
significant corticosterone response [hyporesponsiveness; (Windle et al. 1998b)]. The under-
lying mechanism is not yet clear and either a facilitated stress response during the ascending 
phase and/or an inhibitory effect during the descending phase have been suggested. Ir-
respectively, it is evident that the onset of  a stressor in relation to the phase of  an ultradian 
pulse can determine the physiological response to stress. Similarly, the propensity to behave 
aggressively is increased during the ascending phase of  an ultradian corticosterone pulse 
(Haller et al. 2000b). Furthermore, pulse amplitude and frequency seem to be major deter-
minants in the outcome of  acute HPA axis reactivity with reduced corticosterone responses 
with increased pulse amplitude and frequency (Windle et al. 2001, Atkinson et al. 2006). 
These observations explain for a part the inter-individual variation in responsiveness to a 
stimulus that is normally observed in stress experiments but also emphasises the fact that 
acute HPA axis reactivity heavily depends on the individual pulse characteristics that make 
up the ultradian pattern.
The concept of  ultradian pulses being associated with stress responsiveness is reminiscent 
of  the earlier concept of  rate sensitive feedback. In this respect, several studies showed fast 
negative feedback inhibition only to be present during the brief  interval (i.e. first 2-5 min) 
when plasma corticosterone levels are rapidly rising (e.g. as occurs during stress) and disap-
pears when it has reached a plateau or when infusion is stopped (Dallman & Yates 1969, Jo-
nes & Neame 1971). It has been hypothesised that in the context of  ultradian glucocorticoid 
pulses, the secretory phase of  each ultradian surge could also induce rapid negative feed-
back inhibition generated by the acute rise in glucocorticoid levels consequently resulting 
in inhibition during the descending phase. Hence, the concept of  rapidly alternating phases 
of  HPA axis activation and inhibition which could determine the outcome of  stress res-
ponsiveness depending on the ‘state’ of  the HPA axis (Windle et al. 1998b, Lightman et al. 
2008). In addition, the magnitude of  the stress effect is not only influenced by the phase of  
ultradian pulses, but also seems to depend on the rate of  rise of  hormone concentration (i.e. 
for a peak of  given duration: amplitude height), with increasing negative feedback inhibition 
with increasing corticosterone infusion rate (Dallman & Yates 1969, Kaneko & Hiroshige 








that in both basal and stress-induced circumstances, negative feedback interacts in a rate-
sensitive manner with the different phases and the amplitude of  individual ultradian pulses 
thereby determining the outcome of  stress responsiveness.
 
Figure 3 | The effect of  noise stress (10 min of  114 dB, broken line) on plasma corticosterone concentrations 
in female Sprague Dawley rats when the stress coincided with a rising (left) or falling phase (right) of  a basal cor-
ticosterone pulse. *** p < 0.05 vs falling group. Adapted and modified from (Windle et al. 1998b).
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1.3 Changes in glucocorticoid pulsatile patterns 
 
While the generation and coordination of  ultradian glucocorticoid pulses is an ongoing dis-
cussion, it is clear that secretory corticosteroid patterns can be highly variable between and 
within individuals. For instance in rodents, changes in the pattern of  ultradian pulsatility are 
often seen in physiology during normal transitions throughout the lifespan (Fig. 4). Lacta-
tion increases pulse amplitude while during ageing the hourly pattern becomes disorganised 
(Lightman 1992, Young et al. 2004, Lightman 2008). Sexual diergism in corticosterone pul-
satile characteristics is also evident (Fig. 4A), and is mainly attributed to gonadal steroids as 
hormone replacement after gonadectomy reverses hypersecretion in males and hyposecre-
tion in females (Seale et al. 2004a, Seale et al. 2004b). Also, clear genetic influences in pulse 
characteristics are reflected in different strains of  rat (Lewis and Fischer rats) that differ in 
stress responsiveness and their susceptibility to autoimmune disease (Windle et al. 1998a). 
Overall, the studies described above strongly suggest that ultradian glucocorticoid patterns 
can be remarkably variable depending on the physiological state or genetic background.
Alterations in glucocorticoid pulsatile patterns are, however, also associated with stress-re-
lated disorders. In humans, depression is associated with enhanced pulse magnitude thereby 
abolishing circadian variation in pulse amplitude, resulting in dramatically changed patterns 
of  hormone exposure to tissue (Deuschle et al. 1997, Holsboer 2000, Young et al. 2004). In 
Cushing’s syndrome, the normal variation of  cortisol is dampened or completely abolished 
due to elevations in cortisol levels in the quiescent period [Fig. 4C; (Boyar et al. 1979, van 
Aken et al. 2005)]. Other disorders like Parkinson’s and Huntington’s disease but also panic 
disorders in humans (Abelson & Curtis 1996, Hartmann et al. 1997, Aziz et al. 2009) and 
inflammation and early life stress in rodents (Harbuz et al. 1999, Shanks et al. 2000, Windle 
et al. 2001) are characterised by alterations in pulse characteristics (Fig. 4B). Currently it 
is not known whether the disorganisation in pulsatile patterns is causal to the disorder or 
vice versa. It may however be hypothesised that deviations from the optimal ultradian pat-
tern could precipitate disease as daily variations in glucocorticoid hormone concentrations 
are thought to be fundamental for the maintenance of  physiology, and overall metabolic, 
cognitive and behavioural well being (Dallman et al. 2003, Young et al. 2004, de Kloet et al. 
2005, Herbert et al. 2006). Even so and as described in this chapter, the functional contri-
bution of  ultradian glucocorticoid pulses to HPA axis activity, stress responsiveness and the 









Figure 4 |  Examples of  differences in ultradian corticosteroid rhythms in A | female and male Wistar rats, 
B | adjuvant-induced arthritis after 13 days in rats compared to controls and C | unilateral adenoma in Cushing’s 
syndrome. Data taken from (Windle et al. 2001, Seale et al. 2004a, van Aken et al. 2005). The dark phase of  the
cycle is shown by the filled bar.
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1.4 Coordination of glucocorticoid pulsatile patterns
  
 The suprachiasmatic nucleus  
In mammals, the suprachiasmatic nucleus (SCN; also known as the biological clock) is the 
principal pacemaker in the coordination and generation of  physiological circadian rhythms. 
The rodent SCN consists of  approximately 16.000 neurons located in two clusters in the 
anterior hypothalamus in the brain (Van den Pol 1980). It is entrained by light as it receives 
input from the retina via the retinohypothalamic tract consisting of  photoreceptive ganglion 
cells specialised in luminance coding. Photic cues conveyed to the SCN by this tract ensure 
that internal circadian time is entrained by solar time as it temporally adapts cycles in physio-
logy and metabolism (Berson et al. 2002). Internal time sometimes gets disorganised when 
it loses synchronisation with external day/night cycles as for instance occurs with a jet-lag 
or during sleep disorders (Hastings et al. 2003, Maywood et al. 2006).
Circadian timing is an intrinsic property of  individual SCN cells as isolated SCN cells in 
culture continue to exhibit spontaneous circadian electric and metabolic rhythms (Welsh 
et al. 1995). GABA acts as one of  the primary synchronising signals among SCN neurons 
but other signals (i.e. AVP and vasoactive intestinal polypeptide) have also been described 
(Liu & Reppert 2000, Maywood et al. 2006). Knowledge about the genes that encode the in-
tracellular mechanism that underlies circadian timing comes mostly from genetic screening 
studies in Drosophila while mammalian homologues have been found and cloned recently 
(Reppert & Weaver 2002). Progress in this field has been exponential, but simplistically, the 
core elements are timekeeping genes which function as transcription factors such as Period, 
Clock and Crytochrome. The expression of  these genes are periodically switched on and 
off  by posttranslational modifications in interacting autoregulatory positive and negative 
feedback loops with a periodicity of  approximately 24 hours. Accordingly, waves of  trans-
cription and translation of  key clock components ultimately drive and determine rhythmic 
properties of  SCN neurons (i.e. firing rate, neurosecretion and membrane potential; (Panda 
et al. 2002, Hastings et al. 2003). 
The SCN carries circadian outflow to local clocks in neural or peripheral targets via light 
entrainment, sympathetic nervous system projections, food intake, body temperature but 
also chemical and hormonal cues (Hastings et al. 2003, Cuninkova & Brown 2008). The 
SCN thus functions as the master clock and coordinates a plethora of  peripheral ‘slave’ os-
cillators. Though some intrinsic autonomous components exist, this result in local rhythmic 
expression of  clock genes in almost all bodily tissues, ensuring temporal integration and 
regulation of  local physiological rhythms across an organism (Cuninkova & Brown 2008). 
How molecular transcriptional oscillations exactly control rhythmic neurotransmitter and 








becoming clear (Vansteensel et al. 2008, Houben et al. 2009). A salient detail is that gluco-
corticoids and the GR have been implicated in the rhythmic control of  some clock genes 
such as Per1 and Per2 and in fact seem selectively required for some glucocorticoid functi-
ons such as glucose homeostasis (Balsalobre et al. 2000, So et al. 2009). 
 Generation of  glucocorticoid circadian rhythms 
The HPA axis is one of  the major input targets of  the SCN, regulated via a network of  
complex neuronal pathways which has been subject to many anatomical studies (Swanson 
& Cowan 1975, Van den Pol 1980, Kalsbeek & Buijs 2002). The majority of  projections 
remain confined within the boundaries of  the medial hypothalamus targeting the medial 
preoptic area, the PVN, the subPVN and the dorsomedial nucleus of  the hypothalamus. 
Increasing glucocorticoid levels during the circadian peak are thought to arise from incre-
ased drive from the SCN, most likely due to a number of  different mechanisms. One major 
group of  SCN target neurons comprise the CRH (but also TRH and GnRH) containing 
endocrine cells. Basal activity in corticosterone during the circadian trough is maintained by 
constitutive autonomous secretion of  CRH while increased release in the evening requires 
active stimulation of  afferents that project from the SCN to the PVN and median eminence 
(Kaneko et al. 1980, Engeland & Arnhold 2005). Circadian variation in corticosterone is 
considered to be driven almost exclusively by rhythmic secretion of  CRH, but not so much 
ACTH as corticosterone rhythms persist in absence of  ACTH cycling (Watts 2005, Ulrich-
Lai et al. 2006). Alternative pathways implicate the autonomous nervous system in circadian 
control of  corticosterone via 1) SCN-mediated activation of  excitatory splanchnic nerve 
innervation and 2) adrenal gland sensitivity to ACTH (Jasper & Engeland 1994, Oster et al. 
2006, Ulrich-Lai et al. 2006, Dickmeis 2009). Both consequently result in larger corticoste-
rone bursts in the evening in rodents.
 Generation of  glucocorticoid ultradian rhythms 
The mechanism and location of  the ultradian pulse generator are however less clear. From 
lesion studies it is known that the SCN does not control ultradian corticosterone release as 
these rhythms persist in blood plasma after ablation of  the nucleus (Watanabe & Hiroshige 
1981, Buijs et al. 1993). In that respect, ultradian CRH continues to be rhythmically released 
from isolated macaque hypothalami and rat median eminence, suggesting that generation 
of  rapid phasic CRH pulses is an intrinsic property of  the hypothalamus (Ixart et al. 1987, 
Mershon et al. 1992). However, the underlying mechanisms are not yet clear. Oscillators in 
the adrenal gland itself  have also been identified recently suggesting intrinsic generation 
and/or modification of  pulsatile corticosterone patterns (Oster et al. 2006, Son et al. 2008). 
In addition, the adrenal gland is extensively innervated by autonomous nerve fibers such as 
the splanchnic nerve exerting inhibitory control resulting in very low circulating corticoste-
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rone levels during the circadian trough (Jasper & Engeland 1994). Alternatively, inhibitory 
ultra short feedback is suggested to control the rapid increase and decrease in corticoste-
rone levels thereby generating oscillations in steroid levels (Windle et al. 1998b, Lightman 
et al. 2008). In fact, theoretical modelling has recently demonstrated that a combination of  
delay and feedforward and feedback loops in HPA axis activity creates episodic feedback 
signals at the level of  the pituitary gland that is necessary to maintain feedforward-feedback 
oscillatory activity between the pituitary and adrenal gland, hence creating self-sustaining 
ultradian oscillations in glucocorticoid secretion (Walker et al. 2010). 
 
1.5 Glucocorticoid pulsatile patterns and corticosteroid receptors
 
As outlined in the previous paragraphs, the contribution of  ultradian glucocorticoid pulses 
to physiology but also nuclear receptor functioning is not well understood and must there-
fore be thoroughly addressed. It is known that MR in the brain is activated throughout the 
entire 24-h cycle (Reul & de Kloet 1985, Spencer et al. 1993, Bradbury et al. 1994). GR, 
on the other hand, is additionally recruited when corticosterone levels rise as its nuclear 
retention varies according to circadian fluctuations in corticosterone levels, but also during 
stress (Reul & de Kloet 1985, Kitchener et al. 2004). Moreover, repeated rapid nuclear trans-
location of  hippocampal GR following intravenous corticosterone injections mimicking 
ultradian pulses was demonstrated in rats while MR was continuously retained in the nu-
cleus (Conway-Campbell et al. 2007). More importantly, these studies imply that long- term 
disturbances in ultradian glucocorticoid pulsatility would thus mainly affect GR, rather than 
MR. Therefore, the classical nuclear variants of  MR and GR are distinctively differently 
occupied and activated depending on the pattern of  glucocorticoid exposure which hypo-
thetically could lead to differential regulation of  glucocorticoid target genes. Currently it is 
not known how ultradian glucocorticoid fluctuations affect the membrane-bound variants 
of  MR and GR. It may be hypothesised however that in view of  the rapid non-genomic 
actions of  glucocorticoids together with the slower genomic effects, the relative balance 
of  glucocorticoid action via membrane-bound and nuclear variants of  MR and GR in the 
brain could rapidly change over the duration of  a single ultradian pulse due to fast changes 
in concentrations of  available ligand (Young et al. 2004, Joels et al. 2008a). 
 Intracellular  dynamics of  corticosteroids receptors 
While most studies have looked at gene regulation after long term stimulation by glucocorti-
coids, accumulating evidence indicates that the nuclear receptor mechanism is not the static 
process as previously considered but is in fact highly dynamic. Intra-tissue microdialysis 








levels resulting in a highly dynamic environment for nuclear receptors (Cook 2001, Droste 
et al. 2008). Using photobleaching techniques in living cells it was first discovered that GR 
rapidly exchanges at regulatory sites in the genome in a ligand and ATP-dependent manner 
(McNally et al. 2000, Stavreva et al. 2004). More fundamentally, GR only responds in an ul-
tradian manner to natural glucocorticoids and not synthetic ligands such as dexamethasone. 
This results in consecutive ultradian waves of  receptor nuclear translocation and GR occu-
pancy of  GREs [Fig. 5, (Stavreva et al. 2009)]. Moreover, the dynamic promoter occupancy 
of  glucocorticoid target genes coincides with oscillations in the ‘chaperone protein cycle’, as 
well as RNA Polymerase II loading and exchange, which fluctuate according to the changes 
in the extracellular hormone concentrations. Consequently, this results in ‘gene-pulsing’ of  
transcriptional patterns of  nascent RNA [Fig 5, (Stavreva et al. 2009)]. 
 
Figure 5 | Simplified coupling of  ultradian hormone secretion to GR-driven transcriptional cycling. A | Ultradian 
hormone pulsing by the adrenal glands generates successive high and low levels of  circulating glucocorticoids (black 
dots) which enter the cells. B | In the presence of  hormone, the GR with its chaperones (green crescent, HSP90/p23 
complexes; blue half-ring, HSP70 complex) binds the hormone and translocates into the nucleus. C | Chaperones 
cycle within the nucleus, which accompanies the fast dissociation and reassociation of  hormone with GR. D | The 
association and dissociation of  the hormone-bound GR with DNA, to which chaperones also contribute. The trans-
criptionally active cycle of  DNA-bound GR is permitted by the recruitment of  cofactors (light blue boxes) driving 
the activity of  the RNA Polymerase II (Pol II, dark blue box). Hormone pulses result in similar pulses in transcrip-
tional activity, reflected by bursts of  nascent mRNAs. Adapted and modified from (Desvergne & Heligon 2009). 
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Cyclic activity of  other nuclear receptors (i.e. androgen and estrogen receptors, AR and ER 
respectively) has been described before (Kang et al. 2002, Metivier et al. 2003, Reid et al. 
2003). Interestingly, GR cycling is attenuated during constant presence of  steroid hormone 
while AR and ER continue to oscillate. This suggests that receptor cycling is an intrinsic 
property of  AR and ER while GR oscillatory action is actively externally driven by hormone 
bursts of  the adrenal gland (Jasper & Engeland 1991). At the moment, there is relatively 
little information available on how physiological relevant levels of  glucocorticoid pulses af-
fect MR and GR in target tissues in vivo and specifically in the brain. This not only has im-
portant implications for glucocorticoid biology but could also add to our understanding of  
nuclear receptor functioning. Furthermore as described in the previous paragraphs, episodic 
release of  for instance GnRH and GH prevent receptor desensitisation and maintains target 
tissue responsiveness. In conclusion, it has been proposed that pulsatile glucocorticoid re-
lease coordinates dynamic receptor interactions necessary for transcriptional programming 
(Lightman et al. 2008, Desvergne & Heligon 2009, Stavreva et al. 2009). By rapidly sensing 
changes in the local ligand environment, GR is crucial in propagating biologically appropri-
ate actions. 
 
1.6 Significance of glucocorticoid pulsatility
 
The clinical relevance of  the secretory hormone pattern of  for instance GnRH and GH is 
well recognised (Hauffa 2001). These hormones have proven to be successful targets for 
therapeutic purposes. The pulsatile nature of  glucocorticoids is however poorly understood 
or even regarded as not important. As describe in the previous paragraphs, disturbances 
in glucocorticoid rhythms and aberrant HPA axis functioning are well recognised signs in 
patients suffering from stress-related disorders. Furthermore, it has been hypothesised that 
deviations from the optimal glucocorticoid pattern may  precipitate disease as daily variati-
ons in glucocorticoids are fundamental for physiology, but also emotional and cognitive well 
being (Young et al. 2004, de Kloet et al. 2005, Herbert et al. 2006). New insights in glucocor-
ticoid pulsatility could also have important implications for the therapeutic application of  
glucocorticoids based on the temporal aspect of  hormone action. For instance, Addison’s 
patients suffer from sever hypocortisolimia and could greatly benefit from pulsatile admi-
nistration of  these hormones. Transient release patterns of  other hormones are considered 
crucial for physiology and well being (Belchetz et al. 1978, Thompson et al. 2003, Rothman 
& Wierman 2007). Manipulation of  the temporal aspect is already a successfully used ap-
proach in clinical therapy for instance for GH (Amato et al. 2000) and estrogen-replacement 








However, in relation to glucocorticoids, no such administration protocols have been desig-
ned yet. Better understanding of  pulsatile glucocorticoid release and the underlying nuclear 
receptor mechanism in the brain may therefore greatly contribute to the prognosis and 
treatment of  disease, irrespective of  the currently unknown specific causes of  rhythmic 
corticosteroid dysregulation.
1.7 Scope of the thesis
 
As outlined in this chapter, the significance of  glucocorticoid pulsatility and its importance 
for physiology and brain functioning is not yet clear. However, changes in glucocorticoid 
pulsatile rhythms are thought to compromise ‘resilience’ to stress and may be an important 
factor in the aetiology of  stress-related diseases. The overall objective of  this thesis is there-
fore to assess the role of  glucocorticoid pulsatile patterns in brain and pituitary responsive-
ness to stressful challenges. 
Ultradian corticosterone pulsatility is well characterised in the rat and is highly similar to hu-
man ultradian rhythmicity. Therefore in this thesis, we use the rat as a model system to study 
the consequences of  glucocorticoid pulsatility on different levels of  brain functioning. Due 
to the high frequency of  the endogenous ultradian pulses and the lack of  rhythmic synchro-
nisation between animals, it is necessary to control the pattern of  hormone release. Hereto, 
we have surgically or pharmacologically modulated pulsatile variations in corticosterone 
hormone levels. The endogenous corticosterone pulsatile patterns are effectively elimina-
ted, flattened or mimicked by removal of  the adrenal glands [adrenalectomy (ADX)] and/
or corticosterone replacement in the form of  subcutaneous pellet implantation or automa-
ted intravenous infusion. In addition, the knowledge of  pulsatile corticosterone secretion 
is increasing with the use of  high-frequency automated blood sampling (ABS) techniques 
in free-running animals (Windle et al. 1998a, Droste et al. 2008) in conjunction with the 
development of  sophisticated statistical algorithms (Merriam & Wachter 1982). Recently, 
an automated steroid infusion system together with high frequency ABS was developed 
(Lightman et al. 2008). The use of  this highly sophisticated model system puts us in the uni-
que position to tightly control corticosterone infusion in either pulsatile or constant pattern 
under different experimental conditions. 
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The specific aims addressed in this thesis are:
 1) to determine the effect of  disturbances in pulsatile patterns of  corticoste 
      rone on glucocorticoid signalling in the rat hippocampus.
 2) to investigate the implications of  recovery from disturbed corticosterone 
                   pulsatility for behavioural and neuroendocrine stress responsiveness.
 3) to study the stress-induced neuroendocrine and behavioural response to 
            as stressor as a function of  the pattern, amplitude and phase of  ultradian 
                    glucocorticoid pulses.
 Outline of  the thesis and experimental approach 
In order to study receptor nuclear translocation as a marker for glucocorticoid signalling, we 
need to find the most suitable antibody for further studies. In chapter 2 commercially avai-
lable GR primary antibodies are tested in parallel. Here, GR nuclear translocation patterns 
after glucocorticoid treatment are compared between cultured cells and CA1 pyramidal and 
dentate gyrus granule cells of  the rat hippocampus visualised by immunohistochemistry and 
confocal imaging.
The outcome of  chapter 2 is used in chapter 3 to further characterise receptor transloca-
tion in vivo. We test the hypothesis that glucocorticoid hormone stimulation indeed results 
in MR and GR translocation in the rat hippocampus and that this may depend on the hor-
monal background of  the animal. In this study, both intact and ADX rats are injected with 
a dose of  corticosterone mimicking the stress response. Changes in subcellular distribution 
patterns of  MR and GR at different time points after glucocorticoid injection are measured 
in single cells in the different hippocampal subfields visualised by immunohistochemistry 
and confocal imaging. 
In chapter 4 studies are reported exploring long-term disturbances in endogenous corti-
costerone pulsatile patterns for target tissue sensitivity to an additional glucocorticoid chal-
lenge that mimics the stress response. Diurnal and ultradian corticosterone fluctuations are 
clamped at constant levels by administering corticosterone exogenously by means of  sub-
cutaneous corticosterone pellet implantation in intact animals. Additionally, recovery from 
constant exposure is studied in groups that had the pellet removed 24 hours prior to the 
challenge. Molecular markers for MR and GR responsiveness to this acute challenge were 
visualised in the rat hippocampal area by in situ hybridisation and immunohistochemistry. 
Additionally, molecular approaches such as Western Blot and chromatin immunoprecipita-








Extending chapter 4 by using the same experimental paradigm, we investigate and validate 
in chapter 5 the consequences of  subcutaneous corticosterone pellet implantation on en-
dogenous diurnal and ultradian corticosterone rhythmicity. High frequency ABS is used to 
study the effect on corticosterone levels before and after removal of  corticosterone pellet 
implantation. Behavioural and neuroendocrine responsiveness to noise stress is assessed as 
a functional parameter.
In chapter 6 studies are described investigating the significance of  glucocorticoid pulsatility 
for negative feedback, behavioural stress responsiveness and markers for neuronal activa-
tion after stress. In this study, we specifically discriminate between the pattern, phase and 
amplitude of  ultradian pulses in relation to stress. For this purpose ADX rats are automati-
cally infused with either constant or pulsatile corticosterone patterns. Noise stress is applied 
to study stress-induced ACTH responsiveness in automatically collected blood samples via 
the ABS. Expression levels of  CRH, POMC, MR and GR are used as parameters to cha-
racterise long-term changes in HPA axis activity in different areas of  the brain. In addition, 
c-fos mRNA expression and home cage behaviour are analysed as a measure of  acute stress 
responsiveness. 
A general discussion of  the data is presented in chapter 7 and a synopsis of  the major 






    
       
32
33
            Angela Sarabdjitsingh 
            Onno Meijer 
                                                       Ron de Kloet 
Specificity of glucocorticoid receptor primary 
antibodies for analysis of receptor localisation patterns 
in cultured cells and rat hippocampus
Brain Research, in press
34
Abstract
After glucocorticoid stimulation, glucocorticoid receptors (GRs) are translocated to the 
nucleus to modulate transcription of  glucocorticoid target genes. The subcellular distribu-
tion and trafficking of  GR in cultured cells has been studied quite intensively using several 
techniques. However, the intracellular localisation of  nuclear receptors in ligand-free and 
stimulated conditions in vivo is still controversial, in part because of  inconsistent results 
with different antibodies. Knowledge of  trafficking of  GR in vivo could greatly contribute 
to understanding nuclear receptor signalling.
Therefore, in this study we systematically compared a panel of  different primary GR antibo-
dies using immunohistochemistry and confocal imaging. Nuclear translocation patterns at 
different time points after glucocorticoid stimulation were compared in cultured AtT20 cells 
and rat hippocampal CA1 and dentate gyrus cells. The BuGR2 antibody consistently detec-
ted GR nuclear translocation patterns between in vivo and in vitro settings, but the other 
GR primary antibodies provided contradictory results. While GR H300 and P20 strongly 
detected nuclear GR immunoreactivity after glucocorticoid stimulation in both CA1 and 
dentate gyrus cells, the same antibodies provided poor results in cultured cells. The opposite 
was found for the primary GR M20 antibody.
These data indicate that with a particular glucocorticoid receptor antibody the findings in 
cell culture studies cannot always be extrapolated to in vivo situations. Moreover, different 











Glucocorticoids play a pivotal role in the homeostasis of  many biological systems inclu-
ding the stress response, energy metabolism and the immune and inflammatory response 
(de Kloet et al. 2005). Their effects are mediated by two members of  the nuclear receptor 
family, the mineralocorticoid and glucocorticoid receptor [MR and GR; (Reul & de Kloet 
1985, Mangelsdorf  et al. 1995)]. MR has a high affinity for naturally occurring glucocorti-
coids resulting in extensive receptor occupancy, whereas GR has a tenfold lower affinity for 
corticosterone and is therefore only activated during stress and the circadian peak (Reul & 
de Kloet 1985, Spencer et al. 1993, Kitchener et al. 2004, Furay et al. 2008). 
The most common view on GR activation is that the unliganded receptor is part of  a 
chaperone complex consisting of  several proteins such as heat shock protein 90 and im-
munophilins which stabilise the receptor in the cytosol (DeFranco et al. 1998, Wochnik et al. 
2005, Nishi & Kawata 2006, Picard 2006). Upon glucocorticoid binding, the ligand binding 
domain (LBD) of  GR undergoes a major conformational change and dissociates from the 
chaperone proteins. Exposure of  the nuclear localisation signal triggers the recruitment of  
the transport machinery (i.e. importins) which actively translocate the entire complex to the 
nucleus via a microtubule network (Harrell et al. 2004, Pratt et al. 2004, Fitzsimons et al. 
2008). In the nucleus, GR functions as a ligand-activated transcription factor and mediates 
genomic events by modulating the transcription of  glucocorticoid target genes via transac-
tivation and transrepression (Datson et al. 2008, van der Laan & Meijer 2008).
The subcellular distribution and trafficking of  GR in cultured cells has been studied quite in-
tensively using several techniques such as green fluorescent protein (GFP)-tagged receptors, 
fluorescence after photobleaching (FRAP) and immunohistochemistry which have proven 
to be powerful tools for mechanistic assessment of  nuclear receptor signalling (Htun et al. 
1996, Nishi & Kawata 2006, Kawata et al. 2008, Stavreva et al. 2009). In such studies, MR 
and the progesterone receptor are found in both cellular compartments, while estrogen 
receptor-α and -β are thought to be localised predominantly in the nucleus (Fejes-Toth et al. 
1998, Htun et al. 1999, Lim et al. 1999). On the other hand, GR and the androgen receptor 
are considered to reside in the cytoplasm (Htun et al. 1996, Georget et al. 1997), but also this 
has been disputed (Brink et al. 1992). However, there is much controversy about the subcel-
lular distribution patterns of  nuclear receptors in ligand-free conditions in vivo, as practical 
limitations still restrict the use of  GFP-tagged receptors and FRAP in most animal models 
and thus favour the use of  antibodies.
Knowledge of  trafficking of  GR in vivo could greatly contribute to understanding nu-
clear receptor signalling in the context of  target tissues. During the past decades, several 
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GR-specific primary antibodies have become available for immunohistochemical studies. 
However, inconsistency in expression patterns among antibodies is not uncommon and 
has led to controversial results. Only rarely have different primary antibodies been tested in 
single experiments without any other variable parameters. These studies altogether indicate 
the need for more systematic comparison of  different primary GR antibodies. 
In this study we used immunohistochemistry and confocal imaging to screen a panel of  dif-
ferent GR-specific primary antibodies in cultured cells and in rat hippocampus to compare 
nuclear translocation patterns. We found contradictory translocation pattern between the in 
vitro culture and the living hippocampus. The results indicate that findings from cell culture 
studies cannot always be extrapolated to in vivo situations and that the outcome of  a study 
may depend on the choice of  the antibody. 
Experimental procedures
 Cell culture
AtT-20/D-16V mouse tumour cells were grown and maintained in Dulbecco’s modified 
Eagle’s medium (4500 mg/L glucose; Invitrogen, USA) supplemented with 0.5% penicillin/
streptomycin, 10% horse serum, and 10% fetal bovine serum (Invitrogen Life Technologies, 
The Netherlands) in a humidified atmosphere of  5% CO2 at 37 ºC as described previously 
(van der Laan et al. 2008a). A day before stimulation, 1 x 105 cells per chamber were pla-
ted and maintained in Lab-TekTM Permanox Chamber Slides (Nalge Nunc International, 
Belgium) in steroid-free medium. This medium is devoid of  lipophilic components such as 
hormones and consists of  4500 mg/L glucose (Invitrogen, USA) supplemented with 0.5% 
penicillin/streptomycin and 1% stripped foetal bovine serum. The foetal bovine serum 
was stripped by incubating overnight at 4 ˚C with 2% of  dextran-coated charcoal (Sigma-
Aldrich, The Netherlands), spinning down for 5 min at 3000 rpm  and subsequent filtering 
with autoclaved filter tops. The entire procedure was repeated after which the serum was 
aliquoted and stored at -20 ˚C until use.
 Animals 
Adult male Sprague-Dawley rats (± 250 grams) were purchased from Harlan (Leiden, The 
Netherlands) and group housed (4 animals/cage) in rooms on a 12h/12h light/dark cycle 
(lights on at 07:00 h). Food pellets and drinking water were available ad libitum. Experi-
ments were approved by the Local Committee for Animal Health, Ethics and Research of  
the University of  Leiden (DEC nr. 05080). Animal care was conducted in accordance with 
the EC Council Directive of  November 1986 (86/609/EEC). 
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 Surgery 
To exclude interference from endogenously circulating corticosteroids, animals underwent 
bilateral adrenalectomy (ADX) performed under isoflurane anaesthesia. Animals were let to 
recover for three days while their drinking water was supplemented with 0.9% saline. In order 
to study GR translocation patterns in CA1 and dentate gyrus cells of  the hippocampus, rats 
(n = 3-4) were injected intraperitoneally (i.p.) with 3 mg/kg corticosterone (CORT-HBC; 
Sigma-Aldrich, USA) as described previously (van Steensel et al. 1996, Conway-Campbell 
et al. 2007). Animals were sacrificed at different time points after injection, respectively 0, 
30, 60, or 120 minutes. Blood plasma was collected to verify that the adrenal glands were 
completely removed and to monitor corticosterone levels in blood after injection (Fig. 4E). 
Samples were processed using a corticosterone radioimmunoassay kit according to the 
manufacturer’s instructions (MP Biomedicals Inc., CA., USA).
 Tissue processing
Transcardial perfusion-fixation was performed to process the brains for tissue sectioning 
and immunohistochemistry as described previously (Heine et al. 2004). Briefly, animals were 
deeply anaesthetised in the morning by i.p. injection of  pentobarbital sodium salt (Nembu-
tal 1 ml/kg bodyweight; A.U.V., Cuijk, The Netherlands) and then perfused intracardially 
with ice-cold 0.9% saline followed by 4% PFA in 0.1 M phosphate buffer, pH 7.4. Following 
perfusion the brains were removed, cryoprotected by complete saturation in a solution of  
30% sucrose in 4% PFA, pH 7.4, and snap-frozen, Coronal section were cut at 30 µm using 
a Leica 1900 cryostat, and stored in an antifreeze solution (30% ethylene glycol, 20% glyce-
rol, 0.02 M Na2HPO4, 6.6 mM NaH2PO4) at -20 ˚C until further use. 
 GR immunohistochemistry in cultured cells 
To study receptor translocation patterns after glucocorticoid treatment, cells were stimula-
ted with either vehicle or 10-7 M dexamethasone (Sigma-Aldrich, The Netherlands) known 
to induce significant GR translocation in cultured cells (Nishi et al. 1999, Fitzsimons et al. 
2008). Respectively 0, 5, 15 and 30 min after stimulation, cells were processed for immunof-
luorescence to visualise subcellular distribution patterns of  GR as described previously 
(Morsink et al. 2006). Briefly, cells were fixed with 4% paraformaldehyde (PFA) in 0.1M 
phosphate buffered saline (PBS), pH 7.4. After blocking in PBS supplemented with 5% nor-
mal goat serum and 0.3% TX-100, a panel of  different GR-specific primary antibodies was 
used to detect GR immunoreactivity (IR). The subsequent primary antibodies were used: 
rabbit polyclonals raised against human GR, M-20 (aa 5-20), H300 (aa 121-420) and P20 
(aa 750-769) from Santa Cruz Biotechnology Inc, Germany, or mouse monoclonal BuGR2 
(aa 407-423 of  rat GR) from Abcam, UK and rabbit polyclonal GR-Kawata (N-terminal 








diluted (1:500 or 1:2000 for GR-Kawata) in PBS containing 1 % BSA and 0.1 % TX-100 for 
60 min at room temperature. As a control, the primary antibody was omitted or substituted 
with equal amounts of  normal rabbit or mouse IgG. After washing, cells were incubated 
with AlexaFluor-488 labelled goat-anti-rabbit IgG or AlexaFluor-A488 goat anti-mouse 
IgG (1:1000, Molecular Probes, USA) in PBS containing 0.1 % TX-100 and 1 % BSA for 60 
min at room temperature. Finally, cells were washed and nuclei were visualised with Hoechst 
33258 (1:10000, Molecular Probes, USA). Slides were mounted with Aqua Polymount (Po-
lysciences Inc, USA) and stored in the dark until further analysis. 
 GR immunohistochemistry in rat brain slices 
To study changes in subcellular distribution pattern of  GR-IR in the rat hippocampus as a 
consequence of  glucocorticoid treatment, free-floating immunohistochemistry was perfor-
med on brain slices as described previously (Sarabdjitsingh et al. 2009). Briefly, non-specific 
binding was blocked by incubating the sections in 2% BSA, 0.3% TX-100 in 0.1M PBS. Af-
ter rinsing, sections were incubated with different GR-specific primary antibodies as descri-
bed above [P20, M20 and H300 (1: 500), Santa Cruz Biotechnology, Germany and BuGR2 
(1:500) from Abcam, UK] in 0.3% TX-100 in PBS for 72 hours at 4 ˚C. Serial sections of  
the same animals were used for the different antibodies. At the time of  the current expe-
riment the GR antibody from Kawata was no longer available and therefore not included 
in this experiment. After washing, sections were incubated with AlexaFluor-488 labelled 
goat-anti-rabbit IgG or goat-anti-mouse IgG (1:1000; Molecular Probes, USA) in 0.3% TX-
100, 2% BSA in PBS for 2 hours at room temperature. Finally, nuclei were visualised with 
Hoechst 33258 (1:10000, Molecular Probes, USA) after which sections were mounted with 
Aqua Polymount (Polysciences, Inc), and stored in the dark until further analysis. 
Control sections were incubated with equal amounts of  normal rabbit IgG (Santa Cruz 
Biotechnology, USA), which were used as substitute for the primary antibody. Additionally, 
sections were incubated without any primary antibodies to check for any aspecific binding 
of  the secondary antibodies.
 Confocal imaging and quantification
Subcellular distribution patterns of  GR-IR in both cultured cells and brain slices was exa-
mined by a Leica Q550IW confocal microscope. Images were acquired at 630x magnifica-
tion (155 x 155 µm, 1 μm focal plane). All settings for filters, lasers and images were left 
unchanged during imaging in order to relate changes in nuclear and cytoplasmic GR-IR due 
to experimental conditions and not due to microscope parameters. For the AtT20 cells, a 
group size of  approximately 30 cells per time points was examined, taken from three indi-
vidual wells. Per animal, two frames of  the CA1 pyramidal cell layer or dentate gyrus were 
imaged with 30-40 cells on average.
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Fluorescence intensity values of  nuclear and cytoplasmic GR-IR were quantified by measu-
ring optical density (ImageJ 1.32j analysis software; NIH, USA; http://rsb.info.nih.gov/ij/) 
similarly as described before (van der Laan et al. 2005, Morsink et al. 2006, Sarabdjitsingh et 
al. 2009). Briefly, Hoechst staining was used to identify the boundaries between the nuclear 
surface and cytoplasm of  individual cells and was circled with the analysis software. These 
circles served as a template and were pasted onto the corresponding GR images to measure 
the optical density within and outside the nucleus. Background levels, indicated by sections 
and cells that were incubated with equal amounts of  normal IgG, were also measured and 
subtracted from the total signal to obtain the specific signal. 
 Statistical analysis
Data are presented as mean ± SEM. Differences in mean optical density were examined by a 
one-way ANOVA. Tukey’s post-hoc testing was applied to compare individual groups where 




Visualisation of  GR nuclear translocation patterns in AtT20 cells 
GR subcellular distribution patterns in AtT20 cells visualised with different GR-specific 
antibodies at different time points after dexamethasone (dex) treatment are illustrated in 
Fig. 1. Before stimulation (0 min), GR immunoreactivity (IR) was evenly distributed over the 
nuclear and cytoplasmic compartment with all five antibodies (Fig. 1 A1-E1). Stimulation 
with dex resulted in a significant accumulation in nuclear GR-IR observed with the BuGR2 
(Fig. 1 A1-A4), M20 (Fig. 1 C1-C4) and GR-Kawata antibody (Fig. 1 E1-E4). This effect was 
readily observed 5 min after treatment (Fig. 1 A2, C2 and E2) while complete nuclear trans-
location was reached after 30 min (Fig. 1 A4, C4 and E4). In comparison, dex stimulation 
resulted in very moderate to no nuclear translocation when visualised with the H300 (Fig.1 
B1-B4) and P20 antibody (Fig. 1 D1-D4). 
Quantification of  GR nuclear translocation patterns in AtT20 cells
Fluorescence intensity values were measured in both the nuclear and cytoplasmic compart-
ment of  cells stimulated with dex. Fig. 2 depicts the fold increase in those compartments 
as visualised with the different GR primary antibodies. Nuclear intensity increased approxi-
mately 3-fold after 30 min of  dex stimulation observed with the BuGR2, M20 antibody and 









(Fig. 2B, p < 0.001), while GR-IR with P20 remained unchanged after dex treatment (Fig. 
2D, p = 0.60). A small decrease in cytoplasmic fluorescent intensity was observed with the 
M20 antibody, P20 and GR-Kawata (Fig. 2C-E, p < 0.01).
Figure 1 |  GR nuclear translocation patterns in cultured Att20 cells. Time curve analysis of  subcellular distri-
bution of  GR IR in AtT20 cells 0, 5, 15 and 30 min after 10-7 M dexamethasone stimulation using confocal ima-
ging. A1-E1 | No differences in distribution pattern before stimulation (0 min) between the different antibodies 
M20, GR-Kawata, BuGR2, H300 and P20 were observed. Clear nuclear GR-IR was observed in cells visualised 
with the A1-A4 | BuGR2, C1-C4 | M20 and E1-E4 | GR-Kawata antibody already 5 min after stimulation, while 
moderate to no nuclear localisation was observed with the B1-B4 | H300 and D1-D4 | P20 antibody. Scale bar 
= 10 μm.
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Figure 2 |  Quantification of  GR nuclear translocation patterns in cultured Att20 cells. Fluorescent intensity 
values of  GR-IR in the nuclear and cytoplasmic compartment are shown at 0, 5, 15 and 30 min after 10-7 M dex 
stimulation visualised with different GR primary antibodies. Dex stimulation resulted in approximately 3-fold 
increase in fluorescent intensity in the nuclear compartment visualised with A | BuGR2 (F(3, 108) = 18.20, p 
< 0.001), C | M20 (F(3, 99) = p < 0.001) and E | GR-Kawata (F(3, 105) = 22.01, p < 0.001). Cells visualised 
with B | H300 (F(3, 112) = 10.37, p < 0.001) and D | P20 (F(3,99), p = 0.63) showed modest to no increase in 
the nuclear compartment after stimulation. Interestingly, a small but significant decrease in cytoplasmic IR was 
observed with C | M20 (F(3, 101) = 4.54, p < 0.01), D | P20 (F(3, 99) = 4.08, p < 0.01 and E | GR-Kawata (F(3, 
120) = 16.05, p < 0.001). Data is expressed as mean ± SEM. One-way ANOVA and Tukey’s post-hoc test, ** p < 
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Visualisation of  GR nuclear translocation patterns in rat hippocampal CA1 cells  
Before stimulation (0 min), clear GR-IR was detected in the cytoplasmic compartment of  
CA1 cells with the primary GR BuGR2, H300, M20 and the P20 antibodies (Fig. 3 A1-
D1). No nuclear GR IR was observed at this time point with any of  the antibodies. After 
glucocorticoid stimulation strong accumulation of  nuclear GR-IR was observed with the 
BuGR2 antibody, similar to the observations in cultured cells (Fig. 3 A1-A4). However with 
the other GR primary antibodies striking differences were observed in nuclear translocation 
patterns compared to cultured cells. While in AtT20 cells the M20 antibody nicely visualised 
nuclear localisation of  GR, in CA1 cells the same antibody was not capable in recognising 
nuclear GR-IR molecules at any of  the time points after injection (Fig. 3 C1-C4). Only an 
increase in cytoplasmic GR-IR was detected with this antibody. In contrast, while the H300 
and P20 antibodies poorly detected nuclear GR in the AtT20 cells, in CA1 cells strong nu-
clear GR accumulation, especially with the H300 antibody, was observed already from 60 
minutes after glucocorticoid treatment (Fig. 3 B1-B4 and D1-D4). 
Quantification of  GR nuclear translocation patterns in rat hippocampal CA1 cells 
Fluorescence intensity values were measured in both the nuclear and cytoplasmic compart-
ment of  CA1 cells after corticosterone injection. Fig. 4 depicts the fold increase in those 
compartments as visualised with the different GR primary antibodies. In agreement with 
the confocal images, we observed increased GR-IR in the nuclear compartment after glu-
cocorticoid treatment with some of  the antibodies. Nuclear intensity increased (more than) 
approximately 4-fold 120 min after corticosterone injection observed with the BuGR2, 
H300 (Fig. 4A and B, p < 0.001) and P20 antibody (Fig. 4D, p < 0.01) while no increase was 
observed with the M20 antibody (Fig. 4C, p = 0.42). In contrast, GR-IR in the cytoplasmic 
compartment as visualised with the M20 antibody increased significantly to approximately 
2-fold (Fig. 4C, p < 0.01). 
Quantification of  GR nuclear translocation patterns in rat dentate gyrus cells 
To generalise the in vivo findings in CA1 cells, another hippocampal cell population, granule 
dentate gyrus cells was analysed (Fig. 5). For this purpose, we compared the H300 and M20 
primary antibodies which provided distinctly different results in CA1 cells. In agreement 
with the results from CA1 cells, we observed increased GR-IR in the nuclear compartment 
after glucocorticoid treatment visualised with H300 (Fig. 5A, p < 0.01), but not with M20 
(Fig. 5B, p = 0.62). Similarly, an approximately 2-fold increase was observed in cytoplasmic 
GR-IR intensity with the latter antibody (Fig. 5B, p = 0.04). 
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Figure 3 |  GR nuclear translocation patterns in rat CA1 cells. Time curve analysis of  subcellular distribution 
of  GR-IR in CA1 cells of  ADX rat hippocampus at 0, 30, 60 and 120 min after 3 mg/kg corticosterone injection. 
A1-D1 | Before stimulation (0 min), GR-IR visualised with all GR antibodies was mostly localised in the cytoplas-
mic compartment. In contrast to the AtT20 cells, no increase in nuclear GR-IR was visible after glucocorticoid 
stimulation with the A1-A4 | BuGR2 and C1-C4 | M20 antibody while the B1-B4 | H300 and D1-D4 | P20 
antibodies clearly visualised nuclear GR distribution. Scale bar = 20 μm.
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< Figure 4 |  Quantification of  GR nuclear translocation patterns in rat CA1 cells. Fluorescent intensity 
values of  GR-IR in the nuclear and cytoplasmic compartment of  ADX rat CA1 cells are shown at 0, 30, 60 and 
120 min after 3 mg/kg ip corticosterone injection visualised with different GR primary antibodies. Corticoste-
rone injection resulted in increased fluorescent intensity in the nuclear compartment visualized with A | BuGR2 
(F(3,10) = 14.77, p < 0.001), B | H300 (F(3, 9) = 14.13, p < 0.001) and D | P20 (F(3, 10) = p < 0.01). Interes-
tingly, cells visualised with C | M20 (F(3, 8) = 1.06, p = 0.42) showed no increase in the nuclear compartment 
after glucocorticoid stimulation. The opposite was found for the cytoplasmic compartment in which corticoste-
rone injection resulted in increased GR-IR visualised with C | M20 (F(3, 6) = 12.85, p < 0.01 but not with A | 
BuGR2 (F(3, 10) = 1.11, p = 0.39), B | H300 (F(3, 10) = 1.24, p = 0.34) and D | P20 (F(3, 11) = 0.78, p = 0.53). 
E | plasma corticosterone levels were monitored before and at different time points after injection in ADX rats. 
Before injection (t = 0 min), corticosterone levels were indeed very low or non detectable. Data is expressed as 
mean ± SEM. One-way ANOVA and Tukey’s post-hoc test, ** p < 0.001 and * p < 0.01 vs veh, # p < 0.05 5 vs 
15 and 30 min, n = 3-4 rats per time point.
Figure 5 |  Quantification of  GR nuclear translocation patterns in rat dentate gyrus cells. Fluorescent intensity 
values of  GR-IR in the nuclear and cytoplasmic compartment of  ADX rat dentate gyrus granule cells are shown 
at 0, 30, 60 and 120 min after 3 mg/kg ip corticosterone injection visualised with different GR primary antibodies. 
Corticosterone injection resulted in increased fluorescent intensity in the nuclear compartment visualised with A 
| H300 (F(3,10) = 5.88, p = 0.014) but not with B | M20 (F(3, 9) = 0.62, p < 0.62). However, cytoplasmic GR-
IR increased significantly after glucocorticoid stimulation (F(3, 7) = 3.60, p = 0.04). Data is expressed as mean ± 
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In this study we have investigated the differences between antibodies in determina-
tion of  GR-IR subcellular distribution patterns after glucocorticoid stimulation in cul-
tured cells and in hippocampus. To prevent confounding differential dose-dependent 
steroid effects on GR nuclear translocation (Nishi et al. 1999, Spiga & Lightman 2009), 
and to only study the consequences of  the different GR-specific primary antibodies, 
we choose to expose both cultured cells and rats to very high concentrations of  steroid 
thereby saturating most GR molecules. While some of  the antibodies provided con-
sistent cell specific results in GR nuclear translocation patterns between cultured cells 
and tissue, the data showed for others distinctly different results. The findings demon-
strate that the outcome of  ligand-induced GR nuclear translocation depends on the par-
ticular antibody and cannot always be extrapolated between experimental conditions. 
We observed contradictory results in GR nuclear translocation patterns between cultured 
AtT20 cells and rat CA1 cells with the same primary antibodies (i.e. M20, H300, P20). This 
may reflect either cell type-specificity or procedural differences, and both may be related to 
in vitro versus in vivo conditions. While we have no in vivo data for pituitary cells, another 
cell population in the brain, the granule dentate gyrus cells, showed very similar results as 
were found in CA1. However, we did find two studies where hippocampal GR immuno-
reactivity was successfully detected using the M20 antibody (Sheng et al. 2003, Furay et al. 
2008). Yet these studies used slightly different protocols optimised for DAB staining. There 
are also known biological differences in GR between cultured cells and actual tissue. For 
example, complete redistribution of  nuclear GR over the cytoplasm after steroid withdrawal 
may last more than 24 hours (Hache et al. 1999), while in vivo GR is rapidly shuttled in and 
out of  the nucleus on an hourly time-scale (Conway-Campbell et al. 2007, Sarabdjitsingh et 
al. 2010). We favour the interpretation that the pattern of  nuclear interactions of  GR differs 
in a systematic way between cell lines and tissues, depending on the conditions.
The various stages in the receptor life cycle may also provide differences in the availability 
of  specific epitopes (i.e. steric hindrance due to conformation changes). The antibodies 
used in this study are all raised against the N-terminal domain of  the GR, except the P20 
antibody. This antibody is raised against the end of  the C-terminus (aa 750-769) that har-
bours the ligand binding domain. In AtT20 cells, the latter antibody did not detect nuclear 
GR after glucocorticoid stimulation suggesting that this part of  the C-terminus is hidden 
from the antibody. In rat CA1 cells, the N-terminal raised M20 antibody (aa 5-20) failed to 
detect changes in nuclear GR-IR. This suggests that in this condition, the immunogenicity 
of  the N-terminal domain rather than the C-terminus is affected by ligand-induced confor-
mational changes. Similarly, it is possible that the counter intuitive increase in cytoplasmic 
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immunoreactivity after glucocorticoid treatment, in an antibody-specific manner, is due to 
increased epitope accessibility after stimulation with ligand. Typically, this would not be 
observed with other antibody based techniques that use denaturing methods (e.g. Western 
Blot).
It is also possible that the observed differences between antibodies could be explained 
by the use of  different ligands in the two conditions, dexamethasone and corticosterone. 
The ligand induced conformational change of  the receptor is crucial for the distinction 
between agonists and antagonists, and may also differ to some extent for these two ago-
nists. Functionally, differences between full agonists have been observed for intranuclear 
mobility, but not for translocation at saturating concentrations (Schaaf  & Cidlowski 2003, 
Schaaf  et al. 2005). This in itself  does not exclude the agonist dependence of  the immu-
nogenicity of  GR. Although not all GR antibodies were included then, we have previously 
used corticosterone in cultured cells and indeed have reported similar GR nuclear translo-
cation with the M20 antibody as described here for dexamethasone (Morsink et al. 2006). 
Because changes in conformation induced by different agonists primarily take place in the 
LBD, they probably have little effect on the accessibility of  antibodies raised against the 
N-terminal domain (e.g. H300, M20, BuGR2 and GR-Kawata). The consequences for C-
terminally raised antibodies such as the P20, are however unknown, and we have to be aware 
that particular ligands may cause antibody-dependent outcomes in translocation studies. 
Epitope accessibility is also determined by the local cellular context. Conformation changes 
of  GR are partly determined by dissociation of  chaperones upon ligand binding, binding 
for active transport to the nucleus or to other nuclear proteins and is therefore considered 
a key determinant in receptor function (Pratt et al. 2004, Meijer et al. 2006, Nishi & Kawata 
2006, Picard 2006). Differential expression and regulation of  molecules that make up GR 
complexes have not been systematically compared between cultured cells and tissue yet and 
could therefore contribute to the differences between experimental conditions. 
Furthermore, the intracellular localisation of  GR may also depend on the composition of  
the fixative. For instance, addition of  gluteraldehyde minimises potential redistribution of  
the receptor during the fixation procedure (Brink et al. 1992). Taking these methodological 
aspects into account, some have described a relative absence of  GR in the primate hippo-
campus (Sanchez et al. 2000), while others have shown prominent expression levels of  GR 
in the human hippocampus (Wang 2009). 
Although cross-linking fixation methods are regarded as effective means to preserve protein 
in tissue, it is possible that the different methods of  fixative delivery in our study (i.e. direct 
incubation or transcardial perfusion fixation) result in different fixation strengths [albeit 








epitope accessibility of  the antibody. In that respect, antigen retrieval techniques such as 
heating by microwave or phosphatase pretreatment which aim to reverse deleterious ef-
fects of  fixation (Shi et al. 1996, Pileri et al. 1997, MacIntyre 2001, Shi et al. 2001, Fritschy 
2008), could be used to study the degree of  epitope masking in settings like these. However, 
antigen retrieval techniques which allow renaturation of  the structure of  fixed protein have 
been proven beneficial only in particular circumstances and in some cases tend to increase 
aspecific binding (Lucassen et al. 1995). Though antigen retrieval methods are being widely 
addressed, more detailed studies with different types and durations of  fixatives with ranging 
pH values on receptor distribution are suggested to elaborate on the consequences on re-
ceptor distribution. 
In the current study we chose to investigate GR nuclear translocation patterns under steroid-
free conditions (e.g. adrenalectomy and stripped serum media). Previously we have shown 
that GR, but also MR, nuclear translocation indeed depends on the physiological state of  
an animal but may also interfere with the basal conditions as low levels of  both receptors 
may be retained in the nucleus before glucocorticoid treatment (Sarabdjitsingh et al. 2009, 
Sarabdjitsingh et al. 2010). However, our approach prevented interference of  endogenously 
circulating glucocorticoids and differences in basal steroid conditions between the in vivo 
and in vitro situation.
Even though the recent generation of  transgenic GR-GFP knock-in mice provide pro-
mising animal models for future research (Brewer et al. 2002, Usuku et al. 2005, Nishi et al. 
2007), the current ongoing work still heavily depends on the use of  primary antibodies. 
Besides immunohistochemistry, other antibody-based techniques that study GR in its ‘na-
tural’ folded conformation such as chromatin immunoprecipitation (as opposed to dena-
turation with i.e. Western Blotting) may very well deal with similar epitope specificities as 
describe here. Our data make the point that inconsistency in (subcellular) protein expression 
patterns and controversy in published results could be attributed to a combination of  the 
type of  antibody, epitope accessibility and fixation procedure / composition as well as the 
local cellular context. 
In conclusion, we report that the choice of  the primary antibody can have important im-
plications for the interpretation of  glucocorticoid action on the identification of  receptor 
subcellular distribution patterns and cannot be extrapolated between different conditions. 
We propose the use of  different GR primary antibodies for different purposes. For direct 
comparisons between cultured cells and tissue, the BuGR2 and H300 primary antibodies are 
recommended for visualisation of  GR localisation. For comparisons within cultured cells, 
we recommend the use of  BuGR2, M20 and/or GR-Kawata antibody, while we suggest 
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Abstract
Corticosteroids exert important effects on brain function via glucocorticoid (GRs) and mi-
neralocorticoid receptors (MRs) by inducing receptor translocation to the nucleus, where 
the receptor-ligand complexes modulate transcription of  target genes. Based on studies 
describing uneven receptor expression patterns, regionally different corticosterone action, 
and the importance of  timing of  corticosteroid effects, we hypothesised that differential 
patterns of  MR and GR translocation exist in the rat hippocampus in response to a single 
glucocorticoid stimulus. 
Temporal patterns of  receptor translocation were investigated in both intact and adrenalec-
tomised (ADX) male Sprague-Dawley rats. Animals were sacrificed at different time points 
after intraperitoneal administration of  3 mg/kg corticosterone. Specific MR and GR pri-
mary antibodies were used for immunohistochemistry and confocal microscopy to visualise 
and quantify receptor subcellular localisation in the different subregions of  the hippocam-
pus. 
Results indicate (1) significant subregion-specific differences in translocation patterns for 
both MR and GR, with respect to the extent and timing of  nuclear translocation and (2) 
specific differences between ADX and intact animals that are most prominent in the dentate 
gyrus: while corticosterone given to intact animals induced a marked nuclear increase in 
both MR and GR, in ADX animals nuclear MR signal was already elevated in the absence 
of  hormone and did not change after steroid treatment.
We conclude that in response to a single stress-like increase in corticosterone distinct re-
gion-specific MR- and GR-dependent translocation patterns exist in the rat hippocampus, 










Adrenal corticosteroid hormones are important for the adequate onset and termination of  
the stress response, and as such, are essential factors in the maintenance of  homeostasis. 
Their actions include numerous regulatory effects on brain function such as modulation of  
neurogenesis and memory formation (Herbert et al. 2006), behavioural and neuroendocrine 
responses (Oitzl et al. 1997), but also neuronal excitability and neurotransmitter release 
(Joels 2008). Therefore, excessive corticosteroid levels or insufficient adaptation to stress 
may impair homeostasis and brain function severely and are thus considered major risk 
factors for the onset of  stress-related disorders like depression and post-traumatic stress 
disorder (de Kloet et al. 2005).
One essential issue concerning the functioning of  the stress system is to understand how 
the effects of  corticosteroids are differently mediated by the two types of  corticosteroid re-
ceptors, the mineralocorticoid and glucocorticoid receptor [MR and GR; (Reul & de Kloet 
1985)]. MR and GR are members of  the nuclear receptor superfamily known to act as 
ligand-activated transcription factors (Mangelsdorf  et al. 1995) and are widely present in 
brain. Both receptors are colocalised in high abundance in the hippocampus (Van Eekelen 
& De Kloet 1992, Han et al. 2005), a brain structure important for learning and memory 
and particularly susceptible to the effects of  corticosteroids. Currently, it is widely accepted 
that in absence of  the ligand, the receptors are part of  a large protein heterocomplex con-
taining a number of  chaperone proteins (i.e. Hsp90 and p23), stabilising the complex in the 
cytoplasm. Activation of  MR and GR by ligand binding results in dynamic conformational 
changes thereby rapidly remodelling the chaperone complex and exposing the nuclear loca-
lisation signal. As a consequence, the receptor-ligand complex is actively translocated to the 
nucleus using the microtubule cytoskeleton as a guiding scaffold. In the nucleus, it associates 
with glucocorticoid response elements (GREs) in the promoter regions of  corticosteroid 
target genes in order to modulate their expression (Pratt et al. 2004, Nishi & Kawata 2006, 
Picard 2006). Importantly, corticosteroids differentially affect different neuronal cell po-
pulations underscoring the relevance of  cell specific mechanisms of  signalling (Joels 2006, 
Fitzsimons et al. 2008).
GRE occupancy by GR is a primary determinant of  glucocorticoid responsiveness in cultu-
red cells (So et al. 2007), and is also essential in spatial memory formation (Oitzl et al. 2001). 
Since the import and export of  the receptor from the nucleus are obviously necessary steps 
in the signalling mechanism, receptor translocation could potentially be a more upstream 
rate limiting step in the transduction of  the steroid signal to nerve cells in the brain. Howe-
ver, most knowledge concerning the dynamics of  the corticosteroid receptors is based on 
cell culture models (Nishi & Kawata 2006) and the exact mechanism through which these 
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receptors act in brain is still unclear emphasising the need for more in vivo studies. For 
instance, upon hormone withdrawal in cell lines, GR reassociates rapidly into a cochape-
rone complex, but only slowly redistributes to the cytoplasm over periods that can extend 
over 12–24 h (Hache et al. 1999), while a recent study using rat hippocampal homogenate 
demonstrated more rapid GR translocation to and from the nucleus after administration of  
hormone pulses (Conway-Campbell et al. 2007). 
Previous in vivo studies have focused more on the distribution of  MR and GR in the rat 
hippocampus at limited time points (Ahima & Harlan 1990, Ahima et al. 1991, Cintra et al. 
1994, van Steensel et al. 1996, Han et al. 2005), providing more time-restricted information. 
Others have used hippocampal homogenate to study receptor translocation (Kitchener et 
al. 2004, Conway-Campbell et al. 2007), thereby losing detailed information of  receptor ki-
netics in different hippocampal subregions. The contribution of  the different hippocampal 
subregions on specific processes like neuronal excitability (Joels 2006), but also on learning 
and memory formation (Kubik et al. 2007), has been described previously emphasising their 
individual importance. In line with this concept, it has been suggested that hippocampal 
cells may have unique transporting mechanisms for translocating corticosteroid receptors to 
the nucleus (Nishi & Kawata 2006). Indeed, differential expression of  components of  the 
chaperone complex in the hippocampus like cytoskeletal proteins (Arnold & Trojanowski 
1996) and hsp90 (Patchev et al. 1994) may suggest region-specific translocation patterns of  
the receptors and consequently may explain region-specific regulatory effects of  glucocor-
ticoids. 
Therefore, we assessed the dynamic response of  MR and GR in different subregions of  
the rat hippocampus after corticosteroid treatment providing high resolution and detailed 
information with the use of  immunohistochemistry and confocal imaging. We quantified 
MR and GR translocation patterns in intact and adrenalectomised rats after glucocorticoid 
treatment at different time points after injection and found that subcellular (changes in) 
localisation patterns differ between hippocampal regions.
Experimental procedures
 Animals
Adult male Sprague-Dawley rats (mean weight ± 250 grams) were purchased from Har-
lan (Leiden, The Netherlands) and group housed in rooms on a 12h/12h light/dark cycle 
(lights on at 07:00 AM). Food pellets and drinking water were available ad libitum. Animals 
were handled daily for a week before the start of  the experiment. Animals that underwent 
bilateral adrenalectomy, performed under isoflurane anaesthesia, were let to recover for 
57
three days while their drinking water was supplemented with 0.9% saline. Experiments were 
approved by the Local Committee for Animal Health, Ethics and Research of  the Univer-
sity of  Leiden (DEC nr. 05080). Animal care was conducted in accordance with the EC 
Council Directive of  November 1986 (86/609/EEC).  
 Experimental design 
In order to study MR and GR translocation patterns in the rat hippocampus, both intact 
(n = 4 per group) and adrenalectomised rats (ADX; n = 3 per group) were injected intra-
peritoneally (i.p.) with 3 mg/kg corticosterone (CORT-HBC; Sigma, St. Louis, USA) and 
sacrificed at different time points thereafter. Previous studies have shown that this concen-
tration is sufficient to induce hippocampal GR translocation to the nucleus as detected by 
Western blot (Kitchener et al. 2004, Conway-Campbell et al. 2007) and immunofluorescence 
(van Steensel et al. 1996). ADX animals were sacrificed respectively 0, 30, 60 and 120 min 
after injection while intact animals were sacrificed at 0, 60, 120 and 180 minutes. As a con-
trol, intact animals were injected with vehicle (0.9% NaCl) and sacrificed at 0 and 60 min 
after injection. Though recently it was demonstrated that there is no difference in nuclear 
AM and PM hippocampal protein levels, at least for GR (Furay et al. 2006), the study was 
performed in the morning between 08.00-12.00 AM. All animals were sacrificed before the 
circadian rise in corticosterone levels to prevent interference of  endogenously circulating 
corticosterone levels. In all groups, plasma corticosterone concentrations were measured 
to verify that the adrenal glands were removed completely and to monitor corticosterone 
levels in blood at multiple time points after injection. This was done using a corticosterone 
radioimmunoassay kit (MP Biomedicals Inc., CA., USA) according to the manufacturer’s 
instructions.
 Tissue preparation and processing 
Transcardial perfusion-fixation was performed to process the brains for tissue sectioning 
and immunohistochemistry as described previously (Heine et al. 2004). Briefly, animals were 
deeply anaesthetised in the morning by i.p. injection of  pentobarbital sodium salt (Nembu-
tal 1 ml/kg bodyweight; A.U.V., Cuijk, The Netherlands) and then perfused intracardially 
with ice-cold 0.9% saline, pH 7.4 followed by 4% paraformaldehyde (PFA) in 0.1 M phosp-
hate buffer (PB), pH 7.4. Afterwards, brains were removed and cryoprotected by placing 
them in a solution of  30% sucrose in 4% PFA, pH 7.4 until complete saturation. Brains 
were snap-frozen and using a Leica 1900 cryostat sectioned coronally at 30 μm and stored 








 Free-floating immunohistochemistry 
To study changes in subcellular distribution pattern of  MR and GR immunoreactivity (IR) 
in the rat hippocampus as a consequence of  corticosterone administration, free-floating im-
munohistochemistry was performed on brain slices. First, sections were rinsed thoroughly 
with 0.1M PBS, pH 7.4. To block non-specific binding, slices were incubated with 0.1M PB, 
pH 7.4 containing 2% bovine serum albumine (BSA) and 0.3% TX-100 for two hours. After 
rinsing, sections were incubated with rabbit polyclonal GR (1:500, H300, Santa Cruz Bio-
technology, USA) and mouse monoclonal MR antibodies [1:500, MR1-18 1D5; (Gomez-
Sanchez et al. 2006)] diluted in PBS containing 0.3% TX-100 for 72 hours at 4 ˚C. After 
washing, sections were incubated with AlexaFluor-488 labelled goat-anti-rabbit IgG and 
AlexaFluor-A594 goat anti-mouse IgG (1:1000; Molecular Probes, USA) in PBS containing 
0.3% TX-100 and 2% BSA for two hours. Finally, sections were washed and nuclei were 
visualised with Hoechst 33242 (Molecular Probes, USA) in PBS after which sections were 
mounted with Aqua Polymount (Polysciences, Inc) and stored in the dark until further 
analysis. Controls sections were incubated with equal amounts of  normal rabbit and mouse 
IgG (Santa Cruz Biotechnology, USA) which were used as substitute for the primary anti-
body. Additionally, secondary fluorescent labels were swapped to check cross-reactivity and 
sections were incubated without any primary antibodies to check for any aspecific binding 
of  the secondary antibodies.
 Confocal microscopy and image analysis
To examine the subcellular distribution pattern of  MR and GR IR in the different subfields 
of  the rat hippocampus, a Leica Q550IW confocal microscope was used. Images (630x 
magnification, 155 x 155 µm, 1 µm focal plane) were acquired from the pyramidal cell fields 
CA1, CA2 and CA3 and dentate gyrus (DG). To relate changes in nuclear IR due to expe-
rimental conditions and not due to microscopical parameters, all settings for filters, lasers 
and images were left unchanged during imaging. Per animal, two frames per hippocampal 
subfield were imaged with 30-40 cells on average. 
To assess the percentage of  IR cells in each hippocampal subfield, MR and GR positive 
cells with a signal above background were included as indicated by aspecific antibodies 
(normal IgGs). Background levels were indicated by sections that were incubated with equal 
amounts of  normal IgG. Per animal (ADX n = 12, intact n = 14), all cells from two confocal 
frames for each hippocampal subregion were counted. The multiple sections that were ima-
ged per animal all had a different plane of  focus. The amount of  positive cells as percentage 
of  the total amount of  cells as indicated by the nuclear Hoechst stain is expressed as mean 
percentage (± SEM). No statistical difference was found between the percentages in ADX 
and intact animals.
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To quantify differences in MR and GR subcellular distribution patterns, changes in fluores-
cence intensity values of  nuclear immunoreactivity were measured using ImageJ 1.32j analy-
sis software (NIH, USA; http://rsb.info.nih.gov/ij/) similarly as described previously (van 
der Laan et al. 2005, Morsink et al. 2006). Briefly, Hoechst staining was used to identify the 
boundaries between the nuclear surface and cytoplasm of  individual cells and was circled 
with the analysis software. These circles served as a template and were pasted onto the cor-
responding MR and GR images to measure the optical density (mean grey levels) within the 
nucleus. Non-specific binding (normal mouse and rabbit IgG) and background staining of  
the sections were also measured and subtracted from the total signal to obtain the specific 
signal. Only cells that had a clear ovally-shaped nucleus with a diameter of  approximately 
5-7 µm and showed IR clearly above background were included for analysis thereby exclu-
ding cells that were not in the plane of  focus.
 Statistical analysis
Data are presented as mean ± SEM. Differences in mean optical density were examined by a 
one-way ANOVA. Tukey’s post-hoc testing was applied to compare individual groups where 
applicable. Statistical significance was accepted at p-value < 0.05.
Results
Distribution of  MR and GR immunoreactivity in rat hippocampus 
Dual labelling immunohistochemistry and confocal imaging using specific MR and GR pri-
mary antibodies were used to study subcellular distribution patterns in the rat hippocampus. 
The specificity of  these antibodies for MR and GR was shown earlier by others (Ko et al. 
2002, Wochnik et al. 2005, Gomez-Sanchez et al. 2006), and was here again verified for im-
munohistochemistry by comparing the distribution pattern of  the antibodies to previous 
studies. Results demonstrate a classic distribution pattern for both MR and GR expression 
in the rat hippocampus (Fig. 1A). As expected, high immunoreactivity (IR) for both recep-
tor types was found in CA1, CA2 and DG while in CA3, very low levels of  GR and high le-
vels of  MR IR were detected. On basis of  these results, it was concluded that the antibodies 
were suitable for detection of  MR and GR and therefore appropriate for detecting changes 
in subcellular distribution patterns in the rat hippocampus.
Before measuring translocation patterns of  MR and GR in all subregions of  the hippocam-
pus, the fraction of  cells that contributed to the observed effect was assessed. Therefore, we 








in each of  the individual subregions labelled by the nuclear Hoechst staining (Fig. 1B). No 
significant differences were found between ADX and intact animals. On average, the frac-
tion of  cells that expressed MR and GR were approximately 95% in CA1, CA2 and DG. 
As expected, in CA3 the percentage of  GR IR cells was much lower (44 ± 4 %; average ± 
SEM)) while MR was expressed in more cells (83 ± 2 %). The degree of  colocalisation was 
also assessed in CA1 cells and in percentages were found to be 92.1 ± 2.4 and 91.9 ± 2.0 for 
GR+/MR+ and MR+/GR+ positive cells respectively (data not shown; average ± SEM). 
These number are highly similar to those reported  in a recent study that thoroughly descri-
bed the degree of  colocalisation between MR and GR IR cells (Han et al. 2005).
Confocal imaging of  MR & GR translocation patterns in hippocampal subregions
To study changes in subcellular localisation of  MR and GR as a consequence of  cortico-
steroid treatment, we injected rats with a high dose of  corticosteroids (3 mg/kg i.p.) and 
sacrificed them at different time points thereafter. As a control, intact animals were injec-
ted with vehicle and sacrificed either at 0 or 60 min after injection. Confocal imaging and 
quantification of  MR and GR IR in CA1 cells showed no change in nuclear intensity as a 
consequence of  vehicle injection (Fig. 2A). 
Initially, to avoid interference of  endogenous corticosteroids, adrenalectomised animals 
were used as a model system to investigate MR and GR translocation as a direct conse-
quence of  corticosteroid treatment. In this first study, using ADX rats, predominant nuclear 
localisation of  the signal was still observed 120 minutes after the injection. To also get infor-
mation on the termination of  the response to a single injection, in the second experiment 
with intact animals, we adjusted the time course by omitting an earlier time point (30 min) 
and included a later time point (180 min after injection). Corticosterone levels before and 
after injection were monitored in vehicle injected intact rats and corticosterone injected 
ADX and intact rats (Fig. 2B). As expected, no significant increase in corticosterone level 
was observed in vehicle injected intact rats. Before injection in ADX rats (0 min), no endo-
genously circulating corticosterone was detectable, while in intact animals basal levels were 
36 ± 9 ng/ml. A bolus injection of  3 mg/kg corticosterone resulted in similar peak levels of  
492 ± 61 ng/ml in ADX and 410 ± 56 ng/ml corticosterone 30 min after injection which 
then gradually returned to baseline. 
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Figure 1 | Distribution and quantification of  MR and GR immunoreactive (IR) cells in the rat hippocampus. 
A and B| Confocal imaging of  MR and GR IR using specific MR (upper panel) and GR (lower panel) antibodies 
in the rat hippocampus demonstrate a classic staining pattern. Typically, MR is distributed in the cells of  pyra-
midal cell layers CA1-3 and dentate gyrus. GR is also expressed in these hippocampal subfields but at very low 
levels in CA3 subfield. C | Quantification of  the percentage of  MR (open bars) and GR (filled bars) IR cells 
in different subfields of  the rat hippocampus. IR cells that were clearly above background were included in the 
analysis. Background levels were indicated by expression levels of  non-specific antibodies. In CA1, CA2 and CA3 
almost all cells expressed MR and GR. In the CA3 field, GR is expressed at low levels in approximately 44 ± 4 % 
of  the cell population. Bars indicate mean ± SEM (n=26).
Figure 2 | Representative confocal imaging and quantification of  MR and GR subcellular distribution in CA1 
cells of  vehicle injected intact animals and plasma corticosterone levels. A | As demonstrated by confocal ima-
ging and quantification, no translocation of  either MR nor GR is observed 60 min after vehicle injection in intact 
animals in CA1 cells. B | Plasma corticosterone levels in vehicle injected intact rats and corticosterone injected 
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Confocal imaging of  MR and GR IR at different time points after corticosteroid treatment 
in hippocampus of  ADX rats demonstrated subregion-specific differences in MR and GR 
translocation patterns as illustrated for CA1 and DG in Figure 3. In CA1 (Fig. 3A), we ob-
served rather uniform translocation patterns for MR and GR. For both receptors, IR was 
found to be localised predominantly in the cytoplasmic compartment at time point 0 min. 
Localisation relative to the nuclear compartment was verified using Hoechst as a nuclear 
marker. After corticosterone injection, increasing levels of  nuclear IR for both receptors 
were observed with a maximum at 60 min after injection, demonstrating a classic translo-
cation pattern from the cytoplasmic to the nuclear compartment. Surprisingly, in DG (Fig. 
3B), and to a lesser extent in CA2 and CA3 (data not shown), a considerable amount of  MR 
and GR IR was already present in the nucleus at time point 0 min, when no endogenously 
circulating hormone was present. After injection with corticosterone, an additional increase 
in nuclear MR and GR IR was observed which was more evident for GR than MR. Quanti-
fication of  the translocation patterns of  all the subregions is shown in Figure 4-7.
Quantification of  MR and GR translocation patterns in hippocampal subregions
Changes in MR and GR subcellular distribution were quantified by measuring fluorescence 
intensity values in the nucleus of  MR and GR positive cells in each of  the hippocampal 
subfields of  ADX and intact rats (Fig. 4-7). A significant increase in nuclear IR for both MR 
and GR was observed in CA1 in ADX rats with maximal levels at 60 minutes after cortico-
sterone injection (Fig. 4A). In intact animals, a similar response was observed and at 180 min 
nuclear levels of  MR and GR IR were back to basal again (Fig. 4B). A notable difference 
between intact and ADX rats in MR and GR translocation was found in the DG (Fig. 5). 
While the pattern of  translocation of  MR and GR in DG of  intact rats highly resembled 
CA1 with increased levels at 60 and 120 min and basal levels again at 180 min after injection 
(Fig. 5B), the pattern in ADX rats was quite different (Fig. 5A). Already at 0 min, nuclear 
localisation of  MR and GR was observed in the DG. Corticosterone injection increased 
nuclear levels of  GR significantly 120 min after injection whilst surprisingly, no additional 
increase in nuclear MR IR was observed.
In CA2 (Fig. 6), similar translocation patterns for both intact and ADX rats were observed 
with increased nuclear levels for both MR and GR after 60 min. Though a slight drop in 
nuclear receptor levels was observed at 180 min, levels remained significantly higher than 
the control (0 min) for all the time points measured for GR but not for MR. In CA3 in both 
intact and ADX animals (Fig. 7), a slight but statistically not significant increase in nuclear 
GR levels was observed while MR nuclear signal did increase significantly after 60 min in 
ADX and 120 min in intact animals. 
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Figure 3 | Representative confocal imaging of  MR (red) and GR (green) translocation patterns in hippo-
campus of  ADX rats after corticosterone treatment. A | Classic translocation patterns for both MR and GR are 
observed in CA1. At t=0 min, MR and GR IR is localised mainly in the cytoplasm. After injection, MR and GR IR 
starts to accumulate in the nucleus and is completely nuclear at t =60 min. B | In the DG, nuclear IR of  MR and 
GR is already present at t=0. After injection, an additional increase in nuclear IR for both receptors is observed, 
though to a lesser extent than in CA1.
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Figure 4 | Quantification of  MR and GR nuclear translocation in CA1 of  ADX and intact rats at different 
time points after corticosterone treatment. Nuclear localisation of  MR and GR in CA1 at different time points 
after corticosterone injection is rather similar between A | ADX and B | intact animals for the time points mea-
sured. Bars represent corrected mean grey levels (mean ± SEM). Asterisks indicate significant differences at a 
p-value smaller than 0.05 compared to control (0 min).
Figure 5 | Quantification of  MR and GR nuclear translocation in DG of  ADX and intact rats at different 
time points after corticosterone treatment. Nuclear translocation of  MR and GR in B | intact animals resembles 
translocation patterns in CA1. A | ADX animals show higher nuclear localisation of  MR and GR in controls 
(0 min) compared to intact animals but no significant increase in MR translocation is observed.  Bars represent 
corrected mean grey levels (mean ± SEM). Asterisks indicate significant differences at a p-value smaller than 0.05 
compared to control (0 min).
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Figure 6 | Quantification of  MR and GR nuclear translocation in CA2 of  ADX and intact rats at different 
time points after corticosterone treatment. Nuclear localisation of  MR and GR in CA2 cells demonstrate similar 
translocation patterns between A | ADX and B | intact animals at different time points after corticosterone 
injection. Bars represent corrected mean grey levels (mean ± SEM). Asterisks indicate significant differences at a 
p-value smaller than 0.05 compared to control (0 min).
Figure 7 | Quantification of  MR and GR nuclear translocation in CA3 of  ADX and intact rats at different 
time points after corticosterone treatment. Though the extent of  MR nuclear translocation is larger in A | ADX 
compared to B | intact animals, the patterns are quite similar. No significant increase in nuclear translocation of  
GR is observed in this area. Bars represent corrected mean grey levels (mean ± SEM). Asterisks indicate signifi-
cant differences at a p-value smaller than 0.05 compared to control (0 min).
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Over the last decades, the distribution patterns of  MR and GR in rodent brain have been 
investigated intensively (Ahima & Harlan 1990, Ahima et al. 1991, Van Eekelen & De Kloet 
1992, Cintra et al. 1994, Han et al. 2005). While these studies have proven to be fundamental 
for the current knowledge of  MR and GR localisation in the brain, they did not investigate 
the temporal aspects of  MR and GR dynamics as a consequence of  acute corticosteroid 
treatment in such detail. In this study we investigated MR and GR translocation at different 
time points after acute treatment using GR rabbit polyclonal antibody (H300; Santa Cruz 
Biotechnology) and MR mouse monoclonal antibody (1D5 1-18) both of  which have been 
described and used in literature previously (Ko et al. 2002, Wochnik et al. 2005, Gomez-
Sanchez et al. 2006, Conway-Campbell et al. 2007). 
The expression patterns we obtained for MR and GR are in agreement with previously 
published papers as mentioned above. As expected, both antibodies demonstrated a typi-
cal distribution pattern with clear immunoreactivity in hippocampal subregions CA1, CA2, 
CA3 and DG while GR was expressed at very low expression levels in a subset of  the CA3 
cell population. Combined with information from previously published papers (Ko et al. 
2002, Wochnik et al. 2005, Gomez-Sanchez et al. 2006), we therefore assumed that these 
antibodies indeed were highly capable in specifically recognising MR and GR protein in the 
rat hippocampus and thus can contribute to investigating tissue distribution and the detailed 
changes in subcellular localisation of  MR and GR which can be detected by immunohisto-
chemistry and confocal imaging.
Earlier studies reported on the effects of  a single dose of  corticosterone or aldosterone on 
MR and GR translocation in different regions of  the hippocampus 5 min and 2 hours after 
injection in both ADX and intact rats (Ahima & Harlan 1991, Ahima et al. 1991). Using 
the high spatial resolution that fluorescent immunohistochemistry provides combined with 
the temporal aspects of  the experimental design, the present study provides new and more 
detailed information simultaneously describing the translocation patterns of  MR and GR 
in the different subfields of  the rat hippocampus at multiple time points between 0 and 180 
min in both ADX and intact animals. We show that differences exist in translocation speed 
and extent between various subfields after corticosteroid treatment with CA1 and DG as 
most interesting examples. 
The phenomenon of  hippocampal subregion-specific differences has been described pre-
viously in the literature, though not yet with respect to MR and GR dynamics. It is known 
that specific hippocampal subregions contribute uniquely to specific behavioural processes 
like learning and memory formation (Gilbert et al. 2001, Kubik et al. 2007). In relation to 
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corticosteroids, differential effects on different cell populations have been described (Joels 
2006, Kavushansky et al. 2006), implying region-specific signalling mechanism. For ins-
tance, differences in corticosterone-induced effects on voltage-dependent calcium currents 
and the expression of  calcium channel subunits between CA1 and DG have been observed 
(Joels et al. 2008b) but also subregion-specific effects on serotonin-1A receptor mRNA 
expression down regulation under control of  MR and GR (Meijer & de Kloet 1994, Meijer 
& de Kloet 1995). Furthermore, in CA1, a U-shaped dose-dependency of  corticosterone on 
certain responses like serotonin-1A receptor hyperpolarisation is observed but not in other 
regions like DG (Joels 2006). The differences in translocation and thus participation of  both 
MR and GR between the respective hippocampal subregions may therefore contribute to 
this phenomenon.
The differential regulatory effects of  glucocorticoids on the subregions of  the hippocam-
pus could therefore already start at the level of  receptor translocation and thus be a neces-
sary step in the proper transduction of  the steroid signal in nerve cells, converging into 
higher functional levels. 
An intriguing question left to be answered is what could be the underlying cause for these 
differences in translocation between hippocampal subregions and conditions. Still very little 
is known about region-specific factors that determine steroid receptor translocation rate 
and extent. Differential expression of  genes in the hippocampus that are influencing nuclear 
translocation provide more insight. Unequal distribution patterns of  microtubule-associa-
ted proteins [MAPs; (Arnold & Trojanowski 1996)] and chaperone proteins (Patchev et al. 
1994) in the hippocampus have been described previously but large-scale expression pro-
filing studies on laser-microdissected hippocampal subregions in combination with Gen-
eChip technology revealed more detail in specific differences in cellular context between 
hippocampal subregions (Datson et al. 2004). Interestingly, Datson and colleagues found 
many genes to be differentially expressed between CA3 and DG that belong to the receptor 
transport complex including several MAPs, chaperone proteins like FKbp1a and parts of  
the dynein transport complex. Though the exact functional contribution of  many proteins 
of  the translocation mechanism have yet to be fully elucidated, research concentrating large-
ly on GR dynamics have produced promising models in which MAPs are heavily involved in 
the transport of  GR in a cell type-specific manner (Fitzsimons et al. 2008). 
The local concentration of  corticosterone, or hormonal bioavailability, is another factor that 
could contribute to the subregion-specific differences in translocation patterns, determining 
the exact amount of  corticosterone that is sensed by the cells of  the different subregions. 
One factor could be the energy-dependent efflux transporter P-glycoprotein (Pgp) mdr1b, 
capable of  transporting corticosterone. Specific mdr1b mRNA expression was found in 








the principal layers (Volk et al. 2004). Dentate granule cells express relatively high levels of  
mdr1b mRNA as detected by in situ hybridisation (Karssen et al. 2004) which could contri-
bute to the lesser extent of  nuclear translocation we observed in this area. Another factor 
is the local enzymatic activity of  11β-HSD1 that catalyses the accumulation of  active corti-
costeroids, thereby controlling the concentration of  corticosterone available for corticoste-
roid receptor binding in brain (Seckl 1997). However, studies on regional differences in the 
tissue distribution of  11β-HSD1 in the hippocampus have not been conclusive. Jamieson 
and colleagues described a more homogenous distribution with higher expression levels in 
CA3 (Jamieson et al. 1999), while a more recent paper described regional differences with 
high expression levels in CA1 and DG (Buren et al. 2007). To what extent 11β-HSD1 and 
Pgp mdr1b contribute to the subregional specificity in translocation patterns remains to be 
established.
Though we observed rather similar translocation patterns of  MR and GR between intact 
and ADX rats, the DG provided an interesting exception. In DG, and to a lesser extent in 
CA2 and CA3, even before corticosteroid treatment, a substantial amount of  MR and GR is 
located in the nucleus of  ADX animals. The receptors therefore seem to be retained in the 
nucleus specifically in these regions after removal of  the adrenals, or lack of  glucocorticoids. 
Such retention of  unliganded receptor has been noted before (Brink et al. 1992, Pekki et 
al. 1992), but remains unexplained. At least for MR it is known that the receptor can act 
promiscuous. For instance, not only corticosterone and aldosterone are naturally occurring 
ligands but cross-talk with other steroids, like progesterone, also occurs and could therefore 
influence MR localisation in absence of  glucocorticoids (Rupprecht et al. 1993). These re-
sults raise the question whether corticosteroid receptors dynamics may also be regulated in 
a cell-specific manner by other ligands which in vivo only become evident after ADX and 
may also apply for GR. Additionally, nuclear localisation of  MR and GR after ADX is also 
known to depend on the time after adrenalectomy (Ahima & Harlan 1991, Ahima et al. 
1991). Subregional expression profiling of  glucocorticoid effects has not yet been done and 
the possible changes in the local cellular context due to changes in glucocorticoid levels have 
yet to be described and could provide more insight in these DG-specific effects.  
MR and GR differ in their affinity for several ligands. While GR is also selective for naturally 
occurring and synthetic glucocorticoids; MR binds corticosterone and aldosterone with a 
very high affinity, i.e. about 10-fold higher than GR (de Kloet et al. 2005). Given that endo-
genously circulating levels of  glucocorticoids should be enough to extensively occupy MR 
(Reul & de Kloet 1985) and the lack of  MR nuclear localisation in CA1 of  basal adrenally 
intact animals is striking (Fig. 4B). Possibly, the differences in strain of  rats, experimental 
design, fixation of  the tissue and the choice of  different methodological approaches (i.e. the 
use of  antibodies) could explain these discrepancies with earlier studies. A partial explana-
tion may involve the very low levels of  corticosterone secretion in the morning observed 
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in Sprague-Dawley rats, which may preclude extensive MR occupation (Spiga et al. 2007). 
Based on the higher affinity of  MR for corticosterone, one mightalso expect to see dif-
ferences in translocation kinetics of  MR and GR, e.g. a more rapid translocation of  MR. 
However, we observed rather similar translocation rates of  MR and GR to the nucleus, with 
the exception of  the DG after ADX. This uniform behaviour is most likely explained by 
the dose of  corticosterone that was used in this study. Peak levels of  approximately 410-490 
ng/ml (30 min after injection; Fig. 2B) saturate both MR and GR thereby masking the out-
come of  differences in receptor affinities for the extent of  receptor translocation to the nu-
cleus. The expected differences in translocation rate and onset may probably only be evident 
when lower, more physiological doses of  corticosterone levels are administered. Additional 
information about the relationship between hormone plasma concentrations and receptor 
translocation could come from correlations in individual animals. Unfortunately, the statis-
tical power of  such correlations in the present experiment is very weak, and no meaningful 
relationships resulted from such an analysis (data not shown).
In summary, the results of  this study suggest a revision of  the view that MR and GR trans-
locate uniformly in the rat hippocampus since we have demonstrated that they are trans-
ported in a subregion-specific manner. Even though these data indicate the need for further 
studies on the underlying mechanism of  this differential translocation in the hippocampus, 
they could help to explain the cell type-specific effects of  corticosteroids in the hippocam-
pus. Also, the data show that in CA1, the translocation of  MR to the nucleus occurs in 
response to a rise in ligand concentrations; hence the ligand concentration is rate limiting 
for at least nuclear localisation. In other subfields, the nuclear localisation in absence of  
ligand is not further increased when ligand concentrations rise, hence the receptor seems 
to be the rate limiting factor. Furthermore, our results illustrate that immunohistochemical 
studies can provide detailed information about the localisation of  the receptors in vivo, 
which can assist in the evaluation of  receptor activation during pharmacological treatments 
and physiological conditions. 
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Disrupted corticosterone pulsatile patterns  
attenuate responsiveness to glucocorticoid  
signalling in rat brain
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Abstract
Chronically elevated circulating glucocorticoid levels are thought to enhance vulnerability 
to psychopathology. Here we hypothesised that such sustained glucocorticoid levels, distur-
bing corticosterone pulsatility, attenuate glucocorticoid receptor signalling and target gene 
responsiveness to an acute challenge in the rat brain. 
Rats were implanted with vehicle, 40% or 100% corticosterone pellets known to flatten 
ultradian and circadian rhythmicity while maintaining daily average levels or mimic patho-
logical conditions. Additionally, recovery from constant exposure was studied in groups 
that had the pellet removed 24 hours prior to the challenge. Molecular markers for receptor 
responsiveness (receptor levels, nuclear translocation, promoter occupancy and target gene 
expression) to an acute challenge mimicking the stress response (3 mg/kg ip) were studied 
in the hippocampal area. 
Implantation of  40% and 100% corticosterone pellets dose-dependently down-regulated 
GR and attenuated MR and GR translocation to the acute challenge. Interestingly, while 
target gene Gilz expression to the challenge was already attenuated by tonic daily average 
levels (40%), Sgk-1 was only affected after constant high corticosterone exposure (100%) 
indicating altered receptor responsiveness due to treatment. Washout of  100% cort reco-
vered all molecular markers (partial) while removal of  the 40% cort pellet still attenuated 
responsiveness to the challenge. 
We propose that corticosteroid pulsatility is crucial in maintaining normal responsiveness to 
glucocorticoids. While the results with 100% corticosterone are likely attributed to receptor 
saturation, subtle changes in the pattern of  exposure (40%) induces changes at least as seve-
re for glucocorticoid signalling as overt hypercorticism suggesting an underlying mechanism 











Rhythmic secretion of  glucocorticoids is one of  the major characteristics of  the hypotha-
lamic-pituitary-adrenal (HPA) axis, which plays a pivotal role in maintenance of  homeosta-
sis (de Kloet et al. 2005, Herbert et al. 2006). This rhythmicity is based on approximately 
hourly ultradian bursts of  corticosterone into the blood stream showing circadian variation 
in amplitude (Tapp et al. 1984, Jasper & Engeland 1991, Windle et al. 1998a) and also exists 
at the level of  target tissues such as the brain (Droste et al. 2008). Pulse amplitude and fre-
quency can be remarkably variable in different physiological states, (i.e. lactation and ageing 
(Lightman et al. 2000)). However, dysregulation of  ultradian rhythmicity is also apparent in 
stress-related disease (Deuschle et al. 1997, Hartmann et al. 1997), though its precise func-
tion still remains unknown (Young et al. 2004, de Kloet & Sarabdjitsingh 2008, Lightman 
et al. 2008). 
The actions of  glucocorticoids are mediated by the high affinity mineralocorticoid receptor 
(MR) and the glucocorticoid receptor (GR); the latter receptor has a ten-fold lower affinity 
for corticosterone (Reul & de Kloet 1985). Both nuclear receptors are abundantly expressed 
in the brain, especially in limbic areas such as the hippocampus (Herman 1993, De Kloet 
et al. 1998). MR and GR act as ligand-activated transcription factors that translocate to the 
nucleus upon ligand binding. In the nucleus the receptors modulate target gene expression 
via interactions with specific glucocorticoid responsive elements (GREs) in the regulatory 
region of  glucocorticoid target genes or via protein-protein interactions with other trans-
cription factors (Mangelsdorf  et al. 1995, Datson et al. 2008). Nuclear translocation of  GR 
is known to vary according to circadian fluctuations in corticosterone levels (Kitchener et al. 
2004). Moreover, repeated rapid nuclear translocation of  GR following intravenous cortico-
sterone injections that mimic ultradian pulses was demonstrated in rats (Stavreva et al. 2009) 
while MR was continuously retained in the nucleus (Conway-Campbell et al. 2007), implying 
that disturbances in glucocorticoid pulsatility would mainly affect GR. 
It is now being recognised that access and binding of  steroid receptors to regulatory ele-
ments in the genome (Metivier et al. 2003), including GR, is highly dynamic (George et 
al. 2009, Stavreva et al. 2009). The individual steps of  the receptor signalling cascade (i.e. 
nuclear translocation, chromatin binding and modulation of  target gene expression) to-
gether determine cellular and/or tissue sensitivity to glucocorticoids and efficacy (Kino 
2007). Still, little information is available on how rapidly fluctuating glucocorticoid levels 
in vivo affect receptor signalling, transcriptional output and hence target tissue sensitivity 
thereby determining the functional effects of  glucocorticoid action. Changes in pattern of  
glucocorticoid exposure could possibly contribute to dysregulated glucocorticoid receptor 
signalling. Understanding the interplay between rapidly fluctuating glucocorticoid levels and 
76
receptor signalling therefore could greatly contribute to our knowledge of  cellular and tis-
sue responses. 
In the present study, we aimed to investigate the link between glucocorticoid pulsatility and 
target tissue sensitivity in response to an acute increase in glucocorticoids such as occurs 
during acute stress. Evidence from other hormonal systems suggests that the function of  
rapid ligand bursts is to maintain tissue sensitivity and receptor responsiveness (Hauffa 
2001). Therefore we hypothesised that constant levels of  glucocorticoids, thus loss of  pul-
satility, will similarly affect glucocorticoid signalling by changing the responsiveness of  the 
glucocorticoid receptor and its proximal targets. 
Glucocorticoid pulsatility was abolished by subcutaneous corticosterone pellet implantation 
thereby exogenously inducing constant levels of  glucocorticoids (Akana et al. 1985, Akana 
et al. 1992, Meijer et al. 1997). Consequently, we studied molecular markers for glucocorti-
coid signalling in the rat hippocampal area in response to an acute corticosterone challenge, 
superimposed on the chronically changed pattern of  exposure. We also investigated whether 
these changes can be normalised after reinstatement of  glucocorticoid pulsatility. Here we 
find that the transient response in glucocorticoid signalling is attenuated during exposure to 




Male Sprague-Dawley rats (Harlan, Leiden, The Netherlands) weighing approximately 250 
grams on the day of  surgery, were group housed on a 12 h/12 h light/dark cycle (lights on 
at 07:00 AM) in a temperature controlled facility. Animals were handled daily for a week 
before the start of  the experiment. Food and water were provided ad libitum. All experi-
mental manipulations were done in the morning. Experiments were approved by the Local 
Committee for Animal Health, Ethics and Research of  the University of  Leiden (DEC nr. 
07166). Animal care was conducted in accordance with the EC Council Directive of  No-
vember 1986 (86/609/EEC). 
 Experimental design 
Hormone levels were clamped at different constant levels using 40% and 100% corticoste-
rone (cort) pellets (40 or 100 mg corticosterone; MP Biomedicals, Ohio, USA), and compa-
red to 100 mg vehicle (cholesterol, Sigma-Aldrich, St. Louis, USA). Using isoflurane anaes-
thesia, pellets were subcutaneously implanted in intact animals randomly assigned to either 
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of  the five treatment groups (n = 24): vehicle, 40%, 100%, 40% WO (washout) and 100% 
WO cort. Animals were weighed daily during the seven days after pellet implantation. On 
experimental day 7, blood samples were collected via the tail vein in the morning (08.00) and 
afternoon (17.00) to verify flattening of  circadian cort levels in plasma without anaesthesia 
(Fluttert et al. 2000). Pilot studies indicated initial enhanced release of  corticosterone from 
the pellet on the first two days after implantation and steady-state levels thereafter (Meijer 
et al. 1997). As described in the results section, corticosterone levels were indeed constant 
the day before the corticosterone challenge. In addition, high frequency blood sampling was 
used to verify flattened corticosterone rhythms with higher resolution [10 min intervals; (RA 
Sarabdjitsingh 2009)].
Early in the morning on post-surgery day 8 (08.00-09.00), animals from the WO groups 
were briefly anaesthetised during which the pellet was rapidly removed (washout) while the 
animals from the other groups were sham-operated. To ascertain normalisation in respon-
siveness of  most of  the available GR molecules, the washout period was decided to be 24 
hours, according the half  life time of  GR redistribution to the cytoplasm following hor-
mone withdrawal [t1/2 = 8-9 hours (Hache et al. 1999)]. After 24 hours, animals from all 
five groups were challenged with a high dose of  corticosterone (3 mg/kg ip corticosterone-
HBC; Sigma-Aldrich, USA). Tail blood samples were taken before and during the challenge 
to monitor corticosterone levels in blood. Animals were decapitated (n = 8 per time point 
per treatment group) 0, 60 and 180 min after injection. Brain tissue was collected, snap-fro-
zen in isopentane on dry ice and stored at -80 ºC until further processing. Of  each animal, 
one hemisphere of  the brain was used for immunohistochemistry and in situ hybridisation 
while the hippocampus of  the other hemisphere was isolated for Western blot analysis or 
chromatin immunoprecipitation (ChIP). Additionally, the thymus and adrenal glands were 
dissected, cleaned and weighed.
 Corticosterone measurements 
Blood samples were centrifuged for 15 min at 4000 rpm at 4 ̊ C. Plasma was stored at -80 ̊ C 
until processed using a commercially available radio immuno assay (RIA; MP Biomedicals 
Inc., CA., USA) according to the manufacturer’s instructions. 
 Protein sample preparation 
Hippocampal total protein samples (n = 12) were obtained by homogenising in ice-cold ly-
sis buffer containing 1% NP-40, 1% sodium deoxycholate, 0,1% SDS, 0.15 M NaCl, 50mM 
Tris, pH 7.5 and protease inhibitors (Complete Mini cocktail tablets, Roche, The Nether-









 Western blotting and analysis 
Western blot was performed as described before (Conway-Campbell et al. 2007). Twenty 
µg protein samples were loaded on 5-8% polyacrylamide gels and transferred to PVDF 
membranes (Amersham Biosciences, Uppsala, Sweden). Membranes were probed with 
either primary anti-GR antibody (M20, Santa Cruz Biotechnology) or anti-MR antibody 
[MR1-18 1D5, kindly supplied by Dr. Gomez-Sanchez (Gomez-Sanchez et al. 2006)] and 
subsequently with anti-rabbit IgG-HRP (Santa Cruz Biotechnology) or anti-mouse IgG-
HRP (Amersham Biosciences). Signal was detected using enhanced chemiluminescence 
reagent (ECLplus, Amersham Biosciences) and enhanced chemoluminescence hyperfilm 
(Amersham Biosciences). Membranes were also probed for α-tubulin as a loading control 
(Sigma Aldrich, USA).
Western blot bands were quantified by densitometry using an Epson perfection scanner 
(Epson Europe, NL) and ImageJ analysis software (NIH, USA; http://rsb.info.nih.gov/ij/). 
Optical density of  GR and MR bands were corrected for film background and normalised 
for α-tubulin. Samples were compared within an individual blot, calculating fold induction 
from the control group loaded on each blot (vehicle t = 0). Fold inductions from all data 
sets were pooled to obtain group means ± SEM.
 Immunohistochemistry 
To visualise the subcellular distribution pattern of  MR and GR immunoreactivity (IR) in 
hippocampal CA1, immunohistochemistry was performed on 20 µm slices as described 
previously (Sarabdjitsingh et al. 2009). Sections were incubated with primary GR (H300 
Santa Cruz Biotechnology, USA) and MR antibodies (MR1-18 1D5). After washing, secti-
ons were incubated with secondary antibodies AlexaFluor- A488 and AlexaFluor-A594 IgG 
(Molecular Probes, USA). Nuclei were visualised with Hoechst 33258 (Molecular Probes, 
USA) and slides were mounted with Aqua Polymount (Polysciences, Inc). Controls inclu-
ded incubation of  slides with equal amounts of  normal rabbit and mouse IgG (Santa Cruz 
Biotechnology, USA), swapping of  secondary fluorescent labels and incubation without any 
primary antibodies.
 Confocal microscopy and image analysis 
Nuclear translocation patterns were measured as previously described (van der Laan et al. 
2005, Sarabdjitsingh et al. 2009). Briefly, the Hoechst stain was used as a template to identify 
the nucleus in sections. Fluorescence intensity values of  nuclear IR were measured using 
ImageJ 1.32j analysis software (NIH, USA) on images (630x magnification, 155 x 155 µm) 
acquired with a Nikon confocal microscope (Nikon TE 2000-e). Per animal (n = 8 per time 
point), two frames with 30-40 cells on average were acquired. Non-specific binding (normal 
mouse and rabbit IgG) and background staining of  the sections were also measured and 
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subtracted from the total signal to obtain the specific signal. Cells that had a clear ovally-
shaped nucleus with a diameter of  approximately 5-7 µm and showed IR clearly above 
background were included for analysis thereby excluding cells that were not in the plane of  
focus.
 In situ hybridisation 
In situ hybridisation was used to study expression patterns of  glucocorticoid target genes 
Sgk-1 and Gilz in brain. In situ hybridisation was performed on 20 µm slices as previously 
published (Meijer et al. 2000). 33Phosporus end-labelled oligonucleotide probes (2 x 106 
dpm) for Gilz (van der Laan et al. 2008b) and Sgk-1 (van Gemert et al. 2006) were used. The 
signal was quantified from films exposed 6-8 days (X-OMAT AR, Kodak, Rochester, NY) 
using ImageJ 1.32j analysis software. Relative expression levels were determined and related 
to standard curves of  14C (RPA 504 microscales, Amersham, UK), included to ensure that 
grey values were within the linear range between 0 and 255. Three hippocampal sections per 
animal (n =8 per time point) were analysed. 
 Chromatin immunoprecipitation and RT-qPCR 
Chromatin immunoprecipitation to study Sgk-1 promoter occupancy by GR was adapted 
and modified from Van der Laan et al. (van der Laan et al. 2008b). Fixed chromatin de-
rived from the hippocampi of  three animals was pooled and sheared, yielding fragments 
of  100-500 bp (20 pulses of  30 seconds; Bioruptor, Diagenode). Immunoprecipitation was 
performed with either 6 µg of  GR-specific H300 or normal rabbit IgG (Santa Cruz Bio-
technology) overnight at 4 °C. After DNA recovery (Nucleospin, Macherey-Nagel), RT-
qPCR was performed to study enrichment of  Sgk-1 promoter fragments in the different 
treatment groups (LightCycler FastStart DNA Master PLUS SYBR Green I, Roche), ac-
cording to manufacturer’s instructions. Primers were designed around the glucocorticoid 
response element (GRE) of  the rat Sgk-1 promoter (GGCTCAAAATTTATGCGGAA 
(Sgk-1 forward); CGGAAATAAGTCTCTGCGCT (Sgk-1 reverse). Myoglobulin was used 
a negative control for GR chromatin occupancy: CCTCACATGGGCAGCTATTT (myo-
globin forward); GCTTGTGCAAGTCCAGACAG (myoglobulin reverse). PCR-products 
were analysed on an agarose-gel to check the length of  the amplicon. Immunoprecipitation 
with a non-specific antibody (normal IgG) did not result in increased DNA recovery and 
was used to correct the GR immunoprecipitated samples (Wang et al. 2004, van der Laan 
et al. 2008b) .  
 Statistical analysis 
Data are presented as mean ± SEM. Differences between groups were examined by one-way 
or two-way ANOVA. Tukey’s post-hoc testing was applied to compare individual groups 










Controls for subcutaneous corticosterone pellet treatment  
To validate that subcutaneous corticosterone pellet implantation effectively clamped circa-
dian fluctuations at expected concentrations, morning and evening corticosterone samples 
were taken seven days after pellet implantation (n = 24). Vehicle animals showed typical 
circadian variation in corticosterone levels (21.4 ± 2.7 and 171.7 ± 20.1 ng/ml; morning 
and evening levels, respectively). No circadian variation in morning and evening corticoste-
rone levels were found in the 40% (85.4 ± 6.6 and 90.0 ± 16.4 ng/ml) or 100% cort groups 
(254.8 ± 15.0 and 233.5 ± 14.5 ng/ml) indicating constant exposure around either daily 
average levels or at levels seen during stress-related disorders, respectively. Pellet removal 
in the morning of  post-surgery day 8 resulted in rapid decrease in corticosterone levels 
(morning corticosterone levels the day after pellet removal: 12.5 ± 3.9 and 33.3 ± 6.9 ng/
ml, 40% and 100% cort WO respectively). These values did not differ from vehicle animals 
(22.5 ± 3.0 ng/ml).
Corticosterone pellet implantation led to a dose-dependent decrease in body and thymus 
weight (Fig. 1A-B; F(4, 115) = 158.9; p < 0.05 and F(4, 115) = 208.4; p < 0.001) and decre-
ased adrenal weight (Fig. 1C; F(4, 114) = 21.1; p < 0.01), indicating that corticosterone pellet 
implantation was effective. Pellet removal and 24 hours of  washout of  exogenous cortico-
sterone did not result in recovery of  any of  the parameters measured (Fig. 1; dashed bars). 
Cort pellet implantation down-regulates MR and GR protein in hippocampus 
Western blot analysis for MR and GR was performed on hippocampal homogenate (Fig. 
2). MR protein showed a trend towards reduction in the 100% cort group (Fig. 2A; p = 
0.07). Pellet removal reversed any trend towards decreased MR protein levels in the 100% 
WO cort group. MR protein levels were not affected by 40% cort pellet implantation or 
washout.
Cort pellet implantation reduced GR protein levels in the 40% and significantly in the 100% 
cort pellets groups to 0.76 ± 0.07 and 0.65 ± 0.08, respectively compared to vehicle (F(2, 
31) = 5.1; p < 0.01; Fig. 2B). GR protein levels in the 40% WO cort group were still reduced 
after washout (0.74 ± 0.1), but in the 100% WO cort group a recovery was noted as values 
were not different from vehicle treated animals (0.88 ± 0.13; F(2, 27) = 1.2; p = 0.33).
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Figure 1 | Corticosterone pellet implantation affects glucocorticoid sensitive parameters. Animals implanted 
for 7 days with vehicle, 40% or 100% cort pellets (n=24). The dashed bars depict animals in which the cort pellet 
was removed (40% WO and 100% WO) and show dose-dependent decreases in A | relative body weight gain, 
B | thymus and C | adrenal weight as indicated with one-way ANOVA (* p < 0.05 compared to vehicle; Tukey’s 
post-hoc test).
Next to the effect of  cort pellet implantation, we studied whether there was an acute effect 
of  the corticosterone injection (cort challenge) on MR and GR protein levels. Western blot 
analysis of  hippocampal homogenate of  rats from the time groups 0, 60 and 180 min after 
the cort challenge of  all treatment groups, showed no effect of  time on MR (p = 0.35) or 
GR protein levels (p = 0.49; two-way ANOVA; data not shown) indicating that acute chan-


























































































Figure 2 | Corticosterone pellet implantation decreases MR and GR protein levels. Western blot analysis 
of  receptor protein levels in hippocampal homogenate (n = 12) after 7 days of  vehicle, 40%, and 100% cort 
pellet implantation shows no significant effect on A | MR protein levels. B | A dose-dependent decrease was 
observed for GR protein levels in the 100% cort group. Interestingly, after washout (dashed bars), GR levels 
recovered in the 100% WO group, while the 40% cort group was still affected. Receptor protein levels were 
normalized against α-tubulin. * p < 0.01 compared to vehicle; one-way ANOVA and Tukey’s post-hoc test. 
 
Corticosterone pellet implantation attenuates GR translocation in CA1 cells 
To study a different aspect of  the receptor protein, we visualised corticosterone-induced 
MR and GR translocation patterns to the nucleus, rather than total protein hippocampal 
levels (Fig. 2), using immunohistochemistry and confocal imaging. MR immunoreactivity 
(IR) in CA1 pyramidal cells of  the rat hippocampus was mostly localised in the nucleus be-
fore the cort challenge in all conditions (Fig. 3A and C, left panel). No difference in baseline 
levels of  the different treatment groups was detected (F(2, 19) = 1.5; p = 0.24). Nuclear MR 
IR showed a very modest but significant increase after the challenge only in vehicle pellet 
rats at 60 minutes (Fig. 3A; F(2, 16) = 3.6; p = 0.049); no MR translocation was observed in 
the other treatment groups. Washout of  corticosterone levels did not result in recovery of  
MR nuclear translocation in the 40% and 100% WO groups.
In contrast, low levels of  nuclear GR IR were observed before the challenge in the vehicle 


























































GR IR was observed  (F(2, 18) = 8.8; p < 0.01) which returned back to baseline levels after 
180 min, clearly indicating nuclear translocation of  GR in CA1 cells. Implantation of  the 
40% cort pellet did not affect basal levels of  nuclear GR IR, but completely abolished the 
increase in nuclear GR signal at 60 minutes after the acute injection (Fig. 3B). The 100% 
cort pellet  increased ‘basal’ levels of  nuclear GR significantly (F(2, 18) = 8.7; p < 0.01), 
but no additional nuclear GR localisation was observed after the cort challenge. Washout 
of  corticosterone levels did not result in recovery of  GR nuclear translocation in the 40% 
WO group. However, a trend towards recovery in GR translocation (p = 0.1) was found in 
the 100% WO group (Fig. 3B).
Corticosterone pellet implantation affects glucocorticoid target gene expression
To monitor primary receptor responsiveness we studied the expression profiles of   two 
primary glucocorticoid-responsive genes: Gilz (Yachi et al. 2007, van der Laan et al. 2008b) 
and Sgk-1 (van Gemert et al. 2006) in the rat hippocampal area. 
Figure 3 | Subcellular localisation of  MR and GR in pyramidal CA1 cells is affected by cort pellet implanta-
tion. A | Quantification of  nuclear intensity visualised by C | immunohistochemistry and confocal imaging only 
showed an effect of  the cort challenge on MR nuclear localisation in the vehicle group (* p < 0.05). B | A clear 
transient increase in nuclear GR IR was observed in vehicle animals after the challenge (* p < 0.01). This effect 
was abolished in the 40% and 100% cort groups while basal levels were increased in the 100% cort group (# p 
< 0.01). Removal of  100% cort pellets resulted in a trend (p = 0.1) towards recovery in GR translocation. N = 
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Gilz expression in rat hippocampus 
In vehicle pellet animals, low basal expression of  Gilz was observed in the CA1 pyramidal 
cell layer, while relatively high expression was found in CA3, dentate gyrus and cortex (Fig. 
4A). In CA1 in vehicle animals, the cort challenge led to increased expression levels at 60 
min (F(2, 19) = 3.6; p < 0.05). Gilz mRNA expression in CA1 in the 40% and 100% cort 
pellet groups resembled the GR translocation data. In the 100% cort, but not the 40% 
group, pellet implantation resulted in increased ‘basal’ expression levels (F(2, 20) = 6.4; p 
< 0.05) but neither group responded to the additional corticosterone challenge (Fig. 4B). 
Though pellet removal and washout of  exogenous corticosterone decreased baseline levels 
back to vehicle, the pattern of  gene expression did not fully recover while the kinetics of  
the response in the 100% WO group seemed changed: a trend towards recovery was found 
for the 100% cort WO group at 60 and 180 minutes after injection (p = 0.07). In CA3 (Fig. 
4C), expression levels did not change as a consequence of  time or treatment. 
Sgk-1 expression in rat hippocampal area 
Under basal conditions, Sgk-1 mRNA was expressed in all hippocampal regions, but highest 
in CA3. The corticosterone challenge led to a marked increase in the CA1 hippocampal 
subregion but also in the white matter surrounding the hippocampus which dropped back 
to baseline after 180 min (Fig. 5A). This increase has been reported before and probably 
reflects regulation in oligodendrocytes (van Gemert et al. 2006). Sgk-1 expression in white 
matter (Fig. 5B; corpus callosum) was maximally sustained in the 100% cort group but 
expression in response to constant and acute changes in corticosterone in the 40% cort pel-
let implantation group (F(2,19) = 46.9; p < 0.001) was identical to the vehicle pellet group 
(F(2,20) = 185.5; p < 0.001). Washout of  exogenous corticosterone recovered the transient 
response in Sgk-1 expression in the 100% WO group (Fig. 5B; F(2,20) = 130.1; p < 0.001). 
Similar results were observed for CA1, but in the 100% cort group, induction of  ‘basal’ 
Sgk-1 mRNA levels was absent. In contrast to the data for Gilz mRNA, responsiveness 
remained present in the 40% cort pellet group (Fig. 5C). Similar to Gilz mRNA, in CA3 no 
effect of  constant and acute cort exposure was observed for Sgk-1 mRNA (Fig. 5D).
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Figure 4 | Gilz mRNA expression profiles in rat hippocampus. A | Gilz expression was visualised in vehi-
cle animals 0, 60 and 180 min after the cort challenge (n = 8 per time point) using ISH. Values were calibrated 
against a C14 grey-scale ladder. Quantification of  relative optical density (ROD) in B | CA1 pyramidal cells show 
transient responses in vehicle animals (* p < 0.05) but sustained responses after 40% and 100% cort pellet im-
plantation. Cort pellet implantation increased ‘basal’ levels significantly in the 100% cort group (# p < 0.05). C | 
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Figure 5 | Sgk-1 mRNA expression profiles in rat hippocampus. A | ISH was used to visualise Sgk-1 expres-
sion in vehicle animals 0, 60 and 180 min after the cort challenge (n = 8 per time point). Values were calibrated 
against a C14 grey-scale ladder. Quantification ROD in B | white matter corpus callosum and C | CA1 pyramidal 
cells show transient increases in response to the challenge in vehicle and 40% treated animals, but not in 100% 
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Sgk-1 promoter occupancy by GR correlates with expression profiles
Because the gene expression profiles were different between the treatment groups, we de-
termined whether the altered profiles were also accompanied by changes at the level of  
GR chromatin occupancy using chromatin immunoprecipitation (ChIP) for the Sgk-1 gene. 
Since no significant difference in Sgk-1 expression profiles between vehicle and 40% cort 
animals was observed, we chose to compare vehicle and 100% cort treated animals. In ve-
hicle pellet animals, GR occupancy increased 3.6 ± 0.2 fold at 60 min, and returned back 
to baseline 180 min after the challenge (p < 0.001; Fig. 6), indicating that GR binding at 
response elements correlates with the response profile of  this target gene. Challenging the 
100% cort group did not result in increased DNA recovery in the GR-specific groups since 
levels were already increased before injection. Again, we observed elevated basal levels com-
pared to vehicle (p < 0.01) which was still slightly elevated after washout. Washout of  cor-
ticosterone resulted in recovery of  the transient increase in Sgk-1 promoter occupancy by 
GR by 3.1 ± 0.1 fold 60 min after the challenge (p < 0.001; Fig. 6). Control measurements 
for the negative control locus of  the myoglobulin gene showed no enrichment of  GR in the 
vehicle group after the challenge (p = 0.95; data not shown), indicating that the observed 
increase in promoter occupancy of  glucocorticoid target gene Sgk-1 is specific.
Figure 6 | Sgk-1 promoter occupancy in rat hippocampus. Chromatin immunoprecipitation and RT-qPCR 
to represent Sgk-1 promoter occupancy by GR for vehicle and 100% cort pellet animals (3 hippocampi pooled 
per time point). In the vehicle animals the cort challenge resulted in a transient increase in promoter occupancy 
by GR 60 min after while this response was attenuated in the 100% cort animals. Basal levels were increased 
compared to vehicle (p < 0.01). Washout of  corticosterone shows a recovery in the transient response to the 
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In the present study we used two different concentrations of  corticosterone pellets that 
abolish normal corticosterone pulsatility by clamping hormone levels around daily average 
(40% cort pellet) or at supra-physiological levels as may be seen during pathology (100% 
cort pellet). We have shown considerable changes in molecular markers for both chronic 
and acute glucocorticoid action in the rat hippocampus. Moreover, we demonstrate that the 
consequences of  subtle variations in glucocorticoid pattern are at least as severe as those 
with overt hypercorticism. We therefore propose that pulsatile glucocorticoid levels are es-
sential in maintaining receptor responsiveness, particularly of  the GR, and prevent desensi-
tisation of  some targets. Consequently, we suggest that the pattern of  hormone exposure is 
a major determinant in the adaptive capacity of  target tissues in the face of  acute stress. 
 Validation of  experimental design 
Subcutaneous corticosterone pellet implantation, providing a constant signal in blood plas-
ma, mimics some of  the risk factors for stress-related disease by disrupting normal gluco-
corticoid variation (Young et al. 2004, de Kloet et al. 2005, Herbert et al. 2006, Lightman et 
al. 2008). In line with previous studies that have shown flattening of  circadian corticostero-
ne rhythms (Akana et al. 1985, Akana et al. 1992, Meijer et al. 1997), we effectively clamped 
corticosterone levels around the daily average or at levels seen during chronic stress [40% 
and 100% cort pellet, respectively (RA Sarabdjitsingh 2009)]. This allowed us to directly 
compare the impact of  a corticosterone challenge on molecular targets in the context of  
either constant of  fluctuating hormone patterns. 
Typically, subcutaneous corticosterone pellet implantation results in dose-dependent decre-
ases in body, thymus and adrenal gland weight (Spencer et al. 1991, Akana et al. 1992). This 
decrease was also present in the 40% cort group, though to a lesser extent than the 100% 
cort group, suggesting mild hypercorticism. However, we cannot exclude that the observed 
decreases in the 40% group are due to alterations in the pattern of  plasma corticosterone 
since we assume that changed pulsatility may affect glucocorticoid sensitive parameters. We 
interpret our groups as the 40% cort lacking pulsatility with daily cort exposure in the nor-
mal range and the 100% group lacking pulsatility while having overt hypercorticism.  
 100% corticosterone pellet treatment 
MR and GR are both regulated by glucocorticoids (De Kloet et al. 1998). In the present 
data, the dose-dependent down-regulation of  hippocampal GR rather than MR protein 
(Spencer et al. 1991), was more pronounced after constant corticosterone exposure. Addi-
tionally GR nuclear translocation patterns were clearly more attenuated after the challenge. 
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We assume that MR is already fully saturated under the conditions of  40% cort treatment 
(Reul & de Kloet 1985, Meijer et al. 1997) as no additional increase in nuclear MR translo-
cation was observed in our study. Also, we did not specifically address MR and MR-targets 
as the dose of  corticosterone (3 mg/kg i.p.) that was used to challenge the adrenally intact 
animals is more suitable to study GR-dependent effects. This is supported by the lack of  
glucocorticoid regulation in the CA3 pyramidal cell layer of  the hippocampus. This region 
has very low levels of  GR but expresses MR (Arriza et al. 1988, Ahima & Harlan 1990, 
Sarabdjitsingh et al. 2009). Even though the target genes Gilz and Sgk-1 that were used in 
this study are both expressed in this area under basal conditions, and are regulated by gluco-
corticoids in adrenalectomised animals (van der Laan et al. 2008b), we did not observe any 
change in transcriptional output after constant or acute corticosterone treatment. Thus, our 
data show that both the 40% and 100% pellets in particular affected GR signalling.
GR homologous down-regulation after chronic high glucocorticoid treatment has been 
observed before (Sapolsky et al. 1984, Reul et al. 1989, Spencer et al. 1991). In spite of  
down-regulation, GR still exerted tonic effects, e.g. as is seen from the constant high occu-
pancy of  the Sgk-1 promoter. Many studies described such sustained effects of  chronic high 
corticosterone levels on the brain mediated via GR. For instance, feedback sensitivity of  
the HPA axis after stress is attenuated after chronic treatment with corticosterone through 
occupancy of  GR (Akana et al. 1992, Bradbury et al. 1994). Also, CA1 pyramidal cells seem 
to lose their potential to normalise enhanced activity after stress (Joels et al. 2007), e.g. as 
seen from the risk of  calcium overloading (Karst & Joels 2007) and attenuation of  functio-
nal 5-HT responses by developing resistance to GR-mediated enhancement of  membrane 
hyperpolarisation (Karten et al. 1999). We observed sustained effects of  GR on expression 
of  target genes Sgk-1 and Gilz in a gene and cell type dependent manner. This is in line with 
recent data that show complex kinetic gene response profiles under constant glucocorticoid 
conditions which can be transient but also tonic (John et al. 2009). 
The acute effects of  corticosterone that are superimposed on the 100% corticosterone 
treatment were attenuated, e.g. GR nuclear translocation and Sgk-1 promoter occupancy 
after the cort challenge. The very high circulating levels of  corticosterone are very likely to 
saturate GR and render it non-responsive to additional hormone. This likely creates a non-
favourable situation in which the normal flexibility in glucocorticoid signalling is lost. 
 40% corticosterone pellet treatment 
The results from the present study show that 40% cort pellet treatment, which results in 
much lower, physiologically relevant constant corticosterone levels, also has tonic effects. 
Previous studies have shown attenuated stress responsiveness (Akana et al. 1992, Meijer et 








1997). These effects were interpreted as mediated via MR (Bradbury et al. 1994, Meijer et 
al. 2000). In our study some additional GR mediated effects occurred, e.g. thymus involu-
tion and a trend towards down-regulation of  hippocampal GR protein levels. However, 
40% cort treatment did not change baseline expression of  our rather sensitive expression 
markers. A lack of  GR responsiveness became evident after the acute challenge as no ad-
ditional increase in GR nuclear translocation and target gene expression was observed. This 
suggests that the functionality of  glucocorticoid pulsatility becomes apparent when the 
system is challenged and requires a rapid onset and termination of  tissue responses. In the 
40% cort group the pattern, but not so much the total amount, of  corticosterone exposure 
differs from vehicle animals (RA Sarabdjitsingh 2009). We propose that the pattern of  cor-
ticosterone exposure is therefore a major determinant in glucocorticoid signalling and that 
changes in this pattern have at least as many consequences for cellular responses than overt 
hypercorticism (100% cort). This is also strengthened by the normalisation in GR responsi-
veness after washout of  constant 100% corticosterone levels but not in the 40% cort group. 
This suggests that tonic effects of  glucocorticoids can be reversible and are modulated by 
an underlying mechanism that is sensitive to changes in the normal pulsatile pattern.
The use of  40% cort pellet resulted in aberrant GR translocation while the transcriptional 
profiles of  target genes were affected gene-specifically. While induction of  Gilz expression 
was already attenuated by 40% cort pellet implantation, Sgk-1 expression in the hippocam-
pal area was only sustained after exposure to high levels of  corticosterone (100% cort). We 
therefore conclude that receptor translocation is certainly not rate-limiting for all signal-
ling pathways. The molecular response to glucocorticoids via GR involves many complex 
regulatory actions and cannot therefore simply be explained by the duration and presence 
of  the hormone. These gene-specific effects may be related to differences in the potency 
of  GR at target genes, resulting in different transcriptional output patterns (Meijer 2006, 
John et al. 2009). In addition, rapid receptor dynamics together with the repeated cycling of  
chaperones and cofactors continuously change the local environment to which promoters 
are exposed and underline the time and region -dependency of  receptor effectiveness (Bid-
die & Hager 2009). 
 Conclusion 
Frequency encoding of  intercellular signals is a well accepted mode of  communication in 
mammalian systems including the endocrine system. For instance, rapidly fluctuating levels 
of  growth hormone elicits significant sexual dimorphic effects on gene expression (Wax-
man et al. 1995). Similarly, modulation of  episodic release of  GnRH influences the secre-
tory patterns of  LH and FSH and prevents receptor desensitisation (Belchetz et al. 1978, 
Wildt et al. 1981). These studies imply that ultradian hormone signalling enables systems 
to maintain responsiveness and prevent receptor desensitisation and is supported by our 
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findings. Manipulation of  the temporal aspect is already a successfully used approach in cli-
nical therapy for instance for growth hormones (Amato et al. 2000) and estrogens (Shoupe 
2001). Linking the knowledge about ultradian glucocorticoid pulsatility and receptor signal-
ling could therefore greatly contribute to clinical therapy. 
In the present study, we provide evidence that frequency encoding by rapid glucocorticoid 
signalling is critical in functionally maintaining receptor responsiveness and preventing de-
sensitisation of  some targets. We clearly demonstrate that the ability of  the receptor to 
respond to glucocorticoids as defined by receptor translocation and binding to its proximal 
targets is attenuated when pulsatile corticosterone signalling is lost. We therefore propose 
that the molecular response of  target tissues induced by a corticosterone challenge is a re-
sultant of  the dynamic interplay between the corticosterone exposure regime (pulsatile or 
continuous) and steroid receptor signalling. The findings of  this study suggest that pulsatile 
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Recovery from disrupted ultradian 
glucocorticoid rhythmicity reveals a dissociation  




Ultradian release of  glucocorticoids is thought to be essential for homeostasis and health. 
Deviation from this pulsatile release pattern is considered to compromise resilience to 
stress-related disease, even after hormone levels have normalised. Here, we investigate how 
constant exposure to different concentrations of  corticosterone affects diurnal and ultra-
dian pulsatility. The rate of  recovery in pulsatile HPA activity after withdrawal of  exogenous 
corticosterone is also examined. Finally, the behavioural and neuroendocrine responsive-
ness to an audiogenic stressor is studied.
Adrenally intact male rats were subcutaneously implanted with vehicle, 40% or 100% corti-
costerone pellets for 7 days. The continuous release of  corticosterone from these implants 
abolished diurnal and ultradian corticosterone variation as measured with high frequency 
automated blood sampling. Pellet removal on post-surgery day 8 allowed rapid recovery of  
endogenous rhythms in animals previously exposed to daily average concentrations (40%) 
but not after exposure to high concentrations (100%) of  corticosterone. Behavioural and 
neuroendocrine responsiveness to stress was distinctly different between the treatment 
groups. Audiogenic stimulation one day after pellet removal resulted in a similar corticoste-
rone response  in animals previously exposed to 40% corticosterone or vehicle. The 40% 
pellet group showed, however, less and shorter behavioural activity (i.e. locomotion, risk as-
sessment) to noise stress as compared to 100% corticosterone and vehicle treated animals.  
In conclusion, unlike the animals impanted with 100% corticosterone, we find that basal 
HPA axis activity in the 40% group which had mean daily levels of  circulating cortico-
sterone in the physiological range, rapidly reverts to the characteristic pulsatile pattern of  
corticosterone secretion. Upon reinstatement of  the ultradian rhythm, despite the fact that 
these animals did not differ from controls in their response to noise stress, they did show 









The diurnal variation in the secretion of  glucocorticoids is principally controlled by the 
hypothalamic suprachiasmatic nucleus and is fine-tuned by autonomic nervous system ac-
tivity and afferents of  the central hypothalamic-pituitary-adrenal (HPA) axis (Kalsbeek & 
Buijs 2002, Dickmeis 2009). Daily variations in glucocorticoid hormone concentrations are 
thought to be fundamental for the maintenance of  physiology and well being, as deviations 
from the normal release pattern are considered to enhance vulnerability to stress-related 
disease (Young et al. 2004, de Kloet et al. 2005). These diurnal fluctuations consist of  ap-
proximately hourly, ultradian glucocorticoid hormone bursts that change in amplitude ac-
cording the time of  day (Jasper & Engeland 1991, Windle et al. 1998b, Lewis et al. 2005). 
Superimposed on these rhythms is the HPA-driven glucocorticoid response to a stressor. 
Alterations in glucocorticoid pulsatile patterns can occur and are associated with normal 
transitions in physiological states but also stress-related disorders. For instance in rodents, 
lactation suppresses pulsatility, while during ageing the hourly pattern becomes disorganised 
(Lightman et al. 2000). In humans, depression is associated with enhanced pulse magnitude 
thereby abolishing circadian variation in pulse amplitude, resulting in dramatically changed 
patterns of  tissue exposure to hormone (Holsboer 2000, Young et al. 2004, de Kloet & Sa-
rabdjitsingh 2008, Lightman et al. 2008). However, the functional contribution of  ultradian 
glucocorticoid pulses to HPA axis reactivity and stress responsiveness, and the consequen-
ces of  changes in pulse characteristics for physiology are largely unknown.
Diurnal rhythmicity can experimentally be abolished by subcutaneous implantation of  cor-
ticosterone releasing pellets that elevate circadian trough concentrations. Consequently via 
negative feedback mechanisms this leads to a compensatory lower output of  corticosterone 
from the adrenal cortex at the time of  the circadian peak (Akana et al. 1985, Akana et al. 
1992, Meijer et al. 1997). Previously, we have demonstrated that such flattening of  the 
diurnal corticosterone patterns has substantial effects on glucocorticoid receptor (GR) sig-
nalling in the rat hippocampus: while tonic actions of  glucocorticoids are apparent (Akana 
et al. 1992, Meijer et al. 1997), we found that the response in expression of  glucocorticoid 
marker genes to acute elevations superimposed on the constant hormone signal is atte-
nuated. Surprisingly, constant exposure to moderate concentrations of  corticosterone in 
some aspects had greater consequences for GR responsiveness than overt hypercorticism 
(Sarabdjitsingh et al. 2010). These data indicate that the tissue responsiveness to glucocorti-
coids depends on the pattern of  ligand exposure and that a pulsatile pattern is necessary to 
prevent receptor desensitisation.
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However, a number of  issues are still unresolved. It remains to be proven that ultradian va-
riations are abolished in the pellet model. Also, it is unknown how fast the negative feedback 
action abates after cessation of  constant exogenous corticosterone and when the endoge-
nous pulses re-emerge. Observations in rodents and humans with a history of  changes in 
corticosteroid exposure suggest that even after normalisation of  hormone levels, there are 
residual disturbances in the brain (Ratka et al. 1988, Tiemensma et al. 2010). In that res-
pect, while it is known that neuroendocrine stress responsiveness is clearly affected under 
conditions of  flattened corticosterone (Akana et al. 1985, Akana et al. 1992, Dallman et al. 
2004, Joels et al. 2007), very little data is available on the behavioural response to stress after 
changes in pulse characteristics. 
To this end, adrenally intact male rats were subcutaneously implanted with vehicle, 40% 
or 100% corticosterone pellets, respectively. As such animals were exposed to either high, 
pathological concentrations of  corticosterone (100% pellet) or on average, normal daily 
concentrations but in a continuous (40% pellet) rather than pulsatile manner (vehicle pel-
let). After seven days of  pellet implantation corticosterone pulsatile profiles were measured 
in individual animals using high frequency automated blood sampling (Windle et al. 1998b, 
Atkinson et al. 2006). Pellets were rapidly removed on day 8 to assess how fast ultradian 
rhythms recover after cessation of  constant corticosterone exposure (washout). As functio-
nal readout we measured hormonal and behavioural responsiveness to white noise stress.
We validate that different concentrations of  constant corticosterone exposure in adrenally 
intact rats indeed abolish both diurnal and ultradian rhythmicity. We also find that HPA axis 
activity flexibly recovers from long term exposure to 40% but not 100% corticosterone, but 
that in contrast the behavioural stress responsiveness is affected after washout in the 40% 
corticosterone group, compared to vehicle.
Experimental procedures
      
 Subjects 
Experiments were conducted on male Sprague-Dawley rats (Harlan, UK) weighing approxi-
mately 250 g at the time of  surgery. After arrival, animals were group housed (4 animals 
per cage) under standard environmental conditions and a 14 : 10 h light/dark cycle (lights 
on 05.15 h) and were allowed to acclimatise for a week. Food and water were provided ad 
libitum throughout the experiment. Animal procedures were approved by the University of  
Bristol Ethical Review Group. Animal care was conducted in accordance with Home Office 
guidelines, the UK Animals (Scientific Procedures) Act 1986 and the EC Council Directive 
of  November 1986 (86/609/EEC). 
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 Surgery 
Surgery was performed essentially as described previously (Spiga et al. 2007). Briefly, ani-
mals were anaesthetised with a combination of  Hypnorm (0.32 mg/kg fentanyl citrate and 
10 mg/kg fluanisone, i.m.; Janssen Pharmaceuticals, Oxford, UK) and diazepam (2.6 mg/
kg i.p.; Phoenix Pharmaceuticals, Gloucester, UK). The right jugular vein was cannulated 
by inserting a polythene cannula (Portex, Hythe, UK) into the vessel. The free end of  the 
cannula was exteriorised through a scalp incision and tunnelled through a protective spring. 
During the same surgery, 100 mg pellets containing either 40% or 100% corticosterone 
(40% and 100% corticosterone respectively; ICN Biomedicals, Irvine, USA) or 100% cho-
lesterol (vehicle, Sigma-Aldrich, St. Louis, USA), were subcutaneously implanted between 
the shoulder blades to obtain constant concentrations of  corticosterone in blood (Akana et 
al. 1985, Akana et al. 1992, Meijer et al. 1997). Following surgery, animals were individually 
housed and kept in the automated blood sampling room. The cannula was attached to a me-
chanical swivel that rotated through 360° in a horizontal plane and 180° through a vertical 
plane, allowing the rats to maximise freedom of  movement. The cannulae were flushed daily 
with heparinised saline to maintain patency. 
 
 Experimental design 
One cohort of  animals was used which were subjected to different phases of  the experi-
mental design. 
 Phase 1: basal diurnal and ultradian corticosterone rhythms  
The effect of  different concentrations of  exogenous corticosterone on basal diurnal and 
ultradian corticosterone rhythms was studied. Six days after pellet implantation, the cannula 
of  each animal was connected to an automated blood sampling (ABS) system as previously 
described in detail (Windle et al. 1998b, Atkinson et al. 2006). On post-surgery day 7, blood 
samples (37 µl aliquots) were automatically collected with 10 min intervals at a dilution of  
1:5 in heparinised saline. Due to practical limitations in the number of  samples that can be 
collected with the ABS in the same rat it was not possible to obtain a full corticosterone 
profile on this experimental day. Therefore, samples were collected during the trough (07.00 
and 10.00 hours) and peak (18.00 and 21.00 hours) of  hormonal release, the times during 
which strong differences in diurnal and ultradian concentrations have been described exten-
sively (Windle et al. 1998b, Atkinson et al. 2006, Spiga et al. 2007). Plasma was separated by 
centrifugation and then stored at −80 °C until processed for corticosterone measurements 
as described below. Due to practical reasons in blood sampling we had dropouts in the ve-
hicle group for the endocrine studies (phase 1 and 2). The obtained corticosterone values in 
this group are however consistent between the experiments and with previously published 
data (Atkinson et al. 2006, Spiga et al. 2007). Fortunately, these animals were still available 








 Phase 2: basal diurnal and ultradian corticosterone rhythms after pellet removal 
To investigate whether corticosterone rhythmicity would recover within one day of  ter-
mination of  constant corticosterone administration, on day 8 post-surgery the implanted 
pellets were removed (washout). Between 08.00-09.00 the pellets were removed under brief  
isoflurane anaesthesia (2-3 min) and animals were reconnected to the ABS at 09.30. 
Automated blood sampling started at 10.00 and samples were collected every 20 min (10:00-
13:00) or 10 min (13:00- 05:00). The impact of  exogenous corticosterone replacement on 
body weight, thymus weight and adrenal gland weight has been reported previously (Sa-
rabdjitsingh et al. 2010).
 Phase 3: Stress-induced behavioural and corticosterone responses  
Stress-induced corticosterone release and behavioural responsiveness were studied after 
cessation of  constant corticosterone concentrations. Animals were then exposed to white 
noise stress (99 dB for 10 min) in the morning of  day 9 post-surgery (06.00). Blood samples 
were collected every 20 min using the ABS between 05:00 and 07:20. During the same time 
animal home cage behaviour was recorded using cameras mounted above the cage of  each 
animal. Behavioural analysis was performed 10 min before, during and after relative to the 
onset of  the stressor. 
 Corticosterone measurements 
Blood samples were centrifuged for 15 min at 4000 rpm at 4 ̊ C. Plasma was stored at -80 ̊ C 
until processed using a commercially available radio immuno assay (RIA; MP Biomedicals 
Inc., CA., USA) according to the manufacturer’s instructions. Inter-assay and intra-assay 
variance was 6.9% and 7.3%, respectively. 
 Behavioural analysis  
The following behaviours were analysed with a semiautomatic scoring system (The Obser-
ver Mobile 4.1, Noldus Information Technology, The Netherlands): i) locomotion (walking, 
front and back paws change position), ii) risk assessment (‘seeking’ behaviour while the 
body is still or stretched), iii) face washing (grooming of  face using front paws), iv) body 
grooming (grooming using front and back paws, i.e. scratching), and v) sitting (e.g. sitting or 
sleeping). Total activity was calculated by adding the scores of  behaviours i – iv. In addition, 
the number of  vi) rearing (raising of  the rat and then lowering both front paws) and vii) 
digging events (moving around of  cage bedding with front paws) was counted. The data is 
presented in either 10 min bins (Table 3) or plotted per min to study changes in behavioural 
patterns over time (Fig. 4). 
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 Statistical analysis 
Statistical analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Data 
are expressed as the mean ± SEM except for individual corticosterone profiles. For phase 
1, two-way ANOVA was used to study the diurnal differences in mean corticosterone and 
AUC concentrations between treatment groups. Due to limited number of  samples col-
lected for analysis PULSAR analysis may not be reliable on short time intervals. Therefore, 
as an indication of  ultradian pulsatility, repeated measures-ANOVA was used to analyse the 
effect of  time on corticosterone concentrations in the 3 hours time frames in morning and 
evening. For phase 2, the hormone profile for each individual animal was analysed using 
the PULSAR algorithm (Merriam & Wachter 1982) with previously published G-values 
(Spiga et al. 2007). The following pulse characteristics were analysed: area under the curve 
(AUC), mean daily corticosterone concentration, number, height (absolute increase from 
zero baseline), amplitude (absolute increase from respective baseline) and frequency of  cor-
ticosterone pulses. One-way ANOVA and independent Student’s t-tests were used to test 
statistical differences in pulse characteristics between corticosterone- and vehicle- treated 
rats. For phase 3, repeated measures ANOVA was used to indicate time and treatment ef-
fects in stress-induced corticosterone profiles. Behavioural data were analysed using one-
way ANOVA or two-way repeated measures ANOVA with time and treatment as factors. 
Where applicable, post-hoc tests were used as indicated in the figure legends. With respect 
to repeated measures ANOVA, sphericity (e.g. comparable to homogeinity of  variance) 
was tested with Mauchly’s test. In case the conditions were not met, the rather conservative 
Greenhouse-Geisser correction was used to in order to have a valid F-ratio. Statistical signi-
ficance was accepted at a p-value < 0.05.
Results
Effect of  corticosterone pellet implantation on basal corticosterone rhythms 
Figure 1 depicts mean (Fig. 1A) and individual morning and evening plasma corticosterone 
profiles (Fig. 1B-D) of  animals from each treatment group measured on day 7 of  pellet 
implantation. Mean corticosterone concentrations and AUC are shown in Table 1. In agree-
ment with previous studies (Atkinson et al. 2006, Spiga et al. 2007), we observed in vehicle-
treated animals very low to non-detectable concentrations in the morning and distinctively 
higher fluctuating hormone concentrations in the evening (Fig. 1A and B), indicating sig-
nificant diurnal differences in mean corticosterone concentrations (Table 1; p = 0.03) and 
AUC (p = 0.04). In contrast, exogenous corticosterone exposure induced clear effects on 
corticosterone rhythms: both 40% and 100% corticosterone pellet implantation effectively 








noon and/or in the morning (Fig. 1A, C-D). No statistical differences between morning and 
evening mean corticosterone concentrations or AUC were found within these groups, while 
mean corticosterone concentrations in the 100% group were significantly higher compared 
to vehicle-treated animals (Table 1; p < 0.05).
As expected, ultradian pulses were only detected in the evening in vehicle-treated animals 
(effect of  time: p = 0.02) while the other treatment groups did not show statistically sig-
nificant differences in the morning or evening (Fig. 1A-B). These results show that both 
40% and 100% corticosterone pellet implantation successfully abolished both diurnal and 
ultradian corticosterone rhythms.
Table 1 | Morning and evening AUC and mean corticosterone concentrations in rats implanted with vehicle, 
40% or 100% corticosterone pellets 
                          Time of  day       AUC    Mean corticosterone (ng/ml)
Vehicle  07.00-10.00   164 ± 44                                9.2 ± 3.4
  18.00-21.00   621 ± 102 *                    36.5 ± 13.7 *
40% cort 07.00-10.00           342 ± 77                               21.6 ± 5.0
  18.00-21.00   323 ± 49                    19.1 ± 3.8
100% cort 07.00-10.00 3269 ± 570  #                180.2 ± 41.0  #
  18.00-21.00 3182 ± 501  #                170.3 ± 37.6  #
Values represent mean ± SEM of  AUC and mean corticosterone concentrations in rats exposed to vehicle (n=4), 
40% (n=7) and 100% corticosterone pellet (n=7) for 7 days measured in the morning (07.00 – 10.00) and in the 
evening (18.00 – 21.00). Two-way ANOVA (Games-Howell post-hoc test) was used to analyse diurnal differences 
in AUC (F(5, 12) = 13.1; p < 0.001) and mean corticosterone concentrations (F(5, 13) = 11.9; p < 0.001). Vehicle 
animals showed normal diurnal variation in mean corticosterone concentrations and AUC (* p < 0.05). No diur-
nal differences were detected in the 40% and 100% corticosterone pellet groups. Corticosterone concentrations 
and AUC were significantly higher in the 100% cort treated animals compared to morning and evening concen-






























































































   
   
   
   
   
   
   
   
   
   
   
   



































































































































































































































































































































































































































































































































































































Effect of  pellet removal on basal diurnal and ultradian corticosterone rhythms  
To determine whether endogenous corticosterone pulsatility recovers within one day from 
constant exogenous corticosterone administration, on day 8 post-surgery, pellets were re-
moved early in the morning. Figure 2 shows group averaged and individual plasma cor-
ticosterone profiles over 19 hours after removal of  pellets and reconnection to the ABS 
system. In vehicle-treated animals, typical diurnal and ultradian variation was observed with 
increasing mean corticosterone concentrations and ultradian pulses towards the dark phase 
(Fig. 2A-B). In 40% corticosterone-treated animals, pellet removal resulted in a rapid fall of  
corticosterone to very low concentrations and a recovery of  ultradian and diurnal rhythms 
(see below). The onset of  detectable ultradian pulses was observed around 16.00 suggesting 
a delay in reoccurance of  pulsatility compared to vehicle animals (Fig. 2A and C). 
Though in general a tendency towards decreased corticosterone concentrations was ob-
served, in the 100% corticosterone group no clear effect of  rapid reinstatement of  ultradian 
corticosterone pulsatility was observed (Fig. 2A and D). 
To study ultradian pulsatility in more detail, the PULSAR algorithm was used to identify 
pulse characteristics in individual animals (Table 2). The persistence of  very high corticoste-
rone concentrations in the 100% corticosterone group resulted in very high values for the 
different pulse parameters. To prevent these data from skewing the results and to compare 
the ultradian pattern of  the 40% group to vehicle in more detail, pulse characteristics were 
statistically compared between vehicle and the 40% corticosterone group using independent 
Student’s t-tests. PULSAR analysis revealed a decrease in mean corticosterone concentrati-
ons (p = 0.04) and pulse height (p = 0.04) in 40% cort-treated group, compared to vehicle. 
Furthermore, a trend toward a significant decrease was observed on AUC (p = 0.06) and 
pulse amplitude (p = 0.05). No significant difference in the number of  pulses and pulse 
frequency (p = 0.14) was observed indicating very similar pulse characteristics of  the 40% 





























































































































































































































































































































































































































































































Table 2 | Mean ± SEM of  PULSAR parameters measurements of  treated rats during 13.00 – 05.00 of  the 
sampling period
       Vehicle           40% corticosterone 100% corticosterone
AUC    3491 ± 1124 1747 ± 317     13016 ± 2858
Mean corticosterone (ng/ml)  47.2 ± 14.0 22.4 ± 4.4 *      240.8 ± 65.2
Pulse number     5.8 ± 0.6   3.7 ± 1.4          8.5 ± 1.4
Pulse amplitude (ng/ml)  74.7 ± 19.2 35.6 ± 11.1      165.5 ± 51.0
Pulse height (ng/ml)   91.3 ± 20.1 49.1 ± 11.3 *       337.0 ± 78.3
Pulse frequency (pulse/h)  0.59 ± 0.06 0.39 ± 0.13       0.92 ± 0.11
 
Pellets from rats previously treated for 7 days with vehicle (n=4), 40% (n=6) or 100% corticosterone pellets (n=6) 
were removed in the morning of  post-surgery day 8. PULSAR analysis only demonstrates significantly lower 
mean corticosterone concentrations and pulse height (* p < 0.05) in animals treated with 40% corticosterone 
pellets compared to vehicle as indicated by independent Student’s t-tests. 
Effect of  previous constant corticosterone exposure on stress responsiveness 
To study functional consequences of  previous exposure to constant corticosterone concen-
trations, animals were exposed to noise stress (99 dB for 10 min) while blood samples were 
collected every 20 min using the ABS system. Figure 3 depicts the stress-induced increase 
in corticosterone concentrations in each treatment group. As expected, vehicle animals de-
monstrate an increase in corticosterone concentrations with hormone peak concentrations 
of  103 ± 11.9 ng/ml, 20 min after onset of  the stress (effect of  time: p < 0.001). Inte-
restingly, animals that were previously implanted with 40% corticosterone pellets did not 
differ in their stress response compared to vehicle animals and had similar corticosterone 
peak concentrations (82.6 ± 22.1 ng/ml). Noise stress did not affect plasma corticosterone 
concentrations in the 100% corticosterone pellet group. At the time of  stress basal cortico-
sterone concentrations were increased compared to the other groups (p < 0.01). 
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Figure 3 | Effect of  previous constant corticosterone exposure on stress-induced plasma corticosterone 
release. Values indicate mean + SEM of  plasma corticosterone measured in rats one day after removal of  vehicle 
(n=4), 40% (n=6) or 100% corticosterone pellets (n=5). Blood samples were automatically collected every 20-
min. Rats were exposed to 10 min of  99 dB (hatched bar) which increased corticosterone levels in vehicle and 
40% corticosterone animals (effect of  time: F(7, 96) = 15.7; p < 0.001). No difference in stress-induced corti-
costerone levels was observed between vehicle and 40% corticosterone animals. Animals previously treated with 
100% cort show no significant response to the stressor as basal concentrations were elevated (* p<0.01; two-way 
repeated measures ANOVA and Bonferroni’s post-hoc test).
Effect of  previous constant cort exposure on stress-induced behavioural responses   
Behavioural responsiveness to noise stress was assessed in 10 min intervals before, during 
and after the stress. Complete analysis of  the data is reported in Table 3. Before exposure 
to the stressor, there was no difference between the treatments groups in any of  the beha-
viours analysed, as shown in Fig. 4 and Table 3. 
During the stressor, significant effects and interactions of  time and treatment were found by 
two-way repeated measures and one-way ANOVA. Noise stress significantly induced chan-
ges in locomotion (Fig. 4A; p < 0.001), sitting (Fig 4B; p < 0.001) and risk assessment (Fig 
4C; p < 0.001), respectively, indicating changes in the behavioural pattern over time. Analy-
sis of   interaction effect showed that in the 40% animals, the stressor induced significantly 
less locomotion (p < 0.001) and risk assessment (p = 0.04) compared to vehicle, indicating 
less total activity (p < 0.05); Table 3). Indeed, the duration of  those behaviours after the 
onset of  the stressor was shorter in 40% corticosterone animals compared to vehicle and 
100% corticosterone animals as the percentage of  time spent dropped almost to zero 2-3 
min after onset of  the stressor (Fig. 4A and C). In contrast, in the 100% group there was an 
increase in risk assessment (p = 0.03), number of  digging events (p < 0.01) and a trend of  


































increased rearing events (p =0.1). However, in these animals there was no difference in the 
total activity compared to vehicle animals (p >  0.05; Table 3) indicating differences in the 
make up of  the activity pattern compared to vehicle animals (Fig. 4 and Table 3). Further-
more for both corticosterone-treated groups, there was a decrease in the percentage of  time 
spent face and body grooming during the stressor (Table 3; p < 0.05). 
After cessation of  the stressor, both 40% and 100% corticosterone animals continued to 
show decreased face grooming (Table 3; p < 0.01). No statistical significant differences were 
found in any of  the other behaviours analysed. 
Figure 4  | Behavioural responses to 10 min of  noise stress (99 dB). Behavioural changes to noise stress are 
presented in 1 min bins over time in A | locomotion (F(10, 60) = 13.4; p < 0.001), B | sitting (F(10,60) = 12.3; 
p < 0.001) and C | risk assessment ((F(3.7, 22.0) = 17.9; p < 0.001). Analysis of   interaction effect showed that 
in the 40% animals, the stressor induced significantly less locomotion (F(20, 120) = 2.8; p < 0.001) and risk as-
sessment (F(20, 120) = 1.7; p = 0.04) compared to vehicle, indicating less total activity. Data is presented as mean 
± SEM duration in sec per 1 min bin for vehicle (n=6), 40% (n=7) and 100% corticosterone pellet animals (n=7). 
* p<0.05 compared to vehicle as tested by two-way repeated measures ANOVA and Bonferroni’s post-hoc test. 
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In this study we demonstrated that constant exposure to exogenous corticosterone by means 
of  subcutaneous pellet implantation in adrenally intact rats not only abolishes diurnal cor-
ticosterone rhythmicity but also diminishes rapid ultradian fluctuations. Termination of  the 
constant signal resulted in rapid recovery of  ultradian patterns in animals exposed to daily 
average concentrations (40% corticosterone), but not in animals exposed to high concentra-
tions of  corticosterone (100% corticosterone). Paradoxically, while the endocrine response 
to noise stress in the 40% corticosterone group was also not different compared to vehicle, 
these animals showed the most substantial changes in the behavioural response to stress. 
 Validation of  model system 
Plasma corticosterone concentrations were determined during time frames in which marked 
differences in diurnal and ultradian corticosterone levels have been well described in normal 
intact animals (Jasper & Engeland 1991, Atkinson et al. 2006, Spiga et al. 2007). Irrespective 
of  limitations in the number of  blood samples collected, our approach using high frequency 
ABS led to the novel observation of  disappearance of  ultradian corticosterone pulses after 
constant glucocorticoid administration while maintaining basal concentrations at constant 
daily average (40% corticosterone) or pathological concentrations (100% corticosterone). 
The 40% corticosterone group is of  particular interest given that these animals only dif-
fered in the pattern from vehicle (e.g. constant vs pulsatile) but not in the total amount of  
corticosterone exposure (e.g. AUC and mean corticosterone concentrations). Furtermore, 
this finding confirms the notion that experimentally clamped levels of  glucocorticoids can 
be achieved without adrenalectomy [(Akana et al. 1992, Meijer et al. 1997); provided no 
stressors are applied]. We conclude that 40% corticosterone pellet implantation can be used 
to easily manipulate pulse characteristics in intact rats while maintaining physiological gluco-
corticoid concentrations, whilst 100% corticosterone rather resembles conditions of  stress-
related disease. 
 
We and others have clamped circadian circulating corticosterone concentrations in this way 
before (Akana et al. 1985, Akana et al. 1992, Meijer et al. 1997). The HPA axis via a constant 
negative feedback signal disrupts corticosterone rhythms by adjusting circadian and ultra-
dian trough and peak concentrations resulting in steady-state corticosterone concentrations. 
In fact, episodic feedback signals are crucial for maintaining ultradian feedforward-feedback 
oscillitatory activity between the pituitary and adrenal gland (Walker et al. 2010). We have 
now demonstrated that the current approach is also suitable to study this relationship in 
more detail. 
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 Normalisation of  basal HPA axis activity after corticosterone removal 
Previous studies have shown that for some measures of  HPA axis reactivity, normalisation 
of  circadian corticosterone in adrenalectomised animals is sufficient (Akana et al. 1988, 
Jacobson et al. 1988). Even though the current study does not allow us to fully descriminate 
between ultradian and circadian corticosterone pulsatile patterns in relation to HPA axis 
reactivity, this study is the first to present data on basal ultradian corticosterone patterns 
in intact animals. PULSAR analysis indicated rapid progressive normalisation of  ultradian 
pulse characteristics within approximately 6 hours of  removal of  the 40% corticosterone 
pellet. This is most likely due to a delayed feedback mechanism suppressing pulse ampli-
tude at earlier time points (Walker et al. 2010), and could also potentially affect ACTH. 
Limitations in the volume of  blood that can be collected via ABS preclude conclusions on 
basal and stress-induced ACTH levels. However, this issue has been previously adressed in 
the literature as blunting circadian variation in intact animals by exogenous corticosterone 
administration attenuates ACTH release in response to stress (Akana et al. 1992). Although 
we have no information on the stress response, we observed supressed basal ACTH levels 
in morning and evening before and during corticosterone washout in a separate cohort of  
animals (data not shown). 
The rapid decline of  plasma hormone concentrations after 40% corticosterone pellet re-
moval is in line with the normal corticosterone half  life of  approximately 10 minutes [an 
important factor in allowing the existence of  sharp ultradian peaks (Windle et al. 1998b)]. 
The results of  the 100% corticosterone group are dramatically different. No recovery of  
corticosterone pulsatility was observed, moreover, a very slow decline in circulating hor-
mone concentrations after removal of  the pellet was noticed. A practical explanation for 
the lack of  ultradian recovery could be the formation of  a local corticosterone depot in this 
group of  animals as the slow decline did not follow the half  life time of  corticosterone. 
Even though the pellets were easily removed at the time of  surgery, we noticed a thickening 
of  the skin around the pellet possibly indicating the formation of  a depot due to the very 
high local steroid concentrations. This was not observed in the vehicle and 40% corticoste-
rone groups. In previous studies we did notice a ‘normal’ decline in corticosterone levels 
(Sarabdjitsingh et al. 2010), however. Therefore, it seems very likely that the issue in the 
present study is merely technical and may be attributed to the different sampling methods 
(tail vein sampling vs automated blood sampling) and/or animal supplier and surroundings 
(Leiden vs Bristol). The continued high concentrations prevent conclusions on the recovery 
of  corticosterone pulses after washout of  constant high concentrations of  corticosterone. 
In the context of  sustained stress, or treatment with (synthetic) glucocorticoids, prolonged 
exposure to high concentrations may actually occur. It would be very interesting to further 
explore whether ultradian rhythmicity and behavioural responsiveness is eventually restored 








corticosterone exposure therefore merits thorough investigation in future studies. However, 
for now this group can still be used as a reference for the effects of  the 40% pellet on stress 
responsiveness. 
 Dissocation in behavioural and neuroendocrine response to noise stress 
In agreement with earlier studies (Campeau & Watson 1997, Windle et al. 1998b, Atkinson 
et al. 2006), noise stress evoked a transient increase in corticosterone release in vehicle 
treated animals. Alterations in the basal pulse frequency and amplitude are known to be 
a major factor influencing reactivity to acute stressors (Windle et al. 1998a, Windle et al. 
2001, Atkinson et al. 2006). The normalisation of  the HPA response to stress in the 40% 
corticosterone animals is in line with the return of  basal pulsatile corticosterone secretion. 
Although adrenal weight takes longer than 24 hours to recover (Sarabdjitsingh et al. 2010), 
a finding in line with the decrease in mean corticosterone concentrations and pulse height, 
we conclude that the activity of  the axis in the 40% corticosterone animals seems to be 
very close to normal at the moment we applied the noise stress. Thus, the half  life time of  
the suppression of  HPA axis reactivity that is brought about by 40% corticosterone pellet 
implantation (Akana et al. 1992), is significantly less than 24 hours. This is reminiscent of  
the acute effects of  mineralocorticoid and glucocorticoid receptor (MR and GR) ligands on 
the axis, that last in the order of  hours (Ratka et al. 1989, van Haarst et al. 1996, Atkinson 
et al. 2008, Spiga et al. 2008). The absence of  a HPA response to stress in the 100% group 
may be attributed to any negative feedback mechanism, because of  the high concentrations 
of  circulating steroid at the time of  the stressor.
Interestingly, during the stressor, a strong dissociation between hormonal and behavioural 
stress responsiveness was observed. Our data indicate longer lasting changes induced by 
glucocorticoids in the brain even after normalisation of  basal HPA axis activity. Others 
have also demonstrated behavioural changes in aggression and social deficits in animals 
chronically exposed to low levels of  glucocorticoids (Haller et al. 2004). Using the same ex-
perimental paradigm of  corticosterone pellet implantation as here we recently showed that 
GR levels and molecular signalling in the brain remain significantly affected after removal of  
the corticosterone pellets (Sarabdjitsingh et al. 2010). However, our results may also pertain 
to (m)any neurotransmitter system(s) such as the serotonergic system (Bush et al. 2003), but 
only few data are available. Flattened corticosterone secretion induced by implanted corti-
costerone pellets was previously found to decrease 5-HT1A receptor expression exclusively 
in the rat dentate gyrus (Meijer et al. 1997) and somatodendritic 5HT1A autoreceptors func-
tion in the raphe nucleus (Leitch et al. 2003). Functionally, however chronic excess of  cor-
ticosterone obtained by daily injections of  the steroid, attenuated 5HT1A receptor induced 
membrane hyperpolarisation in hippocampal CA1 neurons without affecting the 5HT1A 
receptors (Karten et al. 1999). How persistent these effects are however is not known.  
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With respect to the behavioural performance of  high corticosterone animals, which in our 
hands was remarkably similar to vehicle rats, most available data point to substantial changes 
in information processing after chronic high corticosterone and stress (Fuchs et al. 2006, 
Joels et al. 2007). Chronic stress modulates limbic regions such as the hippocampus and 
amygdala and influences learning and memory in both rodents and humans (Schwabe et al. 
2008, Schwabe et al. 2009), most likely due to changes in the neuroarchitecture and plasticity 
(Bodnoff  et al. 1995, Fuchs et al. 2006, Joels et al. 2007). Chronic stress and high glucocor-
ticoid concentrations are known to potentiate emotionality and exploratory behaviour in 
rodents (Tejani-Butt et al. 1994, Schwabe et al. 2008). In this study, the 40% corticosterone 
group showed a modest response to audiogenic stimulation in terms of  attenuated behavi-
oural activity (i.e. increased sitting) and risk assessment (i.e. reduced exploration). In con-
trast, the 100% corticosterone group resembles vehicle treated animals more but showed 
higher emotionality to the stressor with increased activity (i.e. increased locomotion, risk 
assessment and rearing). The current design allows dissection of  these different behavioural 
aspects of  chronic corticosterone exposure and suggests that disrupted pulsatility (40%) 
is more linked to exploratory behaviour and risk assessment. How persistent these effects 
are however remains to be determined though previous studies have suggested long-term 
effects of  glucocorticoids on behaviour in rodents and humans (Ratka et al. 1988, Haller 
et al. 2004, Tiemensma et al. 2010). The duration of  disturbed stress responsiveness likely 
depends on the duration of  aberrant exposure. A parametric study of  development and 
duration of  changed responsiveness is needed before the validity of  our model in relation 
to long term changes in humans can be estimated.
Retrospectively, it would certainly have been interesting to study behavioural stress respon-
siveness after 7 days of  pellet implantion. However, as we aimed to focus on longer lasting 
glucocorticoid effects on the brain and possible restoration of  ultradian corticosterone pat-
terns we chose to compare the experimental groups to vehicle. Whether the altered stress 
reactivity in the 40% group after pellet removal is in fact advantageous or detrimental is 
open to interpretation and may depend on the particular circumstances. Our results suggest 
however that the history of  HPA axis pulsatility of  the individual has consequences for 
the behavioural response to stress, underscoring the diversity in the modulatory actions of  
pulsatile glucocorticoid release. 
 Persistence of  behavioural effects 
In the context of  differential responses to an acute stressor, either the history of  corticoste-
rone exposure may differ (De Kloet et al. 1998, Sapolsky et al. 2000) or rapid (non-)genomic 
effects may play a role (Joels et al. 2008a). Ultradian glucocorticoid pulses are translated into 
consecutive bursts of  GR nuclear translocation, DNA binding of  GR and transcriptional 








Stavreva et al. 2009). In addition to the classic intracellular receptors that mediate genomic 
responses, there is strong evidence for non-genomic (behavioural) actions of  glucocorti-
coids (Sandi et al. 1996, Mikics et al. 2004, Schwabe et al. 2009), putatively via low affinity 
membrane-associated MR and GR (Di et al. 2003, Karst et al. 2005). In the 40% group, the 
profile of  corticosterone secretion during the stressor did not differ from control animals, 
and an explanation involving non-genomic mechanisms therefore hinges on changed res-
ponsiveness of  non-genomic effects. 
While the role or significance of  glucocorticoid fluctuations is largely unknown, the evolu-
tionary conservation of  pulsatile endocrine systems suggests important biological and cli-
nical consequences. In stress-related disease there are persistent effects of  changes in basal 
pulse characteristics (Deuschle et al. 1997, Hartmann et al. 1997, Young et al. 2004). Our 
results show a striking parallel with data in humans. Emotional  and cognitive effects are still 
highly prevalent in patients with long-term cured Cushing’s disease compared to matched 
controls indicating possible irreversible effects of  prolonged previous glucocorticoid excess 
[(Tiemensma et al. 2010); submitted]. Washout after corticosterone pellet implantation may 
therefore constitute a model to study these clinically relevant processes.
In conclusion, our data suggest that HPA axis activity is remarkably sensitive to changes in 
the pattern of  corticosterone exposure and adjusts in a reversible fashion to alterations in 
this pattern as long as there is no overt hypercorticism. However, the data also indicate that 
normalisation of  HPA activity in response to an acute stressor does not necessarily indicate 
normal behavioural responses, which may need more time to adapt. We propose that it is 
the pulsatile pattern, rather than the absolute concentrations, of  corticosterone exposure 
that determines subsequent responsiveness to stress, a notion with obvious implications for 
understanding the pathogenesis of  stress related disease.
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Abstract
Ultradian oscillations of  glucocorticoid hormone secretion are crucial for transcriptional 
regulation of  glucocorticoid responsive genes. Furthermore, there is strong evidence for 
disruption of  normal pulsatile patterns in stress-related clinical disease. It is however not 
clear how the pulsatile characteristics of  this hormone affect physiological responses in the 
intact individual.
We have addressed this question by artificially creating different patterns of  corticosterone 
in adrenalectomised rats using a recently developed automated infusion system. This allo-
wed us to administer identical amounts of  corticosterone either by constant infusion or in 
hourly pulses. We also varied the pulse amplitude without altering total administered dose 
by adjusting both the concentration and duration of  infused corticosterone. At the end of  
infusion – and either during the rising or falling phase of  our exogenous pulse – animals 
were exposed to 10 minutes of  99 dB noise stress.
Constant administration of  corticosterone resulted in a blunted ACTH response to stress, 
while pulsatile administration facilitated a brisker response markedly greater in the rising 
than in the falling phase of  a corticosterone pulse. This differential phase-dependent effect 
was also seen in the behavioural response to noise which was much greater in the rising 
phase. The c-fos response was both brain nucleus and glucocorticoid pulse amplitude and 
phase-dependent, clearly showing differential effects of  pulsatility on stress-induced activa-
tion of  different brain circuits.
These data provide strong evidence for a novel mechanism of  pattern-dependent stress 
responsivity in which different brain circuits show differential sensitivity to the phase and 











Glucocorticoid hormones, the final products of  the hypothalamic-pituitary-adrenal (HPA) 
axis, are essential for the control of  homeostasis and the adaptation to stress (de Kloet et al. 
2005, McEwen 2007). In mammals including humans, glucocorticoids are characteristically 
released in approximately hourly hormone bursts by the adrenal gland (Weitzman et al. 
1971, Jasper & Engeland 1991, Windle et al. 1998b, Henley et al. 2009). These rapid ultra-
dian hormone pulses increase in amplitude in anticipation of  the active phase providing a 
circadian release pattern. Superimposed upon these basal endogenous rhythms is the CNS 
mediated glucocorticoid response to a stressor. 
The pulse characteristics of  ultradian rhythmicity in glucocorticoids are remarkably plastic 
and change under different physiological conditions (Lightman et al. 2000). Disorganisation 
of  ultradian rhythmicity has also been described in stress-related disease (Deuschle et al. 
1997, Hartmann et al. 1997, Young et al. 2004, Lightman et al. 2008, Henley et al. 2009). It 
appears that pulse amplitude, frequency and phase are all relevant variables in modulating 
the acute response of  the HPA axis (Windle et al. 1998b, Windle et al. 2001, Atkinson et al. 
2006, Russell et al. 2010). Even at the level of  the behavioural response there is an impact 
of  changes in ultradian pulse characteristics (Sarabdjitsingh et al. 2009b). This suggests that 
brain targets and receptors are responsive to the pulsatile patterns that have been recorded 
in rats for free tissue concentrations of  the glucocorticoid hormone corticosterone (Droste 
et al. 2008).
There is also good in vitro and in vivo evidence that repeated exposure to glucocorticoid 
pulses results in consecutive waves of  glucocorticoid receptor (GR) signalling and eventu-
ally ‘gene pulsing’ of  native transcripts (Conway-Campbell et al. 2007, Stavreva et al. 2009). 
Furthermore, disruption of  pulsatile patterns by continuous corticosterone administration 
attenuates glucocorticoid target gene responses in the rat brain to a subsequent challenge, 
revealing the sensitivity of  receptor-mediated mechanisms to the underlying pattern of  hor-
mone presentation (Sarabdjitsingh et al. 2010). A major area that has not been investiga-
ted however, is the interaction of  glucocorticoid pulsatility with physiological responses to 
stress. 
Recently, a post-hoc analysis during different phases of  the endogenous ultradian cycle, has 
indicated a much greater HPA responsiveness when the stress was applied during the ascen-
ding phase of  a corticosterostone pulse (Windle et al. 1998b), suggesting either a facilitated 
stress response during the ascending phase and/or an inhibitory effect during the falling 
phase. Here we aimed to clarify the importance of  the corticosterone pulses themselves by 
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carrying out a prospective study in which we could control all the glucocorticoid variables, 
and assess both the neuroendocrine and the behavioural response to a stressor at different 
phases and amplitudes of  a pulse.
In order to achieve this goal, we used our recently developed computer controlled system 
in which automated steroid infusion is combined with high frequency automated blood 
sampling in freely moving rats (Lightman et al. 2008). This allows a precise and systema-
tic infusion of  corticosterone in either ultradian or constant patterns in adrenalectomised 
rats without changing the total amount of  corticosterone exposure. The current approach 
provides a unique opportunity to study the functionality of  glucocorticoid pulsatility and 
the consequence of  alterations in ultradian pulses for stress and tissue responsiveness in a 
tightly controlled experimental design. 
Experimental procedures
 Subjects 
Experiments were conducted on male Sprague-Dawley rats (Harlan, UK; ± 250 g at the time 
of  surgery). After arrival, animals were allowed a week acclimatisation to the housing facility 
at 4 per cage under standard environmental conditions (21 ± 1 °C) and a 14 : 10 h light/dark 
cycle (lights on 05.15 h). Food and water were provided ad libitum. Animal procedures were 
approved by the University of  Bristol Ethical Review Group. Animal care was conducted in 
accordance with Home Office guidelines, the UK Animals (Scientific Procedures) Act 1986 
and the EC Council Directive of  November 1986 (86/609/EEC). All possible efforts were 
made to minimise the number of  animals used and their suffering.  
 Surgery 
Intravenous cannulation of  the jugular vein was essentially performed as described before 
(Spiga et al. 2007). Briefly, animals were anaesthetised with a combination of  Hypnorm 
(0.32 mg/kg fentanyl citrate and 10 mg/kg fluanisone, i.m.; Janssen Pharmaceuticals, UK) 
and diazepam (2.6 mg/kg i.p.; Phoenix Pharmaceuticals, UK). The right jugular vein was 
cannulated by inserting a polythene cannula (Portex, UK) modified to contain two thinner 
cannulae to connect to both the infusion and sampling system simultaneously. During the 
same surgery, adrenal glands were removed (ADX) by the dorsal approach. Following reco-
very, animals had free access to food and 0.9% saline supplemented with corticosterone (25 
mg/l, Sigma-Aldrich, USA). Animals were individually housed and kept in the automated 
blood sampling room where the cannulae were attached to a mechanical swivel allowing 
maximal freedom of  movement. The cannulae were flushed daily with heparinised saline to 
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maintain patency. Twelve hours prior to infusion the corticosterone drinking solution was 
replaced with 0.9% saline. 
 Automated corticosterone infusion and blood sampling 
A schematic overview of  the experimental design is depicted in Fig. 1. On post-surgery 
day 4, animals were connected to both the automated blood sampling (ABS) system and 
automated infusion system (Fig. 1A). One of  the double cannulae was used to connect to 
the ABS system for sampling on day 5 as described in detail (Windle et al. 1997, Windle 
et al. 1998b). The other cannula was connected to a recently developed automated infu-
sion system that allows ultradian or constant infusion of  corticosterone (Lightman et al. 
2008). Animals (n = 7 – 14) were infused for 12 hours with either 1) vehicle (3.75 mg/ml 
2-hydroxypropyl-β-cyclodextrin (HBC) in 0.9% saline, Sigma-Aldrich, USA), 2) constant 
corticosterone clamped at 50 ng/ml (0.23 mg/ml corticosterone-HBC in 0.9% saline, Sig-
ma-Aldrich, USA), or in ultradian pulses with an amplitude of  3) 50 ng/ml or 4) 100 ng/ml 
(0.12 or 0.23 mg/ml corticosterone-HBC, respectively, Fig. S1B). All groups were infused 
with the same amount of  corticosterone to maintain equal exposure (area under the curve). 
Accordingly, infusion time was adjusted from 12 to 24 hours in the group receiving 50 ng 
cort pulses (Fig. 1B). Frequency of  pulsatile infusion was 60 min with 20 min on-rate and 
40 min off-rate. Infusion rate was 0.33 ml/hour for constant infusion and 1 ml/hour for 
pulsatile infusion during the on-rate. Animals remained undisturbed in their home cages 
during infusion, blood sampling and exposure to white noise. 
 Experimental design 
Stress responsiveness in the different infusion groups (n = 7 – 14) was determined by ac-
tivation of  a white noise generator in the blood-sampling room. At 10.00 on post-surgery 
day 5, animals were exposed to 99 dB for a fixed period of  10 min. During the same time 
animal home cage behaviour was recorded using cameras mounted above each individual 
cage. Stress was applied 3 min after onset of  either the rising or falling phase of  the last 
ultradian pulse in both the 50 ng and 100 ng corticosterone groups or simultaneously in 
the constantly infused vehicle and corticosterone animals (Fig. 1B). Blood samples (25 µl 
aliquots) were collected remotely using the ABS system at a dilution of  1:8 in heparinised 
saline. Relative to the onset of  the stress, samples were collected at time points  -9, -2, 5, 12, 
19, 26 and 33 min in chilled tubes containing EDTA and Trysalol inhibitors. Animals were 
sacrificed 30 min after termination of  the stressor. Brains and pituitary glands were rapidly 








Figure 1 | Schematic representation of  the experimental design. A | On day 4 infusion of  corticosterone 
or vehicle started either 12 or 24 hours prior to stress. At 10.00 hr on day 5, animals were exposed to 10 min 
of  noise stress (99 dB) and were decapitated 30 min after. Blood samples were automatically collected with the 
ABS before, during and after noise. B | Animals were infused for 12 hours with vehicle (0.9% saline), constant 
corticosterone clamped at 50 ng/ml, 100 ng/ml pulsatile infusion or 50 ng/ml pulsatile infusion. In the last group 
infusion time was increased to 24 hours to maintain an equal area under the curve between all treatment groups. 
Noise stress (indicated by the arrows) was applied 3 min after onset of  a rising or falling phase in the pulsatile 
infused groups or simultaneously in the constantly infused groups. 
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 Hormone measurements 
Blood samples were centrifuged for 15 min at 4000 rpm at 4 ̊ C. Plasma was stored at -80 ̊ C 
until assayed with commercially available kits. ACTH levels were determined via immunora-
diometric assay (IRMA; Diasorin Ltd, UK) and corticosterone via radioimmunoassay (RIA; 
MP Biomedicals Inc., USA) according to the manufacturer’s instruction. All samples were 
processed in the same assay to exclude inter-assay variability. Intra-assay coefficients of  va-
riation were 2.8% and 7.3% for the ACTH and corticosterone assay, respectively. 
 Tissue preparation and in situ hybridisation 
Coronal sections of  PVN, hippocampus, amygdala (14 μm) and pituitary (8 μm) were 
mounted on Superfrost Plus slides (Menzel-Gläser, Germany). In situ hybridisation with 
33Phosporus and 35Sulphur end-labelled oligonucleotide and riboprobes were used to visu-
alise mRNA expression of  c-fos, CRH, POMC, MR and GR as previously described (Rots 
et al. 1996, Karssen et al. 2005). The signal was quantified from films exposed 4 hr – 12 days 
(X-OMAT AR, Kodak, NY) using ImageJ 1.32j analysis software (NIH, USA; http://rsb.
info.nih.gov/ij/). Relative expression levels were determined and related to standard curves 
of  14C (RPA 504 microscales, Amersham, UK). 
 Behavioural analysis 
Home cage behaviour was analysed 10 min before, during and after stress. The following 
behaviours were analysed with a semiautomatic scoring system (The Observer Mobile 4.1, 
Noldus Information Technology, The Netherlands): i) risk assessment (‘seeking’ behaviour 
while the body is still or stretched), ii) face washing (grooming of  face using front paws), 
iii) body grooming (grooming using front and back paws, i.e. scratching), iv) locomotion 
(walking, front and back paws move) and v) sitting (e.g. sitting or sleeping). Total activity 
was calculated by adding the scores of  behaviours i-iv. In addition vi), the number of  rearing 
events (raising of  the rat and then lowering both front paws) was counted. Freezing was also 
included as behavioural variable. However, this type of  behaviour was not observed in this 
study and therefore not included in further analysis.
 Statistical analysis 
Statistical analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). All data 
are expressed as the mean ± SEM. For each study the appropriate tests and post-hoc tests, 
where applicable, were used as indicated in the corresponding figure legends. P-values < 










Effect of  infused corticosterone on stress-induced ACTH release
To study the effect of  stress on different patterns of  infused corticosterone on ACTH 
release, animals were exposed to noise stress while blood samples were collected automati-
cally (Fig. 2). Noise stress evoked a transient increase in ACTH release with hormone peaks 
5 min after the onset of  the stressor in all treatment groups (Fig. 2A; effect of  time: p < 
0.001). Corticosterone infusion attenuated basal as well as (absolute and relative) stress-
induced ACTH levels to noise at all time points after onset of  the stressor compared to 
vehicle infusion (Fig. 2A and B, p < 0.001). The response of  ACTH, however, was much 
greater in the pulsatile infused animal compared to those receiving constant infusion (inter-
action effect: p < 0.001). Interestingly, basal ACTH levels were not affected by the pattern 
of  corticosterone infusion itself  (Fig. 2A).
In the animals receiving the pulsatile infusions, the ACTH response to stress depended both 
on the phase and the amplitude of  the corticosterone pulses. Stressors applied during the 
falling phase of  a corticosterone pulse resulted in significantly lower ACTH responses, both 
for the 50 ng and the 100 ng infused rats (Fig. 2C; p < 0.001). In addition, higher amplitude 
corticosterone peaks (100 vs. 50 ng infusion) led to a lower ACTH response (p < 0.001). 
Similar results were obtained by calculating the relative increase in ACTH from baseline 
(Fig. 2D). 
Markers for central HPA axis activity 
In order to determine whether there were basal hypothalamic or pituitary changes underly-
ing the differences in stress responsiveness we measured the expression of  a number of  
markers. Corticosterone infusion decreased CRH mRNA levels in PVN (Fig. S1A; p = 0.02) 
and POMC mRNA in pituitary (Fig. S1B; p = 0.03) relative to ADX vehicle infused rats, but 
this effect was independent of  the pattern or phase of  corticosterone infusion. 
Both MR and GR mRNA expression in the hippocampal CA1 area were suppressed by 
corticosterone infusion relative to vehicle treated rats (Fig. S2A and B, p < 0.01). However, 
in comparison with constant cort and 100 ng cort infused animals, there was a slight but 
significant higher (p < 0.05) expression of  MR and GR for both 50 ng infused groups. Si-
milar patterns were found for MR in dentate gyrus (p < 0.05) but not in CA3 (Fig. S2C and 
E). GR mRNA expression levels were suppressed uniformly across corticosterone infusion 
groups in CA3 and dentate gyrus (Fig. S2D and F). In addition, there were no significant 
changes in GR expression in the PVN (Fig. S2G, p = 0.7) or pituitary (Fig. S2H, p = 0.16) 
related to the pattern or phase of  corticosterone infusion. 
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Figure 2 | Basal and noise stress-induced ACTH levels. A | 10 min noise stress evoked a transient increase 
in absolute ACTH levels in vehicle, constant or pulsatile corticosterone (50 ng cort pulses) infused animals (ef-
fect of  time: F(6, 180) = 12.93, p < 0.001). Constant corticosterone infusion attenuates stress-induced ACTH 
compared to pulsatile infusion at 5 min after onset of  the stressor (interaction effect: F(10, 180) = 2.52, p < 0.01). 
B | Similar but more pronounced differences were demonstrated by analysing the relative increase in ACTH 
from baseline (time: F(5, 157) = 28.47, p < 0.001; interaction effect: F(10, 157) =  3.24, p < 0.001). C | Stress 
applied 3 min after onset of  the different phases of  the last pulse resulted in increased ACTH release (time: F(6, 
183) = 226.5, p < 0.001). However, stress-induced ACTH release in the falling phase was lower compared to 
the rising phase (interaction effect: F(18, 183) = 18.25, p < 0.001). D | Data plotted as relative increase from 
baseline showed similar results (time: F(5, 158) = 241.2, p < 0.001; interaction effect: F(15, 158) = 21.46, p < 
0.001). Data is analysed by two-way RM ANOVA and Bonferonni’s post-hoc test (*** p <0.01, ** p < 0.05 all 
groups; * p < 0.05 vehicle vs constant; # p < 0.001 50 rising vs 50 ng falling, 50 ng rising vs 100 ng rising, 100 
ng rising vs 100 ng falling; @ p < 0.05 50 ng rising vs 50 ng falling, 50 ng rising vs 100 ng rising; n = 7-14). 
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Immediate early gene c-fos expression in different brain regions 
To evaluate the effects of  different pulse characteristics on neuronal responses to stress, c-
fos mRNA was measured. Region-specific differences in c-fos expression were found in the 
pituitary gland (Fig 3A, p < 0.01), PVN (Fig. 3B, p < 0.001), amygdala  (Fig. 3C, p < 0.01) 
and hippocampal subfield CA1 (Fig. 3D, p = 0.54). Representative images of  c-fos mRNA 
expression in the corresponding areas are depicted in Fig. S3. 
In the pituitary (Fig. 3A), c-fos expression in vehicle infused animals was significantly in-
creased compared to all the corticosterone infused groups (p < 0.01), except the 50 ng 
rising group. In the 50 ng cort infused animals c-fos levels were markedly higher after stress 
exposure during the rising phase (p = 0.03). We observed the opposite in the PVN (Fig. 
3B): with lower c-fos expression during the rising phase of  50 ng cort infused animals (p < 
0.05). In both PVN and pituitary, we found decreased c-fos mRNA expression as a conse-
quence of  increased cort amplitude (veh vs 100 ng cort pulses, p < 0.01). c-Fos expression 
in the amygdala was markedly higher in rats that were stressed during the rising phase of  
the pulse, independent of  its amplitude (Fig. 3C; p < 0.01), while no significant difference 
in c-fos expression between vehicle and constant cort infused was observed. No effect of  
corticosterone treatment or phase was observed in c-fos expression in the CA1 region (Fig. 
3D, p = 0.54), hippocampal subregions CA3 (Fig. S4A, p = 0.47) and dentate gyrus (Fig. 
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< Figure 3 | C-fos mRNA expression in different brain regions. Differential c-fos expression patterns were 
found in A | pituitary gland (F(5,31) = 3.76; p < 0.01), B | PVN (F(5,34) = 14.6; p < 0.001) and C | amygdala 
(F(5,33) = 6.0; p < 0.01) but not in D | hippocampal CA1 cells (F(5,38) = 0.30; p = 0.54). Data represents mean 
± SEM. One-way ANOVA and LSD or Tukey’s post-hoc test, * p < 0.05, ** p < 0.01 veh vs other groups, # p 
< 0.01, $ p < 0.05 (n = 7-8).
Behavioural response to noise stress 
Before and after the stressor, the animals did not differ in total activity (Fig. 4A and S5A). 
During stress, however, the behavioural response of  the 50 ng corticosterone animals was 
phase-dependent as noise stress increased total activity but to a lesser extent in animals 
stressed during the falling phase (Fig. 4A; p < 0.001). 
Detailed analysis of  recordings during the stressor using interaction analysis of  the individu-
al behavioural parameters indicated significantly higher risk assessment in animals stressed 
during the rising phase of  a 50 ng ultradian pulse, particularly in the initial minutes after on-
set of  the stressor (Fig. 4B; p < 0.01). In contrast, animals stressed during the falling phase 
explored less throughout the stress period. Similar results were found for rearing, face and 
body grooming (Fig. S5B and C). 
Figure 4  | Behavioural analysis to noise stress. Noise stress evoked a transient increase in A | total activity 
(F(5, 38) = 21.3; p < 0.001) but significantly more in 50 ng corticosterone infused animals stressed during the 
rising (black bars) compared to the falling phase (open bars). No difference was found before or after the stressor. 
Data is expressed in 10 min bins before, during and after the stressor (n = 7). B | Similarly, behavioural activity 
plotted in 1 min bins during the stressor shows increased risk assessment in 50 ng cort infused animals stressed 
on the rising (interaction effect: F(11, 132)  = 2.6; p < 0.01). Inset indicates total duration per 10 min during the 
stressor. Two-way ANOVA and Tukey’s post-hoc test and two-way RM ANOVA and Bonferroni’s post-hoc test, 
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The concept that rapid fluctuations in endocrine systems are major determinants for the 
outcome of  target tissue responses and physiology has been well explored for GnRH and 
growth hormone (Belchetz et al. 1978, Hauffa 2001, Veldhuis et al. 2001). It is now incre-
asingly being recognised that episodic, pulsatile glucocorticoid release is also crucial for 
hormone signalling in the brain and other tissues (Conway-Campbell et al. 2007, Stavreva et 
al. 2009, Sarabdjitsingh et al. 2010). However, practical limitations in regulating rapid ultra-
dian pulses in living animals have, until now, hampered progress in obtaining evidence for 
the physiological importance of  glucocorticoid pulsatility. The advanced automated steroid 
infusion system used in this study overcomes these limitations and provides the facility to 
ensure the tight control of  infusion of  different ultradian patterns of  corticosterone (Light-
man et al. 2008). This technical development has opened up the opportunity to examine 
how corticosterone pulsatility might interact with stress responsiveness. In the current study 
we have been able to investigate the contribution of  individual ultradian glucocorticoid 
pulse characteristics such as pattern, phase and amplitude in a controlled fashion to stress 
responsivity with a dose that is similar to the normal physiological mean 24 hour corticoste-
rone secretion rate. Without altering the total administered dose we either gave a constant 
infusion or varied the pulse amplitude by adjusting both the concentration and duration of  
infused corticosterone. At the end of  infusion – and either during the rising or falling phase 
of  our exogenous pulse – animals were exposed to 10 minutes of  99 dB noise stress.
This design revealed that the pattern of  corticosterone exposure had a powerful effect on 
ACTH responsivity to the noise stressor while no differences in basal ACTH levels prior 
to stress were observed. Constant infusion of  corticosterone resulted in a clear suppres-
sion of  ACTH response, while pulsatile infusion of  the same dose of  glucocorticoid per-
mitted a larger response. This sensitising effect of  pulsatility was even more pronounced 
during the rising phase of  an ultradian pulse than during the falling phase. In addition, 
animals infused with higher amplitude pulses showed smaller increments in stress-induced 
ACTH release. These data thus clearly show that the neuroendocrine response to stress 
depends on circulating glucocorticoids in both a phase and amplitude dependent manner. 
Our data explain previous studies that retrospectively correlated higher corticosterone re-
sponses to a stressor with the rising phase of  an endogenous pulse and lower mean cor-
ticosterone responses with increased pulse frequency (Windle et al. 1998b, Windle et al. 
2001). Other data suggest however that negative feedback of  glucocorticoids should be 
greatest when corticosterone levels are rapidly rising within physiological concentrations 
in a process termed rate sensitive feedback (Dallman & Yates 1969, Kaneko & Hiroshige 
1978). Whether the observed phase-dependence of  the ACTH response is due to a delayed 
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inhibition after the rapid increase of  corticosterone or possibly the facilitation of  ACTH 
responsiveness during the ascending phase, cannot be answered from the present studies as 
we could not explore the apparent rate sensitivity in our studies using multiple physiological 
pulses of  corticosterone rather than single infusions. What is clear from our design however, 
is that the onset of  a stressor in relation to the phase or amplitude in a regimen of  repeated 
ultradian pulses, is a major determinant of  acute ACTH responsiveness and negative feed-
back inhibition. As constant corticosterone administration attenuates stress-induced ACTH 
release, every surge in glucocorticoid level could serve to prepare and maintain flexibility in 
ACTH release for adequate responses to stress. 
In the current study, c-fos immediate early gene expression was used as a stressor-specific 
marker for activation of  pituitary and brain pathways involved in the stress response. Since 
the pattern of  corticosterone infusion only had an effect on ACTH release during noise 
stress and not under basal conditions, we studied c-fos expression following this stressor 
and  clearly show selective activity of  the pituitary and different neuronal pathways which 
depend on temporal aspects of  the ultradian cycle. 
The c-fos data in the pituitary gland suggest an interaction of  pulse phase and amplitude and 
resembles the pattern of  stress-induced ACTH release. Further interpretation is precluded 
by the fact that ACTH release is not always reflected in c-fos expression, if  only because of  
the different time domains in which the responses develop (Ginsberg et al. 2006, Weinberg 
et al. 2007). Despite this, corticosterone clearly feeds back on the HPA axis imposing similar 
phase and amplitude dependence of  the ACTH and c-fos response to stress-induced signal-
ling, probably via pituitary and supra-pituitary sites (Windle et al. 1998a, Russell et al. 2010). 
Our observations in the PVN also demonstrate interaction of  pulse phase and amplitude in 
c-fos expression. The role of  the PVN as ultradian feedback integrator is complicated. CRH 
neurones are not only themselves glucocorticoid sensitive but are also heavily innervated 
by networks of  both inhibitory GABAergic and excitatory glutamatergic synaptic inputs 
from different brain nuclei, such as the amygdala and prefrontal cortex, that are under the 
influence of  corticosterone (Herman et al. 2003, Herman et al. 2004). These various stress 
pathways and the integrated feedback signal produced by ultradian exposure together deter-
mine PVN outflow and are likely to contribute to the different pattern of  c-fos activation 
found in this nucleus. The hippocampus, which is also regarded as a major input and exerts 
a trans-synaptic, primarily inhibitory, influence on the PVN (Jankord & Herman 2008), is 
different again, and shows no differential c-fos response to either acoustic stimulation or 
corticosterone pulsatility. Acoustic stimulation typically results in a wide pattern of  brain 
activation including specific brain circuits involved in the stress response to noise but is 
known induce low c-fos responses in the hippocampus (Campeau & Watson 1997, Burow 








The most fascinating c-fos response was seen in the amygdala. This nucleus is of  prime 
importance in the response to emotionally salient stimuli, with arousing experiences able 
to modulate amygdala structure and function (McGaugh 2004, Roozendaal et al. 2009). Of  
particular relevance to the current studies is its involvement in the behavioural responses to 
noise (Campeau & Watson 1997, Burow et al. 2005). We have not only been able to demon-
strate a correlation between behaviour response and c-fos activation, but have now clearly 
shown for the first time that this is tightly related to the phase of  the ultradian corticosteroid 
cycle.
An important aspect of  these studies is that in addition to c-fos and neuroendocrine re-
sponses, there are also behavioural correlates to the amplitude and phase of  the ultradian 
corticosterone pulses. We find that behavioural activity was highest when the noise stress 
was experienced during the rising phase of  corticosterone infusion. These data fit well 
with the work of, Haller et al. observed, following post hoc evaluation of  their results, that 
the propensity of  rats to behave aggressively was increased during the rising phase of  an 
ultradian pulse (Haller et al. 2000a). These data strongly suggest differences in reactivity of  
emotional brain centres, such as the amygdala, and that the emotionality and exploratory 
response to stress could be modulated by rapid fluctuations in corticosterone. The tempo-
ral correlations of  the stress induced behavioural pattern of  ACTH release and c-fos ex-
pression in the amygdala, suggests some glucocorticoid mediated integration, although the 
detailed mechanism of  the links needs further evaluation. What we can conclude however 
is that both the neuroendocrine and behavioural response to stress vary over the ultradian 
cycle with hourly surges in corticosterone resulting in a more intense response to stress.
 
The mechanism underlying HPA pulsatility is itself  a fascinating question with recent 
evidence suggesting a pituitary-adrenal oscillatory mechanism dependent on hypothala-
mic gain (Walker et al. 2010). The current study provides a framework to understand the 
mechanism(s) underlying the ultradian phase dependent changes in sensitivity of  stress res-
ponsiveness. Logically one can assume that this is either related to an increased break during 
the falling phase or increased drive during the rising phase or indeed a combination of  
both of  these. With respect to feedback effects that might be part of  the explanation of  
our data, recent evidence suggest that centrally anti-mineralocorticoids can interfere with 
the dynamic generation and regulation of  basal ultradian HPA activity and fast feedback in 
the rat (Atkinson et al. 2008), GR however is involved at the pituitary level and is likely to 
be responsible for recent data demonstrating the rapid inhibition of  ultradian pulsatility by 
glucocorticoids (de Kloet et al. 1974, De Kloet et al. 1975, Russell et al. 2010). 
Which ever of  these is the base, the time domain of  the altered efficacy of  pulsatile corti-
costerone in control of  ACTH release and behavioural stress responsiveness, suggests that 
rapid non-genomic effects play a role, although there is also increasing evidence for rapid 
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genomic responses to glucocorticoids (Stavreva et al. 2009). These non-genomic effects are 
thought to be mediated via putative membrane-bound variants of  MR and GR (Hinz & 
Hirschelmann 2000, Karst et al. 2005). The non-genomic MR in limbic structures enhances 
the presynaptic glutamate release probability and reduces postsynaptic hyperpolarisation via 
the ERK1/2 pathway and K+-conductance with the net result to enhance excitatory trans-
mission (Olijslagers et al. 2008). On the other hand, non-genomic GR in PVN reduces net 
neuronal excitatory transmission via endocannabinoids and nitric oxide (Di et al. 2003, Di 
et al. 2009). The balance between rapid non-genomic and slower genomic effects via mem-
brane-bound and nuclear variants of  MR and GR (De Kloet et al. 1998) may rapidly change 
over the duration of  a single ultradian pulse and mediate differential modulatory effects of  
corticosterone in different areas of  the brain. Studies in modulating different aspects of  the 
pulse frequency as well as pulse peak and nadir, should allow us to address such mechanistic 
issues in the future and in particular help explain the enhancement and suppression of  c-
fos responses during the ascending and descending phases of  the corticosteroid pulse seen 
most markedly in the amygdala. 
Although ultradian activity of  the HPA axis has been recognised for many years, it is only 
recently that we have become aware of  the critical importance of  rapid ultradian oscillations 
in glucocorticoid hormone exposure for transcriptional control and target tissue responsi-
veness (Conway-Campbell et al. 2007, Stavreva et al. 2009, Sarabdjitsingh et al. 2010). We 
have been able to demonstrate in the ADX corticosterone infused rat that the cyclical alte-
rations in HPA responses described by Windle et al in intact rats (Windle et al. 1998b), as 
well as cyclical behavioural responses, are actually a consequence of  the changing levels of  
circulating glucocorticoid – and indeed this is the first evidence for functional consequences 
of  ultradian glucocorticoid pulsatility. This will be important not only for our understan-
ding of  glucocorticoid biology and signalling but probably also for the elucidation of  the 
pathophysiology and aetiology of  stress-related disorders (Dallman et al. 1987, de Kloet et 
al. 2005, Herbert et al. 2006). 
Furthermore, the reduced ACTH and behavioural responses following continuous adminis-
tration of  glucocorticoids, serves as a warning to both experimental neuroendocrinologists 
and clinicians that steady state glucocorticoid levels are likely to result in unphysiological 
effects. For optimal function it seems that ultradian activity “primes” the HPA axis and dif-
ferent brain circuits through rapidly alternating feed forward and feedback modes providing 
“resilience” to the fundamentally important stress response.
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Figure S1 | mRNA expression of  central HPA axis markers. Compared to vehicle, corticosterone infusion 
significantly lowered A | mCRH expression in PVN (F(5,33) = 3.2; p = 0.02) and B | mPOMC expression in the 
pituitary gland (F(5,31) = 3.0; p = 0.03). One-way ANOVA and Tukey’s post-hoc test, * p < 0.05 veh vs other 
groups (n= 7-8).
Figure S3 | C-fos mRNA expression in different brain regions. Representative images of  c-fos in situ hybridi-
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Figure S2 | MR and GR mRNA expression in different brain regions. Compared to vehicle infused animals, 
corticosterone infusion significantly lowered MR expression in A | hippocampal CA1(F(5,33) = 35.9; p < 0.001), 
C | CA3 (F(5,36) = 17.4; p < 0.001) and E | DG (F(5, 34) = 28.5; p < 0.001. Similar results were found for 
GR expression in B | CA1 cells (F(5,33) = 14.1; p < 0.001), D | CA3 (F(5,38) = 14.0, p < 0.001) and F | DG 
(F(5,34) = 4.30; p < 0.01. Interestingly, MR and GR expression in CA1 and MR in DG was significantly incre-
ased in animals that were pulsatile infused with 50 ng corticosterone peaks. No difference in GR expression due 
to treatment or phase was observed in G | PVN (F(5,30) = 0.60; p = 0.7) or H | pituitary (F(5,34) = 1.7; p = 
0.16). One-way ANOVA and Tukey’s post-hoc test, *** p < 0.001 veh vs other groups, $ p < 0.05 vs 50 ng cort 
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Figure S4 | C-fos mRNA expression in different regions of  the brain. Infusion of  vehicle or corticosterone 
did not differentially affect noise stress-induced c-fos expression in hippocampal subfields A | CA3 (F(5, 37) 
= 0.94; p = 0.47) or B | dentate gyrus (F(5,37) = 0.80; p = 0.56). Data was statistically analysed with one-way 
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As outlined in the general introduction, the significance of  pulsatile glucocorticoid hormone 
secretion for physiology is not yet clear. Changes in these patterns are thought to compro-
mise resilience and may thus be an important factor in the aetiology of  stress-related disea-
ses (Young et al. 2004, Lightman 2008). The overall objective of  this thesis was therefore to 
assess the role of  glucocorticoid pulsatile patterns in central glucocorticoid signalling and 
the neuroendocrine and behavioural responsiveness to stressful challenges. 
 Model system and experimental design 
Practical limitations in the control of  high frequency ultradian pulses in living animals have 
hampered progress in obtaining evidence for the functional consequences of  glucocorticoid 
pulsatility. Furthermore, the lack of  rhythmic synchronisation between animals necessitates 
control of  the pattern of  hormone release. In the current thesis we surgically or pharma-
cologically modulated pulsatile corticosterone hormone levels by exogenous steroid admi-
nistration or automated steroid infusion either with or without automated blood sampling 
(Lightman et al. 2008). The technical development and availability of  these methods has 
opened up the opportunity to examine how corticosterone pulsatility might interact with 
stress responsiveness and has indeed provided the first data beyond descriptive correlates 
as described in this thesis. 
7.2 Glucocorticoid signalling
 
 Glucocorticoid signalling mechanism 
Accumulating evidence suggests that nuclear receptor access and binding to regulatory ele-
ments in the genome, but also methylation of  DNA is highly dynamic (Metivier et al. 2003, 
Reid et al. 2003, Kangaspeska et al. 2008). With respect to GR, it is now being recognised 
that rapid ultradian oscillations in glucocorticoid hormone exposure are also crucial for 
transcriptional control (Desvergne & Heligon 2009, George et al. 2009, Stavreva et al. 2009). 
Upon glucocorticoid treatment, GR rapidly translocates to the nucleus in both cultured cells 
and hippocampal tissue (chapter 2 and 3). Irrespective of  the administration paradigm, MR, 
however, is continuously retained in the nucleus of  hippocampal cells (Conway-Campbell 
et al. 2007). Therefore we suggest that fluctuating levels of  glucocorticoids which are con-
veyed into oscillatory activity of  GR but not MR, result in differential recruitment of  the 
receptors and coregulators which may involve different pathways in transrepression and 
transactivation of  glucocorticoid target genes in the brain. This difference in ultradian re-
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cruitment of  MR and GR may simply reflect their different ligand binding affinities, kinetics 
and in vivo clearance rate (Reul & de Kloet 1985, Spencer et al. 1993). MR is extensively 
occupied at very low levels of  circulating corticosterone and remains bound to ligand for 
much longer (t½= 45 min) than GR (t½= 5 min). GR thus rapidly associates and dissociates 
from its endogenous ligand and is recruited in an ultradian manner. Hence, we propose that 
disturbances in glucocorticoid pulsatility will therefore mainly affect this receptor rather 
than MR.
 Glucocorticoid signalling in the rat brain
In relation to the brain, little information is available on how rapidly fluctuating glucocorti-
coid levels in vivo affect receptor signalling, transcriptional output and consequently target 
tissue sensitivity thereby determining the functional effects of  glucocorticoid action and 
efficacy (Kino 2007). We have shown considerable changes in molecular markers for both 
chronic and acute glucocorticoid action in the rat hippocampus after disruption of  endo-
genous pulsatile patterns (chapter 4). Overt hypercorticism (100% corticosterone) resul-
ted in maximally sustained responses, most likely due to receptor saturation rendering GR 
non-responsive to additional hormone. This possibly creates a non-favourable situation in 
which the normal flexibility in glucocorticoid signalling is lost. Many studies described such 
sustained effects of  chronic high corticosterone levels on the brain mediated via GR. For in-
stance, feedback sensitivity of  the HPA axis after stress is attenuated after chronic treatment 
with corticosterone (Akana et al. 1992), through occupancy of  GR (Bradbury et al. 1994). 
Also, CA1 pyramidal cells seem to lose their potential to normalise enhanced activity
after stress (Joels et al. 2007), e.g. as seen from the risk of  calcium overloading (Karst & Joels 
2007) and attenuation of  functional 5-HT responses (Karten et al. 1999). 
Clamping corticosterone levels at daily average levels (40% corticosterone), however, did 
not alter baseline expression of  our rather sensitive expression markers. Remarkably, this 
treatment did still attenuate the transient response to a glucocorticoid challenge mimicking 
the stress response (chapter 4). The findings of  this study suggest that pulsatile glucocor-
ticoid release is required to maintain the normal ‘resilience’ in glucocorticoid target tissue 
responsiveness. Furthermore, subtle changes in the pattern of  pulsatile exposure seem to 
induce changes at least as severe for glucocorticoid signalling as overt hypercorticism. This 
notion is strengthened by the normalisation in GR responsiveness after washout of  con-
stant 100% corticosterone levels but not in the 40% cort group. Using similar administra-
tion paradigms, previous studies have shown attenuated stress responsiveness (Akana et al. 
1992) and suppressed levels of  5-HT1A receptor expression exclusively in the rat dentate 
gyrus (Meijer et al. 1997). These effects were interpreted as mediated via MR (Bradbury et 
al. 1994, Meijer et al. 2000). We and others now provide support for the additional involve-
ment of  GR in target tissue responses (Conway-Campbell et al. 2007, Stavreva et al. 2009), 
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as we show that particularly this receptor is sensitive to changes in the underlying pulsatile 
pattern of  corticosterone.  
 Conclusion 
Understanding the interplay between rapidly fluctuating glucocorticoid levels and receptor 
signalling could greatly contribute to our knowledge of  cellular and tissue responses as 
changes in the pattern of  glucocorticoid exposure could possibly contribute to dysregulated 
glucocorticoid receptor signalling (Kino 2007). We propose that the molecular response 
of  target tissues induced by a corticosterone challenge is a resultant of  the dynamic inter-
play between the corticosterone exposure regime (e.g. pulsatile or continuous) and steroid 
receptor signalling. The pattern of  hormone exposure therefore seems a major factor in 
maintaining receptor responsiveness determining the adaptive capacity of  target tissues in 
the face of  acute stress. 
 
7.3  HPA axis activity
Daily variations in glucocorticoid hormone concentrations are thought to be fundamental 
for the maintenance of  physiology and well being as deviations from the normal release 
pattern are considered to enhance vulnerability to stress-related disease (Young et al. 2004, 
de Kloet et al. 2005, Herbert et al. 2006). However, the consequences of  changes in pulse 
characteristics to HPA axis (re)activity are largely unknown. In the context of  circadian 
rhythms, it has been shown that basal HPA axis activity and the neuroendocrine response 
to stress is clearly affected under conditions of  flattened corticosterone (Akana et al. 1985, 
Akana et al. 1992, Dallman et al. 2004). However actual disruption of  ultradian variation 
with respect to this pellet model remained to be proven. During chronic glucocorticoid 
exposure, the HPA axis via negative feedback adjusts circadian trough and peak concentra-
tions resulting in steady-state corticosterone concentrations (Akana et al. 1985, Akana et al. 
1992, Meijer et al. 1997). This consequently may disrupt episodic feedback signals crucial in 
maintaining ultradian feedforward-feedback oscillitatory activity between the pituitary and 
adrenal gland (Walker et al. 2010). We have now demonstrated that besides circadian varia-
tion, also rapid ultradian glucocorticoid pulses can be effectively flattened around the daily 
average by subcutaneous implantation of  40% corticosterone pellets (chapter 5). This not 
only mimics some of  the risk factors for stress-related disease, it also provides a good and 
easy to manipulate model to study the consequent disruption in feedback activity. 
Until now it was unknown how fast the negative feedback action abates after cessation of  








tion of  constant exogenous corticosterone exposure resulted in rapid progressive norma-
lisation of  ultradian pulse characteristics within approximately 6 hours after removal of  
the pellet (chapter 5). This is most likely due to a delayed feedback mechanism suppressing 
pulse amplitude at earlier time points (Walker et al. 2010). Thus, the half  life time of  the 
suppression of  HPA axis reactivity that is brought about by 40% corticosterone pellet im-
plantation (Akana et al. 1992), is significantly less than 24 hours. This is reminiscent of  the 
acute effects of  MR and GR ligands on the axis, that last in the order of  hours (Ratka et al. 
1989, van Haarst et al. 1996, Atkinson et al. 2008, Spiga et al. 2008). 
The endocrine response to noise stress also rapidly restored after reoccurrence of  basal 
pulsatility. Paradoxically, we still observed substantial changes in the behavioural response to 
stress (chapter 5, discussed elsewhere in this chapter). These results show a striking parallel 
with observations in humans with a history of  changes in cortisol exposure which sug-
gest that even after normalisation of  hormone levels there are residual disturbances in the 
brain (Tiemensma et al. 2010). Washout after continuous corticosterone administration may 
therefore constitute a model to study these clinically relevant processes. 
 Conclusion 
We conclude that HPA axis activity is remarkably sensitive to changes in the characteristic 
pulsatile pattern of  corticosterone exposure but adjusts in a reversible fashion to these alte-
rations. We propose that it is the pulsatile pattern, rather than the absolute concentrations, 
of  corticosterone exposure that determines subsequent responsiveness to stress, a notion 
with obvious implications for understanding the pathogenesis of  stress related disease.
 
7.4 Neuroendocrine stress responsiveness in relation to pulse 
      characteristics
Glucocorticoids play a major role in regulation of  HPA axis activity through negative feed-
back inhibition (Keller-Wood & Dallman 1984, Dallman et al. 1987, Sapolsky et al. 1990), 
mediated via MR and GR (Ratka et al. 1989, van Haarst et al. 1996, Hinz & Hirschelmann 
2000, Atkinson et al. 2008, Russell et al. 2010). The physiological importance of  rapid and 
adequate feedback is directly underlined by many clinical studies that, for instance as seen 
during major depression, attribute hyperactivity of  the HPA axis to defective negative feed-
back action of  glucocorticoids (Dinan 1994). As a result, maladaptive feedback can have 
many adverse consequences including cognitive dysfunction and mood alterations, immu-
nodeficiency, cardiovascular disorders and energy metabolism disorders (Dallman et al. 
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1987, De Kloet et al. 1998). It is however not clear how the feedback mechanism interacts 
with ultradian glucocorticoid rhythmicity.
The data presented in this thesis shows that glucocorticoid negative feedback inhibition 
brought about by corticosterone infusion, here in the context of  stress, depends on the pat-
tern, phase- and amplitude of  corticosterone pulses (chapter 6). Constant infusion of  corti-
costerone resulted in a clear suppression of  ACTH responsiveness and has been described 
in literature before (Akana et al. 1992). Interestingly, pulsatile exposure of  corticosterone 
resulted in a larger, more flexible response in ACTH responsivity to noise stress. This sen-
sitising effect of  pulsatility was even more pronounced during the rising phase of  an ultra-
dian pulse than during the falling phase. In addition, animals infused with higher amplitude 
pulses showed smaller increments in stress-induced ACTH release. These data thus clearly 
show that the neuroendocrine response to stress depends on circulating glucocorticoids in 
both a phase and amplitude dependent manner. This is in line with previous studies that 
retrospectively correlated higher corticosterone responses to a stressor with the rising phase 
of  an endogenous pulse and lower mean corticosterone responses with increased pulse 
frequency (Windle et al. 1998b, Windle et al. 2001, Atkinson et al. 2006). However, we 
originally hypothesised that negative feedback of  glucocorticoids should be greatest when 
corticosterone levels are rapidly rising within physiological concentrations in a process ter-
med rate sensitive feedback (Dallman & Yates 1969, Kaneko & Hiroshige 1978). Although 
this apparent rate-sensitivity was not specifically addressed here, we found no evidence for 
this phenomenon. Comparisons between studies are complicated by the difference in dura-
tion of  corticosterone exposure. In our study measurements were made after several pulses 
rather than the single infusions performed previously. The underlying explanation therefore 
most likely hinges on differential activation of  genomic and non-genomic effects of  corti-
costeroids and will be discussed later in this chapter.
 Conclusion 
It has recently been demonstrated that rapidly oscillating feedforward and feedback loops 
between the pituitary and adrenal gland give rise to ultradian corticosterone rhythms (Wal-
ker et al. 2010). Therefore, ultradian pulses may represent rapidly alternating phases of  HPA 
axis activation and inhibition (Windle et al. 1998b, Lightman et al. 2008). In that respect, 
we suggest and clearly demonstrate differential HPA axis responsiveness over the ultradian 
cycle as the relation of  the onset of  a stressor to the phase or amplitude of  ultradian pulses 
is a major determinant in acute HPA axis responsiveness. Continuous exposure to glucocor-
ticoids attenuates stress-induced ACTH release. Therefore, we propose that transient surges 
in glucocorticoid level as achieved during the pulses serve to prepare and maintain flexibility 








7.5 Behavioural responsiveness to stress
While alterations in the basal pulse frequency and amplitude are known to be a major fac-
tor influencing neurendocrine reactivity to acute stressors (Windle et al. 1998a, Windle et 
al. 2001, Atkinson et al. 2006), very little data is available on the behavioural response to 
stress. The results presented in chapter 5 demonstrate persistent changes in behavioural 
responsiveness after a history of  flattened corticosterone rhythms, even after normalisation 
of  basal HPA axis activity. Similar results in humans describe highly prevalent emotional 
and cognitive effects in patients with long-term cured Cushing’s disease compared to mat-
ched controls (Tiemensma et al. 2010). These and our results suggest that changes in the 
history of  HPA axis pulsatility of  the individual has consequences for behaviour, emotion 
and cognition and may thus indicate possible irreversible effects of  prolonged previous 
glucocorticoid excess on the brain. Future research should determine how persistent the 
consequences of  a period of  chronic glucocorticoid exposure are.
Besides the corticosteroid history of  an animal (chapter 5), behavioural stress responsive-
ness also seems to depend acutely on the phase of  ultradian pulses (chapter 6). In line with 
the previously described increased neuroendocrine response, we found that total activity 
and risk assessment were highest when the noise stressor was experienced during the rising 
phase of  corticosterone infusion. Behavioural responsiveness has been correlated to ultradi-
an corticosterone pulses before. In a model in which animals were divided post-hoc, others 
observed that the propensity to behave aggressively was increased during the rising phase of  
an ultradian pulse (Haller et al. 2000a). These data strongly suggest that brain centers such 
as the amygdala, normally activated and modulated by emotionally arousing experiences 
(McGaugh 2004, Roozendaal et al. 2009), may respond differently depending on the rapid 
fluctuations in corticosterone and thereby ‘pulse-dependently’ modulate the emotional and 
exploratory response to stress.
Though mostly examined under conditions of  chronic exposure, glucocorticoids are indeed 
known to modulate, in different time domains, limbic regions such as the hippocampus and 
amygdala (Herman et al. 2003, Jankord & Herman 2008). This may influence learning and 
memory processes in both rodents and humans (Schwabe et al. 2008, Schwabe et al. 2009), 
most likely due to changes in the neuroarchitecture and plasticity (Bodnoff  et al. 1995, 
Fuchs et al. 2006, Joels et al. 2007). Such changes may pertain to (m)any neurotransmitter 
system(s) and substantial changes in information processing after chronic corticosterone 
and stress (Fuchs et al. 2006, Joels et al. 2007). But we have also shown that genomic re-
sponses of  particularly GR in the brain are sensitive to changes in hormone patterns and, in 
fact, remain significantly affected after removal of  chronic corticosterone exposure (chapter 
4). In addition, there is strong evidence for non-genomic (behavioural) actions of  glucocor-
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ticoids (Sandi et al. 1996, Mikics et al. 2004, Schwabe et al. 2009) via putative low affinity 
membrane-associated MR and GR (Di et al. 2003, Karst et al. 2005). Thus, an explanation 
for the variations in behavioural response to stress may involve non-genomic and genomic 
effects on multiple targets, including responsiveness of  MR and GR themselves. 
 Conclusion 
Our results suggest that the history as well as the actual phase of  HPA axis pulsatility of  
the individual somehow are a determinant factor in the behavioural response to stress. We 
thus postulate that both the neuroendocrine and behavioural response to stress vary over 
the ultradian cycle as every hourly surge in corticosterone seem to open a window of  enhan-
ced susceptibility to stress. Understanding the significance of  this hourly enhanced stressor 
susceptibility opens up interesting new perspectives for the role of  ultradian rhythmicity 
in physiology and behaviour. Whether the reduced stress reactivity during a descending 
ultradian phase is in fact advantageous or detrimental is still open for investigation and may 
depend on the particular circumstances.
 
7.6 Differential activation of neuronal pathways 
It is currently unclear to what extent central structures are sensitive to ultradian glucocor-
ticoid regulation. The audiogenic stressor we used typically results in a wide pattern of  
brain activation (Campeau & Watson 1997, Burow et al. 2005). This includes many auditory 
structures but also specific brain circuits involved in the stress response to noise such as 
the PVN, amygdala, prefrontal cortex. We used c-fos immediate early gene expression as a 
marker for activation of  neuronal pathways involved in the stress response in the context 
of  ultradian pulses and is extensively discussed in chapter 6. As described previously in 
literature but also in our hands, the hippocampus does not seem to be responsive to audio-
genic stimulation (Campeau & Watson 1997, Burow et al. 2005). Hence, this specific type 
of  stressor may not be appropriate for analysis of  the influence of  the pattern, magnitude 
or phase of  corticosterone pulses specifically in this area. On the other hand, we also clearly 
show that noise stress-induced c-fos expression in other brain circuits (i.e. PVN, pituitary 
and amygdala) are responsive to the magnitude and/or phase of  ultradian pulses.
 
 Conclusion 
Glucocorticoid target tissues and the receptors located there are exposed to rapidly fluc-
tuating levels of  steroid hormone (Cook 2001, Droste et al. 2008). This, together with the 
impact of  changes in ultradian pulse characteristics on behavioural stress responsiveness 








also demonstrate that neuronal pathways induced by noise stress respond selectively to 
different aspects of  the ultradian cycle. A plausible explanation hinging on region-specific 
pulsatile effects of  glucocorticoids most likely includes the local cellular receptor mecha-
nism due to differential presence of  MR and GR and (nuclear) cofactors in the different 
brain regions. 
 
7.7 Possible mechanisms underlying glucocorticoid pulsatility
The  present studies, together with recent literature on corticosteroid receptor action pro-
vides a framework for mechanistic understanding of  the physiological effects of  ultradian 
glucocorticoid pulses. MR and GR are involved themselves in the dynamic generation and 
maintenance of  basal ultradian HPA axis activity (Spiga et al. 2007, Atkinson et al. 2008). 
As a consequence of  rapidly changing ligand concentrations and differences in affinity, MR 
and GR may be differentialy recruited along the duration of  a single ultradian pulse. The 
results described in this thesis suggest that MR and GR expression and function also seem 
to depend on the pattern and concentration of  corticosterone administration and are dif-
ferentially regulated in different brain areas (chapter 3, 4 and 6). 
Both receptors are also involved in stress-induced HPA axis activity by mediating in comple-
mentary fashion the feedforward and feedback modes of  glucocorticoid feedback operation 
(Ratka et al. 1989, Bradbury et al. 1994, van Haarst et al. 1996, Hinz & Hirschelmann 2000, 
Russell et al. 2010). The time domain of  some parameters measured in the current thesis 
(i.e. ACTH release and behavioural stress responsiveness in chapter 6) suggests a role for ra-
pid non-genomic, rather than slow genomic actions of  glucocorticoids, via putative low affi-
nity membrane-bound variants of  MR and GR (Orchinik et al. 1991, Hinz & Hirschelmann 
2000, Di et al. 2003, Karst et al. 2005). The non-genomic MR in limbic structures enhances 
the presynaptic glutamate release probability and reduces postsynaptic hyperpolarisation via 
the ERK1/2 pathway and K+-conductance with the net result to enhance excitatory trans-
mission (Karst et al. 2005, Olijslagers et al. 2008). On the other hand, non-genomic GR re-
duces net neuronal excitatory transmission via endocannabinoids and nitric oxide (Di et al. 
2003, Di et al. 2009). It is currently believed that the initial rise in corticosterone (e.g. during 
stress or the onset of  an ultradian pulse) triggers non-genomic actions via the membrane-
bound receptors which over time activate the slower, genomic GR. This has evolved into 
a new concept of  corticosteroid action in the brain in which fast MR-triggered excitability 
via the membrane receptor interplay with the slow MR and GR-mediated genomic events 
(Joels et al. 2008a).  
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In relation to our ACTH data (chapter 6), a ‘brake’ during the falling phase is suggested by 
decreased ACTH release, i.e. development of  a classical genomic feedback signal during 
rising phase that becomes apparent within 20 minutes and is predicted to maintain recipro-
city until the next pulse. Alternatively increased ‘drive’ during the rising phase could result in 
stimulation of  ACTH release or behaviour through activation of  a rapid feedforward signal. 
The latter would likely depend on non-genomic mechanisms. Similar mechanisms may also 
underlie the translation of  ultradian corticosterone oscillations into adequate behavioural 
responses but also more fundamental processes such as synaptic transmission and neuronal 
excitability. The apparent pure ‘ascending phase’-dependent effect on c-fos expression in 
the amygdala in particular seems to call for an explanation involving a rapid, non-genomic 
component.
 Conclusion 
It seems that the mechanism underlying responsiveness to ultradian glucocorticoid pulsati-
lity involves a balance between rapid non-genomic and slower genomic effects via membra-
ne-bound and nuclear variants of  MR and GR that rapidly change over the duration of  a 
single ultradian pulse. This may differ depending on the area of  the brain resulting in chan-
ging states of  responsiveness to environmental input. The current model system in which 
we impose hourly ultradian pulses provides a unique position to address such mechanistic 
issues in future studies.
 
7.8 Perspectives
 Clinical relevance 
Until now, the clinical relevance of  the pulsatile nature of  glucocorticoids was poorly under-
stood or sometimes even regarded as not important. As described in this thesis, disturban-
ces in glucocorticoid pulsatile patterns and aberrant HPA axis functioning are well recog-
nised signs in patients suffering from stress-related disorders. Deviations from the optimal 
pulsatile pattern are considered to precipitate disease as daily variations in glucocorticoid 
hormone concentrations are thought to be fundamental for the maintenance of  physiolo-
gical, metabolic, cognitive and behavioural well being (Dallman et al. 2003, de Kloet et al. 
2005, Herbert et al. 2006). Newly acquired insights in glucocorticoid hormone pulsatility 
could therefore be of  great importance for the elucidation of  the aetiology and pathophy-
siology of  stress-related disorders (Young et al. 2004, Lightman et al. 2008). In addition, this 
will also result in more insight into the consequences of  long term glucocorticoid excess or 








Knowledge of  pulsatility also has important implications for the therapeutic application of  
glucocorticoids. Transient release patterns of  other hormones are considered crucial for 
physiology and well being (Belchetz et al. 1978, Thompson et al. 2003, Rothman & Wier-
man 2007), as manipulation of  the temporal aspect is already a successfully used approach 
in clinical therapy for instance for growth hormones (Amato et al. 2000) and estrogen-
replacement therapy in post-menopausal women (Shoupe 2001). However, in relation to 
glucocorticoids, no such administration protocols have been designed yet. Better understan-
ding of  pulsatile glucocorticoid release and the underlying nuclear receptor mechanism may 
therefore greatly contribute to the prognosis and treatment of  disease. 
 Future directions
It is currently not known if  disorganisation of  rapid fluctuations in glucocorticoid levels are 
causally linked to the aetiology of  stress-related disease or vice versa. Unravelling the me-
chanisms that underlie the secretory pattern of  corticosterone release, but also under condi-
tions of  stress, is thus essential. The generation of  MR and GR specific transgenic knockout 
models but also the development of  infusion systems that allow to control ultradian pulses, 
now provides a unique position to address such mechanistic issues in future studies. Many 
scenarios come to mind and a few are outlined in some detail below.
As extensively discussed is the previous paragraphs, we suggest that the different compo-
nents of  ultradian pulses (i.e phase and amplitude) have different effects on stress-activated 
circuitry. It is thus very likely that distinctly different mechanisms are operating simply due 
to the difference in the duration of  glucocorticoid exposure. In that respect, the balance 
between rapid non-genomic and slower genomic effects via membrane-bound and nuclear 
variants of  MR and GR could rapidly change over the duration of  a single ultradian pulse. 
Moreover, the recruitment of  MR and/or GR during stress, superimposed on the ultradian 
and circadian pattern, would also depend on the phase of  the pulse. One approach would 
be to use either pharmacological or genetic knock-out models to systematically study the 
role of  MR and GR in basal and stress-induced HPA axis activity and behavioural activity 
as a function of  these different pulse characteristics to unravel the underlying mechanism. 
A complicating factor is that genetic models tend to be based on mice, while the rapid sam-
pling/infusion system that we used exists only for rats (and humans). Besides an endocrine 
and/or behavioural context, it would also be very interesting to study at a more fundamental 
level the involvement of  (membrane) MR and GR in rapid modulation of  synaptic trans-
mission and neuron excitability by ultradian corticosterone rhythms. 
Measurement of  HPA axis secretagogues (i.e. AVP and CRH) may also be an appropriate 
approach to understand acute effects of  ultradian glucocorticoid pulses. The primary action 
of  AVP within the axis is the potentiation of  CRH action on the pituitary (Gillies et al. 1982, 
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Rivier & Vale 1983). Thus increased release of  AVP may sensitise corticotrophs to the pul-
satile CRH signals reaching them. Besides potentiating the magnitude of  each ACTH burst, 
pulsatile administration of  AVP to corticotrophs also causes a more rapid rise in ACTH 
release during each CRH pulse (Evans et al. 1988). The measurement of  these peptides may 
therefore provide more insight in supra-pituitary integration of  glucocorticoid pulsatility. 
Furthermore, it has recently been demonstrated that the circadian rhythm in glucocorticoids 
is partly attributed to rhythmic steroidogenesis in the adrenal gland (Son et al. 2008), which 
could gate adrenal sensitivity to ACTH (Oster et al. 2006). It is however not known to what 
extent ultradian corticosterone secretion is explained by these observations and how ultra-
dian ACTH release relates to changes in adrenal responsiveness.
The endocannabinoid system works as an important neuromodulatory system by negative 
modulation of  basal and stress-induced HPA axis activity (Cota et al. 2007). Endocannabi-
noids are suggested to modulate CRH, ACTH and glucocorticoid levels and fast negative 
feedback via rapid non-genomic effects of  glucocorticoids (Manzanares et al. 1999). Gluco-
corticoids induce retrograde signalling of  endocannabinoids from CRH-containing neurons 
and thereby inhibit excitatory transmission via activation of  presynaptic CB1 receptors in 
the PVN (Di et al. 2003). How endocannabinoids are exactly involved in ultradian glucocor-
ticoid pulsatility and negative feedback is not known but it has been proposed that ultradian 
oscillations are generated by inhibitory ultra-short cycles in negative feedback inhibition 
within the hypothalamus (Windle et al. 1998b, Lightman et al. 2008), but also between the 
pituitary and adrenal gland (Walker et al. 2010). Endocannabinoids could underlie such a 
self-sustaining mechanism in ultradian fluctuations as the rapid rise in corticosterone le-
vels during every secretory phase (but also during stress) could potentially generate a fast 
feedback signal. Consequently this may result in inhibition of  corticosterone secretion and 
thus cyclic levels of  glucocorticoids. In addition, endocannabinoids are known to be under 
negative glucocorticoid regulation in the hippocampus and striatum (Di et al. 2003, Hill et 
al. 2005b) but in fact increase activity in the limbic forebrain after glucocorticoid exposure 
which may contribute to the region-specific effects of  glucocorticoids (Hill et al. 2005a).
Finally, ultradian glucocorticoid pulses induce consecutive waves in GR signalling and trans-
criptional initiation of  target genes in cultured cells (Stavreva et al. 2009). However, just 
a few studies have addressed the consequences of  ultradian corticosterone exposure for 
nuclear receptor signalling in the brain  [(Conway-Campbell et al. 2007) and chapter 4]. In 
that respect large scale gene expression profiling studies of  for instance the hippocampal 
transcriptome or analysis of  single target genes, would be very valuable in understanding the 
significance of  ultradian hormone fluctuations for MR and GR signalling in the brain. Also, 
the consequences for protein levels have not been thoroughly examined. Furthermore, as 
new technologies are rapidly developing, whole genome-wide receptor binding studies toge-








petitive cycling between MR and GR together with the transcription and proteasome machi-
nery on the chromatin of  glucocorticoid response elements according to rapidly changing 
hormone levels which eventually determine transcriptional output. 
 
7.9 General conclusions
The results presented in the current thesis have evolved in a new concept in glucocorticoid 
endocrinology. Even though the link between the different markers used here is uncertain, 
glucocorticoid signalling as well as behavioural and neuroendocrine responsiveness to stres-
sors are all rapidly and transiently modulated by ultradian corticosterone pulses. We thus 
provide strong evidence for functional consequences of  ultradian glucocorticoid pulsatility. 
Moreover, we have revealed that in particular the GR is affected when glucocorticoid pul-
satility is disrupted and could thus provide an excellent target for therapy to normalise the 
downstream effects of  disturbances in glucocorticoid rhythms in stress-related disease. It 
also provides a handle to tackle long term problems seen after withdrawal of  high glucocor-
ticoid exposure, for instance such as seen postoperatively in ‘cured’ Cushing’s disease. The 
newly acquired insights are thus of  great importance for the understanding of  glucocor-
ticoid biology but also for the elucidation of  the pathophysiology and aetiology of  stress-
related disorders. As continuous administration of  glucocorticoids attenuates many of  the 
investigated parameters, we conclude that the significance of  glucocorticoid pulsatility lies 
in ‘priming’ the HPA axis and different brain circuits through rapidly alternating feedfor-
ward and feedback modes providing full responsiveness and ‘resilience’ in the coordination 






    
       
152
Summary
The HPA axis is one of  the major neuroendocrine axes of  the body as it controls a plethora 
of  functions in the brain and periphery via its end secretory product, the glucocorticoids 
cortisol and corticosterone. In mammals including humans, glucocorticoids are characteris-
tically released in approximately hourly hormone bursts by the adrenal gland. These rapid 
ultradian hormone pulses increase in amplitude, and to a lesser extent in frequency, in anti-
cipation of  the active phase providing a circadian pattern of  hormone release. Interestingly, 
pulse amplitude, frequency and phase all seem to be major determinants in the acute res-
ponse of  the HPA axis. It is however not clear how rapid ultradian oscillations contribute 
to physiology such as target tissue responsiveness of  brain and the response to stress. The 
objective of  this thesis is therefore to assess the role of  glucocorticoid pulsatile patterns in 
brain glucocorticoid signalling and the neuroendocrine and behavioural response to stress. 
Chapter 2 describes the screening of  a panel of  GR primary antibodies in order to find 
the most suitable antibody to study GR nuclear translocation as a potential marker for tis-
sue responsiveness using immunohistochemistry and confocal imaging. Hereto, ADX rats 
and cultured AtT20 cells were stimulated with a high dose of  glucocorticoids. Interestingly, 
while some antibodies (i.e. BuGR2, H300) were consistent between the two conditions, 
we found opposing results in GR nuclear translocation patterns for some GR primary an-
tibodies (i.e. M20, P20) between cultured cells and rat CA1 cells. The latter findings were 
confirmed in another hippocampal cell population, granule dentate gyrus cells. We therefore 
concluded that findings from cell culture studies cannot always be extrapolated to in vivo 
situations and that the outcome of  antibody-dependent studies can depend heavily on the 
choice of  the antibody. The H300 GR primary antibody consistently demonstrated nuclear 
translocation patterns in both cultured cells and in brain sections and was therefore chosen 
to continue further studies.
In chapter 3 we further characterised receptor nuclear translocation in the rat hippocampus 
as a potential marker for glucocorticoid signalling. Hereto, both intact and ADX rats were 
injected with a high dose of  corticosterone mimicking the stress response. Subcellular dis-
tribution patterns of  MR and GR at different time points after injection were measured in 
single cells in the different hippocampal subfields using the same methodology as chapter 2. 
We found significant subregion-specific differences in translocation patterns for both MR 
and GR, with respect to the extent and timing of  nuclear translocation. Moreover, specific 
differences between ADX and intact animals that are most prominent in the dentate gyrus. 
We conclude that in response to a single stress-like increase in corticosterone distinct regi-








The effects of  long-term disturbances in endogenous corticosterone pulsatile patterns on 
molecular markers for target tissue sensitivity to an additional glucocorticoid challenge mi-
micking the stress response are described in chapter 4. Diurnal and ultradian corticosterone 
fluctuations were clamped at constant levels in intact animals by exogenous administration 
of  corticosterone by means of  subcutaneous corticosterone pellet implantation. Addition-
ally, recovery from constant exposure was studied in groups that had the pellet removed 24 
hours prior to the challenge. Molecular markers for receptor responsiveness to this acute 
challenge were examined in the rat hippocampal area. The constant exposure to the steroid 
resulted in dose-dependent down-regulation of  GR and attenuated MR and GR transloca-
tion to the acute challenge. Interestingly, while glucocorticoid responsive expression of  Gilz 
to the challenge was already attenuated during stable daily average levels (40%), resistance 
of  Sgk-1 gene expression to the challenge was only observed after constant high cortico-
sterone exposure (100%). Washout of  100% cort recovered all molecular markers (partial) 
while removal of  the 40% cort pellet still attenuated responsiveness to the challenge. This 
finding suggests differential responsiveness of  the two genes due to treatment. Using these 
molecular markers we conclude that tissue responsiveness to glucocorticoids is maintained 
by pulsatile rather than constant exposure to the hormone. 
In chapter 5 flattening of  ultradian and circadian glucocorticoid pulsatility via subcuta-
neous pellet implantation was verified and validated by high frequency automated blood 
sampling with 10 min intervals. Corticosterone rhythms were effectively flattened around 
daily average (40%) or at levels seen during stress-related disease (100% cort). Removal of  
the corticosterone pellet resulted in rapid recovery of  ultradian pulsatility in the 40% group 
but not in the 100% group, most likely due to a local depot formation in the skin. However, 
we found a dissociation between neuroendocrine and behavioural responsiveness to noise 
stress. Animals previously exposed to 40% corticosterone showed less and shorter behavi-
oural activity to noise stress compared to 100% corticosterone and vehicle treated animals 
while their endocrine response was similar to vehicle animals. This data suggest that even 
though HPA axis activity adjusts in a reversible fashion to alterations in the characteristic 
pulsatile pattern of  corticosterone, this happens in spite of  longer lasting changes in the 
brain affecting stress responsiveness. 
Chapter 6 describes the neuroendocrine and behavioural response to stress in relation 
to ultradian corticosterone pulses. We have addressed this question by infusing identical 
amounts of  corticosterone but in constant or hourly pulsatile patterns in ADX rats. We also 
varied the pulse amplitude without altering total administered dose by adjusting both the 
concentration and duration of  infused corticosterone. At the end of  infusion – and either 
during the rising or falling phase of  our exogenous pulse – animals were exposed to 10 
minutes of  99 dB noise stress. Constant administration of  corticosterone resulted in a blun-
ted ACTH response to stress, while pulsatile administration facilitated a brisker response 
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markedly greater in the rising than in the falling phase of  a corticosterone pulse. This diffe-
rential phase-dependent effect was also seen in the behavioural response to noise which was 
much greater in the rising phase. Interestingly, we found strong region-specific differences 
in c-fos neuronal expression patterns as a function of  either pulse amplitude or phase, in-
dicating that under stress different brain circuits are differentially affected by glucocorticoid 
pulsatility. We conclude that the current data provide strong evidence for pattern-dependent 
stress responsivity in which different brain circuits show differential sensitivity to the phase 
and amplitude of  pulsatile corticosterone exposure.
As discussed in chapter 7, a new concept in the endocrinology of  glucocorticoids has 
evolved from the data presented in this thesis showing that pulsatile release of  glucocorti-
coids is a major determinant in ‘resilience’ of  glucocorticoid signalling and stress responsi-
veness. Moreover, we have revealed that in particular the GR is affected when glucocorticoid 
pulsatility is disrupted and could thus provide a excellent target for therapy to normalise 
the downstream effects of  disturbances in glucocorticoid rhythms in stress-related disease. 







Stress, zowel fysiek als psychisch, zorgt voor snelle fysiologische veranderingen in het li-
chaam. Activering van het sympathische zenuwstelsel resulteert via adrenaline en noradre-
naline in o.a. een verhoogde hartfrequentie, bloeddruk en bloedtoevoer naar de spieren. Dit 
stelt een individu in staat om vrijwel direct en adequaat op de situatie te reageren. Daarnaast 
zorgt activering van de hypofyse-bijnier as [in het Engels: hypothalamic-pituitary-adrenal 
(HPA) axis] voor acute afgifte van de glucocorticoïd stresshormonen (cortisol bij de mens, 
corticosteron bij knaagdieren). Deze hormonen zijn essentieel in het vrijmaken van beschik-
bare energie voor de reactie op stress maar controleren ook een overvloed aan functies in de 
periferie en de hersenen zoals cognitie, emotie en perceptie. De acties van glucocorticoïden 
worden gemedieerd via twee receptoren, de mineralocorticoïd en de glucocorticoïd receptor 
(MR en GR), die samen HPA-as activiteit handhaven. MR wordt geacht tonische HPA-as 
activiteit en de drempel van het systeem te reguleren (‘pro-actieve’ modus), terwijl GR het 
herstel van stress te bevordert (‘reactieve’ modus). 
Het is recentelijk beschreven dat vrijwel alle hormonen in het lichaam, inclusief  de gluco-
corticoïden, worden afgegeven volgens een bepaald pulsatiel patroon. Dit is het ultradiane 
ritme en zorgt voor de uurlijkse afgifte van glucocorticoїden door de bijnier in alle zoogdie-
ren, waaronder de mens. Het circadiane ritme dat onder invloed van de biologische klok in 
de hersenen staat superponeerd hier dag/nacht fluctuaties op. Het circadiane en ultradiane 
ritme werken nauwgezet samen om zo intrinsieke ritmiciteit van de HPA-as te controleren 
vanwege de grote invloed op onder andere gezondheid, vitaliteit en het immuunsysteem. 
Het is op het moment bekend dat tijdens chronische stress of  ziekte de vatbaarheid voor 
stress-gerelateerde en autoimmuunziekten toeneemt. Bovendien zijn stoornissen in het ka-
rakteristieke pulsatiele patroon van glucocorticoïd afgifte vaak beschreven in stress-gerela-
teerde pathologie. Het is echter niet duidelijk hoe snelle ultradiane oscillaties in glucocor-
ticoid niveaus bijdragen aan fysiologie, stress responsiviteit en receptor signalering in het 
brein. Het doel van het beschreven onderzoek in dit proefschrift is daarom gericht op de rol 
van glucocorticoïd pulsatiele patronen op glucocorticoïd signalering in de hersenen, HPA-as 
activiteit en de neuroendocriene en gedragsrespons op stress.
Hoofdstuk 2 beschrijft een studie waarin wordt gezocht naar het meest geschikte antili-
chaam om het proces van GR nucleaire translocatie te visualiseren als mogelijke marker 
voor weefsel responsiviteit. Met behulp van immunohistochemische technieken en confo-
cale microscopie werd een panel van GR primaire antilichamen getest in zowel een cellijn 
als hersenweefsel. Om nucleaire translocatie van GR te induceren zijn bijnierloze ratten 







sommige antilichamen (bijv BuGR2 en H300) overeenstemmende resultaten vertonen tus-
sen de twee condities, we tegenstrijdige resultaten in translocatiepatronen tussen gekweekte 
cellen en rat hippocampale CA1 cellen met andere GR antilichamen vinden (bijv M20, P20). 
De laatste bevindingen werden ook bevestigd in granulaire dentate gyrus cellen, een andere 
hippocampale celpopulatie. Wij concluderen dat de bevindingen in cellijnen niet altijd kun-
nen worden geëxtrapoleerd naar de in vivo situatie en dat de uitkomst van antilichaamafhan-
kelijke onderzoeken sterk kan afhangen van de keuze van het antilichaam. Aangezien de GR 
H300 antilichaam consistent nucleaire translocatie patronen in zowel gekweekte cellen als in 
hersenen secties heeft aangetoond werd deze gekozen om verdere studies voort te zetten. 
In hoofdstuk 3 hebben we receptor nucleaire translocatie in de hippocampus van ratten als 
een mogelijke marker voor glucocorticoïd signalering verder gekarakteriseerd. Zowel intacte 
als bijnierloze ratten zijn geïnjecteerd met een hoge dosis corticosteron om de stressres-
pons na te bootsen. Vervolgens is met dezelfde methode als beschreven in hoofdstuk 2 de 
subcellulaire localisatie van MR en GR op verschillende tijdstippen na injectie gemeten in 
verschillende subgebieden van de hippocampus. We hebben significante subregio-specifieke 
verschillen in de translocatiepatronen voor zowel MR en GR gevonden met betrekking tot 
de omvang en de timing van de nucleaire translocatie. Bovendien waren de specifieke ver-
schillen tussen intacte en bijnierloze dieren het meest prominent in de gyrus dentatus. We 
concluderen dat in reactie op een met stress vergelijkbare stijging in corticosteron niveaus er 
regio-specifieke verschillen in MR en GR translocatie patronen bestaan in de hippocampus 
van ratten. 
De effecten van langdurige verstoringen in glucocorticoïd pulsatiele patronen op molecu-
laire markers voor weefselgevoeligheid worden beschreven in hoofdstuk 4. Exogene toe-
diening door middel van subcutane corticosteron pellet implantatie werd gebruikt om zowel 
circadiane als ultradiane corticosteron fluctuaties op een constant niveau in intacte dieren 
vast te ‘klemmen’. Om stressachtige weefselresponsen te induceren werden alle dieren na 
een week geïnjecteerd met een extra dosering glucocorticoïd. Eventueel herstel van con-
stante blootstelling werd onderzocht in groepen waarin 24 uur voorafgaand aan de extra 
injectie de corticosteron pellet was verwijderd. Vervolgens zijn verschillende moleculaire 
markers voor receptor functie onderzocht in de hippocampus van de rat. Constante bloot-
stelling aan de steroïden resulteerde in een dosis-afhankelijke vermindering van GR niveaus 
en resistentie in MR en GR translocatie na de acute injectie. Interessant is dat constante 
blootstelling aan dagelijks gemiddelde niveaus (40%) de glucocorticoïd-afhankelijke inductie 
van target gen Gilz al verminderde, terwijl de expressie van Sgk-1 alleen werd beïnvloed na 
blootstelling aan constante hoge corticosteron niveaus (100%). Deze bevinding suggereert 
gen-specifieke verschillen in glucocorticoid responsiviteit, afhankelijk van het patroon van 
corticosteron toediening. Het uitwassen van hoge concentraties resulteerde verder in vrijwel 
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volledige normalisatie van alle moleculaire markers, terwijl 24 uur na het verwijderen van 
de 40% cort pellet weefsel responsiviteit nog steeds aangedaan was. Met behulp van deze 
moleculaire markers concluderen we dat de flexibiliteit in weefselreactiviteit op glucocorti-
coïden wordt onderhouden door pulsatiele in plaats van voortdurende blootstelling aan het 
hormoon. 
In hoofdstuk 5 is met behulp van een geautomatiseerd bloedafnamesysteem met hoog fre-
quente intervallen (elke 10 minuten) het afplatten van ultradiane en circadiane glucocorticoïd 
pulsatiliteit via subcutane pellet implantatie gecontroleerd en gevalideerd. Uit de resultaten 
blijkt dat na beide manipulaties corticosteron ritmes inderdaad effectief  zijn afgeplat rond 
het dagelijks gemiddelde (40% cort) of  op een niveau vergelijkbaar met stress-gerelateerde 
ziekte (100% cort). Verwijdering van de corticosteron pellet resulteerde in een snel herstel 
van ultradiane pulsatiliteit in de 40% groep, maar niet in de 100% groep. Dit laatste is 
waarschijnlijk te wijten aan de formatie van een lokaal depot in de huid. Interessant genoeg 
vonden we een dissociatie tussen de neuroendocriene en gedragsreactie op geluidstress 24 
uur na verwijdering van de pellet. Dieren blootgesteld aan 40% corticosteron vertonen ver-
minderde en verkorte reactiviteit op geluidstress in vergelijking met 100% corticosteron en 
controle dieren, terwijl hun endocriene respons vergelijkbaar was met de controle dieren. 
Deze gegevens wijzen erop dat hoewel HPA- as activiteit flexibel omgaat met veranderingen 
in het karakteristieke pulsatiele patroon van corticosteron, dit gepaard gaat met langer du-
rende veranderingen in de hersenen die de gedragsmatige stress responsiviteit bepalen. 
Hoofdstuk 6 beschrijft de relatie tussen ultradiane corticosteron pulsen en de neuroen-
docriene en gedragsreactie op stress. Hiertoe zijn bijnierloze ratten geïnfuseerd met gelijke 
hoeveelheden corticosteron, maar in óf  constant, óf  uurlijkse pulsatiele patronen. Door 
aanpassing van zowel de concentratie en de duur van corticosteron-infusie hebben we ook 
gevarieerd in de amplitude van de puls, zonder de totale toegediende dosis te wijzigen. Aan 
het einde van de infusie - en zowel tijdens de stijgende of  dalende fase van een uurlijkse puls 
– werden de dieren blootgesteld aan 10 minuten 99 dB geluidstress. Constante toediening 
van corticosteron resulteerde in een afgeplatte ACTH respons op stress, terwijl pulsatiele 
administratie resulteerde in een aanzienlijk grotere respons die meer prominent was tijdens 
de stijgende dan in de dalende fase van een corticosteron puls. Dit fase-afhankelijke ef-
fect hebben we ook waargenomen in de gedragsreactie op geluidsstress. Verder hebben 
we sterke regio-specifieke verschillen in c-fos neuronale expressie patronen als functie van 
pulsamplitude of  fase gevonden, waaruit blijkt dat onder stress de hersenen verschillende 
circuits differentieel worden beïnvloed door glucocorticoïd pulsatiliteit. De huidige gege-
vens verstrekken sterk bewijs voor patroon-afhankelijke stress responsiviteit in de hersenen 
waarin verschillende circuits differentiële gevoeligheid tonen voor de fase en amplitude van 








Het functioneren van het stress systeem onder invloed van de pulsatiele afgifte van gluco-
corticoïd stress hormoon is nog niet eerder onderzocht. In de fysiologie staat hormoon 
pulsatiliteit centraal en kan een grote rol spelen bij ziekte. Kennis over het functioneren van 
dit systeem en begrip van de celprocessen in het brein kan dus van groot belang zijn voor 
het gericht ontwikkelen van nieuwe farmaca en therapieën voor het behandelen van stress-
gerelateerde ziekten zoals bijvoorbeeld depressie. Zoals uitvoerig besproken in hoofdstuk 
7 dragen de resultaten van dit proefschrift bij aan een nieuw concept in de neuroendocri-
nologie van glucocorticoïd stresshormonen. Pulsatiele blootstelling aan glucocorticoïden 
blijkt een belangrijke factor in de ‘veerkracht’ van glucocorticoïd signalering en stress re-
activiteit. Verder hebben we aangetoond dat met name de GR wordt beïnvloed wanneer 
glucocorticoïd pulsatiliteit is verstoord. Dit eiwit zou dus uitstekend als doelwit kunnen 
functioneren voor therapie en normalisatie van de downstream effecten van stoornissen in 
glucocorticoïd pulsatiele patronen in stress-gerelateerde ziekten. Mogelijke mechanismen en 
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